VAERS Reports 037 A22B

VAERS 2684612

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

kritisch

Staat: -
Alter: 80,0
Geschlecht: F
Eingang: 21.09.2023
Impfdatum: 27.06.2022
Beginn: 14.08.2023
Tage bis Beginn: 413,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute respiratory failure Anticoagulant therapy Asthenia Blood creatinine Blood sodium decreased Clostridium difficile colitis Clostridium difficile infection Computerised tomogram thorax abnormal Condition aggravated Cough COVID-19 Chest X-ray abnormal Chronic kidney disease Chronic obstructive pulmonary disease Chronic respiratory failure Decreased appetite Diarrhoea Diverticulitis

Symptomtext

Patient is a 81 y.o. female patient of MD with history of recent diagnosis respiratory failure (requiring supplemental oxygen), recent C. difficile infection, COPD, PAF, hypertension presented to hospital with fevers, myalgias. Recent admission to hospital 8/8/23 - 8/11/23 for acute resp failure due to pneumonia COPD and pulmonary HTN. Was discharged home on doxycycline. Hospital course was complicated by acute diverticulitis and C diff colitis(found on day of discharge) Covid-19 Virus Infection Date of onset of symptoms: Unsure since patient has had 3 prior hospitalizations in the last month for respiratory issues and pneumonia (approximately beginning of July 2023). Symptoms Symptoms present on admission: Fevers, malaise, cough Date of covid positive test: 08/14/23 (COVID tests on 07/28/23 and 08/08/23 negative) Vaccination status: vaccinated Imaging: CXR: possible airspace disease in left lung base. CT chest 08/08/23 showed small left-sided pleural effusion/infiltrate. Oxygen requirements on admission: 2 L nasal cannula, which patient has been using intermittently for the last month. Current oxygen requirements: requiring 1 L n/c, especially with ambulation Consultants following: Infectious disease Medical therapy: completed doxycycline(from previous admission), was given 1 dose of IV steroids in ED. Paxlovid contraindicated with Xarelto. Per ID given remdesivir x 3 days(completed 8/17) Anticipated special isolation end date: 08/19/23 Chronic respiratory failure Has been requiring supplemental oxygen (2 L nasal cannula) intermittently with exertion for the last couple of weeks. In setting of recent hospitalizations for COPD exacerbations and pneumonia as well as history of pulmonary hypertension and untreated OSA. Requiring 2 L nasal cannula on admission. Evaluated by pulmonology team during last hospitalization. Breathing treatments as needed. Home oxygen evaluation completed- 1 L with rest and 2 L with ambulation C. difficile infection Watery stool for the last 4 days. Diagnosed with C. difficile infection on 08/11/23. Continue oral vancomycin, complete 7 more days on discharge, pt has medication at home from prior hospitalization Diarrhea slowly improving PAF Rate controlled. Resume xarelto. Not on rate controller medications. Allergies noted to metoprolol and diltiazem COPD No gross signs of acute exacerbation. On Trelegy at home, transitioned to Spiriva and Dulera here Breathing treatments as needed.CKD Creatinine is 0.98; GFR 60 (baseline GFR in the 50s). Monitor renal function closely. Hypertension Normotensive on admission. Now SBP running 140-160s Restarted home Losartan. Added Hydralazine 25 mg TID, however HRs in 100s, will discontinue Allergies noted to metoprolol and diltiazem Started norvasc 5 mg daily, resume on discharge Hyponatremia Sodium 130(8/16), likely due to decreased appetite and diarrhoea Trending down, 128(8/18) LR 500 cc bolus ordered, encouraged oral salt intake Started LR 75 cc/hr x 10 hours Na improved to 131 today Generalized weakness Poor appetite Started 8/14. Feels weak PT/OT- no therapy needs

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 5,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2664184

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

kritisch

Staat: -
Alter: 30,0
Geschlecht: M
Eingang: 01.08.2023
Impfdatum: 29.05.2022
Beginn: 11.01.2023
Tage bis Beginn: 227,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Pulmonary embolism

Symptomtext

ACUTE PULMONARY EMBOLISM

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2630597

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

kritisch

Staat: -
Alter: 65,0
Geschlecht: F
Eingang: 11.05.2023
Impfdatum: 07.06.2022
Beginn: 25.08.2022
Tage bis Beginn: 79,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute myocardial infarction

Symptomtext

ACUTE ST ELEVATION MI, INFEROLATERAL WALL.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute myocardial infarction
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2623232

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

kritisch

Staat: -
Alter: 56,0
Geschlecht: M
Eingang: 28.04.2023
Impfdatum: 12.06.2022
Beginn: 27.10.2022
Tage bis Beginn: 137,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute myocardial infarction

Symptomtext

PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE ACUTE NON ST ELEVATION MI

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute myocardial infarction
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2594345

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

kritisch

Staat: WA
Alter: 84,0
Geschlecht: M
Eingang: 09.03.2023
Impfdatum: 06.06.2022
Beginn: 03.03.2023
Tage bis Beginn: 270,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute respiratory failure COVID-19 COVID-19 pneumonia Pneumonia SARS-CoV-2 test positive

Symptomtext

Patient received Moderna COVID vaccine on 3/27/21, 4/23/21, 11/13/21, and 6/6/22. On 3/3/23, patient admitted to our inpatient facility (med/surg unit) with acute respiratory failure with hypoxia, community acquired and COVID-19 pneumonia. Patient discharged home on 3/7/23.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 4,0
Labordaten: COVID status positive 3/3/23.
Aktuelle Erkrankungen: -
Vorgeschichte: medical history of coronary artery disease, CVA, peripheral vascular disease, hypercholesterolemia, hypertension, type 2 diabetes, obstructive sleep apnea, essential thrombocytosis, trigeminal neuralgia, diastolic congestive heart failure, osteoarthritis, and morbid obesity
Andere Medikamente: amlodipine, aspirin, atorvastatin, azelastine nasal sp, vitamin d3, vitamin b12, furosemide, hydroxyurea, ipratropium nasal sp, losartan, metformin, myrbetriq, omeprazole, oxcarbazepine, triamcinolone top
Allergien: cetirizine, carbamazepine, iodine, lisinopril, omeprazole
Vorherige Impfungen: -

VAERS 2573178

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

kritisch

Staat: -
Alter: 74,0
Geschlecht: F
Eingang: 01.02.2023
Impfdatum: 26.07.2022
Beginn: 07.01.2023
Tage bis Beginn: 165,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute respiratory failure Angiogram pulmonary abnormal Arteriosclerosis Arteriosclerosis coronary artery Brain natriuretic peptide increased Bronchial wall thickening COVID-19 Cardiomegaly Diastolic dysfunction Dyspnoea Echocardiogram abnormal Ejection fraction Emphysema Lymphadenopathy Malaise Mesenteric arteriosclerosis Productive cough Respiration abnormal

Symptomtext

Patient is a 74 y.o. female patient of PRIVATE, MD with history of hypertension, hyperlipidemia, COPD, brain aneurysm, cervical cancer, degenerative disc disease with lumbar radicular pain presented to Doctors Hospital with worsening shortness of breath. Acute respiratory failure with hypoxia Covid-19 Virus Infection Date of onset of symptoms: 1/4/2023- 3 days prior to admission Symptoms present on admission: Shortness of breath cough yellow phlegm production malaise Date of covid positive test: 1/7/2023 Vaccination status: vaccinated Imaging: CTPA?No evidence for acute pulmonary embolism. Mild bilateral perihilar airway wall thickening reflect sequela of infectious or inflammatory bronchiolitis. No focal lobar lung consolidation. Multiple mildly prominent bilateral hilar lymph nodes measuring up to 1 cm thick at the right hilum, likely reactive or inflammatory etiology. Cardiomegaly with extensive left and right coronary artery calcifications. Extensive bilateral upper lobe centrilobular emphysema. Moderate bilateral peripheral upper and lower lung interstitial lung disease. Heavy atherosclerotic calcifications at the celiac and superior mesenteric arteries origin Oxygen requirements on admission: 4 L Current oxygen requirements: RA however desats down to 74% on rest after 2 passes to door 1/11. Takes some time to recover back to 85-91%. Will give another day to finish 5 day remdesivir course. On 2L NC 1/12, no significant desats with ambulation Medical therapy: Decadron and remdesivir started 1/8/2023- last remdesivir dose 1/12 Consultants following: None Anticipated special isolation end date: 1/14/2023 Continue to wean O2 as able Hypertension Restart home doses of lisinopril Monitor closely and give as needed labetalol as needed for systolic blood pressure more than 180 or diastolic more than 110 SBP controlled COPD Not in acute exacerbation Continue Advair, albuterol Remote history of using oxygen?patient has not use oxygen at home for the last 8 years, previously with API with CPAP? Elevated BNP In setting of cardiomegaly, increased calcification in coronary arteries noted on CTPA Follow-up 2D echo-EF 60-65% with grade 2 diastolic dysfunction and elevated LV filling pressures with no significant valvulopathy, no pericardial effusions no evidence of pulmonary hypertension. There is a prominent fat pad. Hyperlipidemia Continue home doses of statin Depression Continue home doses of citalopram Qtc check 1/9 well under 500 in low 400s. Ok to continue at current dose Patient seen and examined in full PPE on day of discharge. Breathing continues to improve. On 2 L nasal cannula. She did walk with me in the room 2 passes from the bed to the door and back only dropped briefly to 89 but quickly recovered. SBP was more consistently in the high 80s?low 90s. O2 evaluation was completed qualified for 2 L nasal cannula. Case management was consulted to help get this set up

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 5,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2566873

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

kritisch

Staat: KY
Alter: 95,0
Geschlecht: M
Eingang: 24.01.2023
Impfdatum: 21.06.2022
Beginn: 14.07.2022
Tage bis Beginn: 23,0
Dosis: 1
Route/Site: IM / RA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

COVID-19 Death SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

Patient had a breakthrough infection and passed away.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: CKD COPD Dementia HTN
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2521876

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

kritisch

Staat: MI
Alter: 49,0
Geschlecht: M
Eingang: 02.12.2022
Impfdatum: 23.05.2022
Beginn: 23.11.2022
Tage bis Beginn: 184,0
Dosis: 4
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Acute respiratory failure Anticoagulant therapy Aspiration Axillary vein thrombosis Bipolar disorder Cerebral infarction Cerebrovascular accident Electroencephalogram Encephalopathy Endotracheal intubation COVID-19 CSF glucose increased CSF protein increased CSF red blood cell count positive CSF white blood cell count General physical health deterioration Generalised tonic-clonic seizure Hyperkalaemia

Symptomtext

COVID+ 11/23/2022. Vaccination status - moderna x4 BRIEF OVERVIEW: Discharge Provider: MD Primary Care Provider at Discharge: None Physician, DO None Admission Date: 11/23/2022 Discharge Date: 11/30/2022 Active Hospital Problems Diagnosis Date Noted POA ? Acute and chronic respiratory failure (acute-on-chronic) 11/23/2022 Unknown ? Stenotrophomonas and E. coli Pneumonia 11/23/2022 Yes ? Obesity hypoventilation syndrome 11/23/2022 Yes ? Acute/Subacute Left Parietal Infarct 11/23/2022 Yes ? Seizure disorder 11/23/2022 Yes ? Bipolar affective disorder 11/23/2022 Yes ? Acute possibly toxic, metabolic, or infectious encephalopathy 11/23/2022 Yes DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Acute and chronic respiratory failure (acute-on-chronic) [J96.20] HOSPITAL COURSE: Patient is a 50 year old male resident with medical history of oxygen dependent COPD, chronic hypoxemic and hypercapnic respiratory failure, OHS, OSA non-compliant with Bipap, bipolar disorder, schizoaffective disorder, seizure disorder, GERD, tricuspid regurg initially presented to hospital 9/17/22 for respiratory distress. His course was complicated by E.coli pneumonia (treated with ceftriaxone 7 day course), aspiration event resulting in acute respiratory distress requiring intubation and mechanical ventilation on 9/19, MRSA pneumonia (linezolid x10 days) and seizures. He had similar prior hospitalizations for pneumonia and COPD exacerbations requiring trach placement. Tracheostomy was placed 10/3. Discharged to Select LTACH 10/12/22 for continued ventilator weaning. He was weaning from vent on t-piece - tolerating well and was advanced to and oral diet. Approximately 11/13 he started to decline with decrease in LOS, shock requiring vasopressors and back on the ventilator. He had been febrile and encephalopathic during this time. 11/15 he was noted to have grand mal seizure by staff and was given 8mg Ativan. EEG placed but did not reveal seizure activity. 11/22 he became unresponsive. MRI brain 11/22 with acute to early subacute left parietal infarction, chronic right frontal infarction, chronic ischemic demyelination, acute on chronic paranasal sinusitis, lesion within the left ethmoid sinus (could be mucocele), marked abnormal tissue in the left mastoid sinus. Sputum culture from 11/20 grew E.coli and Stenotrophomonas. 11/23 he is arousable to voice but remained encephalopathic, so decision was made to admit to ICU. Given concern for meningitis he was started on ampicillin, vancomycin, cefepime, and acyclovir, as well as Bactrim for the E.coli/Stenotrophomonas PNA with ID following closely. ENT consulted for ethmoid sinus lesion and felt this was a mucocele and could be followed up in 1-2 months. Neurology following for stroke and meningitis. Psychiatry also consulted for polypharmacy in setting of bipolar/schizoaffective and recommending keeping clozapine as is for now. Tested positive for COVID on 11/23, started on Decadron. Concern for seizure activity early 11/24, requiring propofol gtt and norepinephrine, but no seizure noted on EEG. RUE subclavian, axillary, brachial vein DVT 11/25, started heparin gtt. LP 11/25 with protein 165, glu 91, 1 WBC, 220 RBC. MRI of brain 11/25 was negative for acute ischemia and showed no convincing evidence suggestive of meningitis. Course complicated by hyperkalemia - possibly related to heparin and treated with Lokelma. Improving responsiveness, alert and following simple commands as of 11/26. Hemodynamically stable, awaiting discharge to LTAC D/C to Hospital LTAC 11/30/22

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 7,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Bipolar affective disorder Acute and chronic respiratory failure (acute-on-chronic) Stenotrophomonas and E. coli Pneumonia Obesity hypoventilation syndrome Acute/Subacute Left Parietal Infarct Seizure disorder
Andere Medikamente: lacosamide (Vimpat) 200 mg tablet tablet Indications: Seizure disorder Take 1 tablet (200 mg total) by mouth 2 (two) times a day. cloBAZam (ONFI) 10 mg tablet Indications: Seizure disorder Take 1 tablet (10 mg total) by mouth 1 (one)
Allergien: ClonazepamOther Fluphenazine Haloperidol MolindoneOther Risperidone
Vorherige Impfungen: -

VAERS 2500473

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

kritisch

Staat: MI
Alter: 78,0
Geschlecht: M
Eingang: 07.11.2022
Impfdatum: 07.10.2022
Beginn: 04.11.2022
Tage bis Beginn: 28,0
Dosis: 3
Route/Site: SYR / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Acute respiratory failure Anticoagulant therapy Asthenia Blood creatinine Blood urea Brain natriuretic peptide COVID-19 Chills Computerised tomogram thorax abnormal Condition aggravated Cough Dehydration Depression Dyspnoea Dyspnoea exertional Fatigue Fibrin D dimer increased Hypophagia

Symptomtext

Chief Complaint: Cough and shortness of breath Additional Medical History: Patient is a 78-year-old male with a history of coronary artery disease, asthma, COPD, arthritis and depression. He presented to the emergency room by EMS complaining of worsening cough and shortness of breath over the last 3 days. Patient states 3 days ago he developed a cough which has progressively become worse. He states the cough is productive at times of yellowish colored sputum. He feels short of breath especially with seen when he is coughing or moving around. He denies fever or chills or sick contacts with similar symptoms. The shortness of breath became significant just prior to arrival at which point he called EMS. EMS arrived on the scene to find the patient hypoxic at 85% on room air. He was transported to the hospital. On 2 L nasal cannula he is oxygenating at 93 to 95%. He is otherwise alert and appropriate. He is in mild distress on presentation. He denies any chest discomfort or swelling of his lower extremities. He quit smoking 25 years ago. Associated Symptoms: cough, depression, fatigue, palpitations, shortness of breath, sputum, weakness, wheezing

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 4,0
Labordaten: 2:40 PM patient did respond nicely to oxygen through the nasal cannula at 2 L/min. He will have a full work-up for pneumonia including cardiac enzymes, BNP and D-dimer. He will have blood cultures, lactic acid and COVID testing. Patient will have a nebulizer treatment and steroid given here in the emergency room while we await further testing. 3:11 PM patient is positive for COVID. He also has an elevated D-dimer over 900. Patient will have routine CTA of the chest for further evaluation to rule out a pulmonary embolism. He will require admission for further care and treatment. He continues to rest comfortably at this time and oxygenating well on nasal cannula. 4:59 PM CT of the chest shows multifocal pneumonia with a right lower lobe consolidation. No evidence of pulmonary embolism. The case was discussed with Dr. who accepted the admission for further care and treatment. Problem 1: Acute respiratory failure due to COVID-19 Plan 1: The patient presented with a 3-4 days history of upper respiratory symptoms including productive cough shortness of breath shaking chills. Patient was found to have COVID 19. The patient is vaccinated and booster which make his risk of deterioration less severe. He responded nicely to oxygen continue with the steroids oxygen breathing treatment. Problem 2: Bilateral pneumonia Plan 2: Superimposed on COVID-19. The CT scan clearly showed bilateral scattered focal consolidation consistent with bacterial pneumonia. Patient does have leukocytosis and tachycardia consistent with sepsis. The patient received the fluids antibiotics steroids awaiting culture and sensitivity to adjust oral antibiotics. Problem 3: Dehydration, moderate Plan 3: Patient had decreased p.o. intake and he has a bump in his BUN and creatinine. He received bolus in the emergency room I will continue with the fluid resuscitation. His tachycardia already improved. Problem 4: DVT prophylaxis
Aktuelle Erkrankungen: unknown
Vorgeschichte: CAD Asthma arthritis COPD arrhythmia
Andere Medikamente: Not Currently Taking Home Medications.
Allergien: No Known Allergies
Vorherige Impfungen: -

VAERS 2482157

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

kritisch

Staat: WA
Alter: 79,0
Geschlecht: F
Eingang: 18.10.2022
Impfdatum: 31.05.2022
Beginn: 12.10.2022
Tage bis Beginn: 134,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute respiratory failure COVID-19 COVID-19 pneumonia Encephalopathy Intensive care SARS-CoV-2 test positive Sepsis

Symptomtext

Patient received Pfizer COVID vaccine on 1/21/21 (lot # EL1284), 2/11/21 (lot # EN6201), 11/4/21 (lot # FH8020), and Moderna COVID vaccine on 5/21/22 (lot # 037A22B). Patient resides at a long-term care facility for advanced dementia and was on hospice. On 10/22/22, patient admitted to CCU with high flow nasal cannula for acute hypoxemic respiratory failure due to COVID-19, severe sepsis 2/2 Pneumonia due to COVID-19 virus, and acute encephalopathy. Patient was transferred out from CCU to med/surg unit on 10/13/22. Patient was discharged back to long-term care facility on 10/17/22.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 5,0
Labordaten: COVID status positive 10/13/22.
Aktuelle Erkrankungen: -
Vorgeschichte: history of advanced (Alzheimer's versus Parkinson's) dementia on hospice at long-term care facility, wheelchair-bound and nonverbal at baseline), and questionable seizure disorder not on antiepileptics
Andere Medikamente: acetaminophen, aspirin, bisacodyl, vitamin d3, divalproex, gabapentin, haloperidol, hyoscyamine, loperamide, lorazepam, morphine, ondansetron, polyethylene glycol, psyllium, sennosides, ziprasidone
Allergien: shellfish
Vorherige Impfungen: -

VAERS 2467469

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

kritisch

Staat: OH
Alter: 82,0
Geschlecht: M
Eingang: 03.10.2022
Impfdatum: 24.05.2022
Beginn: 06.09.2022
Tage bis Beginn: 105,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acute respiratory failure Angiogram pulmonary abnormal Aspiration Asthenia COVID-19 Clostridium difficile colitis Clostridium difficile infection Delirium Disorientation Dysphagia Dyspnoea Fall Haemoglobin decreased Hypophagia Lung infiltration Malnutrition Normocytic anaemia Oesophageal disorder

Symptomtext

Clinical Summary Patient is a 82 y.o. male patient with history of bladder cancer, HTN, HLD, CKD II, TIA. Presents with shortness of breath and weakness. COVID positive, s/p 10d isolation. S/p remdesivir, CAP coverage, and steroid treatment. Weaned to RA from initial 5L requirement. Course complicated by recurrent c.diff infection, treating with vancomycin taper per ID. Palliative followed, patient qualifies for hospice and is s/p hospice informational visit this admission. Patient opts to pursue SNF. Discharged to facility. Problem List Acute Hypoxic Respiratory Failure, resolved Covid-19 Virus Infection, improved Secondary to COVID-19 viral infection with superimposed bacterial CAP, possible underlying pulmonary fibrosis Covid test (+) 9/6/22, isolation ended 9/13/22 Fully vaccinated 5L O2 via NC -- > SORA S/p Remdesivir, Decadron, Rocephin, Zithromax IS, pulm toilet, Duo-nebs Q6H PRN Per Pulm: outpatient PFTs, repeat CT to follow up pulm infiltrates Discharged to SNF Recurrent C.difficile Colitis Initial infection 6/3/22 without confirmed treatment Again positive on 7/13/22 and s/p 14d PO vancomycin This admission, C. dif positive on 9/13/22 ID consulted: NAP-B1 PCR (+). Ongoing Vancomycin Taper. Goals of Care Patient and family met with Palliative Care this admission Patient does qualify for Hospice (pulm disease, dementia) Current goals of care: FULL code and SNF placment Discharged SNF placement Severe malnutrition, POA Generalized weakness In the setting of bladder cancer 105 lb weight loss since 1/2021 Boost supplementation TID, regular diet Nutrition followed Dementia Delerium Waxing and waning orientation to place, situation Likely delirium on underlying dementia SLUMS score 10, FAST stage 7B; ambulation is lost Recurrent Falls Prior admissions for presyncopal, syncopal events Likely due to poor PO intake at home PT following; AMPAC 13 SNF placement Dysphagia Suspected Chronic Aspiration CTPA demonstrates debris within distal esophagus Speech Pathology consulted: ground solids, thin liquids, small bites Chronic Normocytic Anemia History of GIB Multifactorial: iron deficiency, anemia of chronic disease Admission Hgb 9.6, near b/l 10-11 in setting of IVF Daily CBC stable, no evidence of GIB this admit Elevated troponin without evidence of cardiac ischemia Chronically elevated, flat on admission In setting of AKI, hypovolemia Asymptomatic, EKG without ischemia Okay to discontinue telemetry Hyponatremia, resolved Likely secondary to poor PO intake Na nadir 127, Na 135 wnl 9/19 BMP MWF Bladder Cancer Oncologist: S/p transurethral resection Cystoscopy 05/22 negative 2 years of pembrolizumab (Keytruda) per Oncology Hypertension Hyperlipidemia Continue home atorvastatin Home lisinopril continued Mediastinal and right hilar adenopathy Grossly stable from previous CTs, including June 2022 Suspected due to immunotherapy Recent PET scan - no significant uptake Oncology considering referral to pulmonology if pt continues to have progressive cough and respiratory symptoms Recommend outpatient follow-up and monitoring

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 17,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2422905

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

kritisch

Staat: OH
Alter: 57,0
Geschlecht: F
Eingang: 29.08.2022
Impfdatum: 27.05.2022
Beginn: 12.07.2022
Tage bis Beginn: 46,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja

Angiogram pulmonary abnormal Anticoagulant therapy Laboratory test Pain in extremity Peripheral swelling Pulmonary embolism SARS-CoV-2 test negative Scan with contrast abnormal Thrombosis Ultrasound Doppler abnormal

Symptomtext

RIght leg pain started 7/12, swelling noted 7/15. ED visit 7/17 with hospitalization overnight for anticoagulation. Dx of large clot in right leg veins, small bilateral PEs.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: 2,0
Labordaten: Vasc lab Venous Duplex Ultrasound for DVT (7/17) Right leg Acute DVT - Femoral vein throughout, popliteal vein, posterior tibial vein, peroneal vein and gastrocnemius vein CT Angio Chest with Contrast (7/17) Acute occlusive pulmonary embolic disease bilaterally, worse on left Coronavirus 2019 by PCR (7/17) Negative
Aktuelle Erkrankungen: None
Vorgeschichte: Hx. Leiden Factor V mutation
Andere Medikamente: Synthroid 150 mcg/day Vitamin D 50 mcg/day
Allergien: Benzoyl Peroxide
Vorherige Impfungen: -

VAERS 2364312

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

kritisch

Staat: MA
Alter: 82,0
Geschlecht: F
Eingang: 15.07.2022
Impfdatum: 25.05.2022
Beginn: 25.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: SYR / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Arthralgia Death Pain in extremity Platelet count decreased Body tinea Interchange of vaccine products Malaise Osteoarthritis Pruritus Rash Sciatica

Symptomtext

Somewhere between 20JUN2022 and 04JUL2022, the patient passed away; tinea corpus; osteoarthritis/Knee pain,hip/hip pain bilaterally/back pain; sciatica; rash; itch; Interchange of vaccine products; reported she had not been feeling well/had not been feeling well since she had received the Moderna vaccine; severe leg pain; This spontaneous case was reported by a patient family member or friend and describes the occurrence of DEATH (Somewhere between 20JUN2022 and 04JUL2022, the patient passed away) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A22B) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below. Patient had never diagnosed with COVID positive test or diagnosis. and No other vaccines were given to the patient within 1 month prior to Moderna COVID-19 vaccine. The patient's past medical history included Thyroid cancer (Started on 2019 or 2020 (Unsure of exact date) and Cancer in remission) in February 2022. Previously administered products included for Product used for unknown indication: PFIZER BIONTECH COVID-19 VACCINE (Dose 1, Lot number: EM9809) on 13-Feb-2021, Pfizer (Dose 2, Lot number: EN6206) on 06-Mar-2021, Pfizer (Dose 1st booster, Lot number: FJ1620) on 18-Nov-2021, Simvastatin (elevated LFTs) and Cholestyramine (Cholestyramine (tight throat and abdomen)). Past adverse reactions to the above products included LFTs raised with Simvastatin; No adverse event with PFIZER BIONTECH COVID-19 VACCINE, Pfizer and Pfizer; and Throat tightness with Cholestyramine. Concurrent medical conditions included Drug allergy (Allergy to Cholestyramine, Simvastatin and Timolol), Penicillin allergy (Penicillin (vaginal infection)), Type 2 diabetes mellitus (Started 15 years ago), Blood pressure high (Started 20 years ago or so (Unsure of exact date) and currently in Stable condition), Obesity (Started 40 years ago (Unsure of exact date) and improved, with weight loss of about 17-18 lbs in 3 months from FEB2022 to MAY2022) and Glaucoma (Eye drops possibly for glaucoma). Concomitant products included DORZOLAMIDE for Glaucoma, AMLODIPINE, ACETYLSALICYLIC ACID (ASPIRINE), CLOTRIMAZOLE, COD LIVER OIL [COD-LIVER OIL], FLUOCINONIDE, MENTHOL, ZINC OXIDE (GOLD BOND), HYDROCHLOROTHIAZIDE, INSULIN LISPRO, INSULIN, KETOCONAZOLE, INSULIN GLARGINE (LANTUS), LATANOPROST, LEVOTHYROXINE, LEVOTHYROXINE SODIUM (SYNTHROID), LISINOPRIL, METFORMIN, CALCIUM, MAGNESIUM, ZINC, CALCIUM CARBONATE (TUMS [CALCIUM CARBONATE]) and CYANOCOBALAMIN (VIT B12) for an unknown indication. On 25-May-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-May-2022, the patient experienced MALAISE (reported she had not been feeling well/had not been feeling well since she had received the Moderna vaccine) and PAIN IN EXTREMITY (severe leg pain). On an unknown date, the patient experienced DEATH (Somewhere between 20JUN2022 and 04JUL2022, the patient passed away) (seriousness criteria death and medically significant), BODY TINEA (tinea corpus), OSTEOARTHRITIS (osteoarthritis/Knee pain,hip/hip pain bilaterally/back pain), SCIATICA (sciatica), RASH (rash), PRURITUS (itch) and INTERCHANGE OF VACCINE PRODUCTS (Interchange of vaccine products). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Rash and Itch, at an unspecified dose and frequency; LIDOCAINE (LIDODERM) at an unspecified dose and frequency; DICLOFENAC (topical) at an unspecified dose and frequency and PARACETAMOL (TYLENOL) for Pain, at a dose of UNK, prn. The patient died on an unknown date. The cause of death was not reported. An autopsy was performed, but no results were provided. At the time of death, BODY TINEA (tinea corpus), OSTEOARTHRITIS (osteoarthritis/Knee pain,hip/hip pain bilaterally/back pain), SCIATICA (sciatica), RASH (rash), PRURITUS (itch), MALAISE (reported she had not been feeling well/had not been feeling well since she had received the Moderna vaccine), PAIN IN EXTREMITY (severe leg pain) and INTERCHANGE OF VACCINE PRODUCTS (Interchange of vaccine products) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered PAIN IN EXTREMITY (severe leg pain) to be related. No further causality assessments were provided for DEATH (Somewhere between 20JUN2022 and 04JUL2022, the patient passed away), BODY TINEA (tinea corpus), OSTEOARTHRITIS (osteoarthritis/Knee pain,hip/hip pain bilaterally/back pain), SCIATICA (sciatica), RASH (rash), PRURITUS (itch), MALAISE (reported she had not been feeling well/had not been feeling well since she had received the Moderna vaccine) and INTERCHANGE OF VACCINE PRODUCTS (Interchange of vaccine products). Patient height was reported as 5/4.5 Patient concomitant medications included Multivitamins with Iron and Neocin and Allergy tablet as needed. Patient had severe leg pain on the evening after receiving the vaccine. The pain had continued, and she had not been feeling well up until 13-Jun-2022. Patient then visited urgent care on 20-Jun-2022 to get a diagnosis and treatment for the leg pain she was experiencing. The urgent care report stated the patient's diagnoses as hip pain bilaterally, tinea corpus, hip, knee, back pain, osteoarthritis, and sciatica. Urgent care also prescribed medicine for rash and itch for the patient. However, caller was not aware of this complaint. Somewhere between 20-Jun-2022 and 04-Jul-2022, the patient passed away. Her deceased body was found on 04-Jul-2022 at her residence after a wellness check was performed. The exact date of death of patient is unknown. The medical examiner stated that the patient had passed away at least several days before being discovered. Toxicology was performed and however, the result will not be available for 90 days. The medical examiner has also stated that the patient's body had decayed enough, that if a clot was the suspect in the death, it would not be identified due to the decomposition of the body. Patient had not been feeling well since she had received the Moderna vaccine. The reporter thought that patient's leg pain could have been since she was running errands on 25-May-2022. She states that this could be a potential severe, rare side effect of the vaccine and finds it necessary to report it. Company Comment This spontaneous case concerns an 82-year-old female patient, with concurrent medical conditions of Type 2 diabetes mellitus, Blood pressure high, Obesity and past medical history of Thyroid cancer (Started on 2019 or 2020 and Cancer in remission in February 2022), who experienced the serious Fatal unexpected event of Death (Somewhere between 20JUN2022 and 04JUL2022, the patient passed away) and other non-serious events which occurred approximately after 25 days of fourth dose of mRNA-1273 vaccine in the covid-19 vaccination series. An autopsy was performed and the result and further details were not provided. Patient had severe leg pain on the evening after receiving the vaccine. The pain continued for 20 days later consulted and diagnosed as hip pain bilaterally, tinea corpus, hip, knee, back pain, osteoarthritis, and sciatica with medicine for rash and itch. Somewhere between 20-Jun-2022 and 04-Jul-2022, the patient passed away and identified by wellness check. The medical examiner has stated that the patient's body had decayed enough, that if a clot was the suspect in the death, it would not be identified due to the decomposition of the body. It was also noted that patient received 3 doses with PFIZER BIONTECH COVID-19 VACCINE prior to current vaccination (interchange of vaccine products). Patient's Concurrent medical conditions of Type 2 diabetes mellitus, Blood pressure high, Obesity and elderly age could be the risk factors and Thyroid cancer (Started on 2019 or 2020 and Cancer in remission in February 2022) could be contributing factors for the event death. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.; Sender's Comments: This spontaneous case concerns an 82-year-old female patient, with concurrent medical conditions of Type 2 diabetes mellitus, Blood pressure high, Obesity and past medical history of Thyroid cancer (Started on 2019 or 2020 and Cancer in remission in February 2022), who experienced the serious Fatal unexpected event of Death (Somewhere between 20JUN2022 and 04JUL2022, the patient passed away) and other non-serious events which occurred approximately after 25 days of fourth dose of mRNA-1273 vaccine in the covid-19 vaccination series. An autopsy was performed and the result and further details were not provided. Patient had severe leg pain on the evening after receiving the vaccine. The pain continued for 20 days later consulted and diagnosed as hip pain bilaterally, tinea corpus, hip, knee, back pain, osteoarthritis, and sciatica with medicine for rash and itch. Somewhere between 20-Jun-2022 and 04-Jul-2022, the patient passed away and identified by wellness check.The medical examiner has stated that the patient's body had decayed enough, that if a clot was the suspect in the death, it would not be identified due to the decomposition of the body. It was also noted that patient received 3 doses with PFIZER BIONTECH COVID-19 VACCINE prior to current vaccination (interchange of vaccine products). Patient's Concurrent medical conditions of Type 2 diabetes mellitus, Blood pressure high, Obesity and elderly age could be the risk factors and Thyroid cancer (Started on 2019 or 2020 and Cancer in remission in February 2022) could be contributing factors for the event death. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.; Reported Cause(s) of Death: Somewhere between 20JUN2022 and 04JUL2022, the patient passed away

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Blood pressure high (Started 20 years ago or so (Unsure of exact date) and currently in Stable condition); Drug allergy (Allergy to Cholestyramine, Simvastatin and Timolol); Glaucoma (Eye drops possibly for glaucoma); Obesity (Started 40 years ago (Unsure of exact date) and improved, with weight loss of about 17-18 lbs in 3 months from FEB2022 to MAY2022); Penicillin allergy (Penicillin (vaginal infection)); Type 2 diabetes mellitus (Started 15 years ago)
Vorgeschichte: Medical History/Concurrent Conditions: Thyroid cancer (Started on 2019 or 2020 (Unsure of exact date) and Cancer in remission); Comments: Patient had never diagnosed with COVID positive test or diagnosis. and No other vaccines were given to the patient within 1 month prior to Moderna COVID-19 vaccine.
Andere Medikamente: AMLODIPINE; ASPIRINE; CLOTRIMAZOLE; COD LIVER OIL [COD-LIVER OIL]; DORZOLAMIDE; FLUOCINONIDE; GOLD BOND; HYDROCHLOROTHIAZIDE; INSULIN LISPRO; INSULIN; KETOCONAZOLE; LANTUS; LATANOPROST; LEVOTHYROXINE; SYNTHROID; LISINOPRIL; METFORMIN; CALCI
Allergien: -
Vorherige Impfungen: -

VAERS 2364312

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

kritisch

Staat: MA
Alter: 82,0
Geschlecht: F
Eingang: 15.07.2022
Impfdatum: 25.05.2022
Beginn: 25.05.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Arthralgia Death Pain in extremity Platelet count decreased Body tinea Interchange of vaccine products Malaise Osteoarthritis Pruritus Rash Sciatica

Symptomtext

Somewhere between 20JUN2022 and 04JUL2022, the patient passed away; tinea corpus; osteoarthritis/Knee pain,hip/hip pain bilaterally/back pain; sciatica; rash; itch; Interchange of vaccine products; reported she had not been feeling well/had not been feeling well since she had received the Moderna vaccine; severe leg pain; This spontaneous case was reported by a patient family member or friend and describes the occurrence of DEATH (Somewhere between 20JUN2022 and 04JUL2022, the patient passed away) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A22B) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below. Patient had never diagnosed with COVID positive test or diagnosis. and No other vaccines were given to the patient within 1 month prior to Moderna COVID-19 vaccine. The patient's past medical history included Thyroid cancer (Started on 2019 or 2020 (Unsure of exact date) and Cancer in remission) in February 2022. Previously administered products included for Product used for unknown indication: PFIZER BIONTECH COVID-19 VACCINE (Dose 1, Lot number: EM9809) on 13-Feb-2021, Pfizer (Dose 2, Lot number: EN6206) on 06-Mar-2021, Pfizer (Dose 1st booster, Lot number: FJ1620) on 18-Nov-2021, Simvastatin (elevated LFTs) and Cholestyramine (Cholestyramine (tight throat and abdomen)). Past adverse reactions to the above products included LFTs raised with Simvastatin; No adverse event with PFIZER BIONTECH COVID-19 VACCINE, Pfizer and Pfizer; and Throat tightness with Cholestyramine. Concurrent medical conditions included Drug allergy (Allergy to Cholestyramine, Simvastatin and Timolol), Penicillin allergy (Penicillin (vaginal infection)), Type 2 diabetes mellitus (Started 15 years ago), Blood pressure high (Started 20 years ago or so (Unsure of exact date) and currently in Stable condition), Obesity (Started 40 years ago (Unsure of exact date) and improved, with weight loss of about 17-18 lbs in 3 months from FEB2022 to MAY2022) and Glaucoma (Eye drops possibly for glaucoma). Concomitant products included DORZOLAMIDE for Glaucoma, AMLODIPINE, ACETYLSALICYLIC ACID (ASPIRINE), CLOTRIMAZOLE, COD LIVER OIL [COD-LIVER OIL], FLUOCINONIDE, MENTHOL, ZINC OXIDE (GOLD BOND), HYDROCHLOROTHIAZIDE, INSULIN LISPRO, INSULIN, KETOCONAZOLE, INSULIN GLARGINE (LANTUS), LATANOPROST, LEVOTHYROXINE, LEVOTHYROXINE SODIUM (SYNTHROID), LISINOPRIL, METFORMIN, CALCIUM, MAGNESIUM, ZINC, CALCIUM CARBONATE (TUMS [CALCIUM CARBONATE]) and CYANOCOBALAMIN (VIT B12) for an unknown indication. On 25-May-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-May-2022, the patient experienced MALAISE (reported she had not been feeling well/had not been feeling well since she had received the Moderna vaccine) and PAIN IN EXTREMITY (severe leg pain). On an unknown date, the patient experienced DEATH (Somewhere between 20JUN2022 and 04JUL2022, the patient passed away) (seriousness criteria death and medically significant), BODY TINEA (tinea corpus), OSTEOARTHRITIS (osteoarthritis/Knee pain,hip/hip pain bilaterally/back pain), SCIATICA (sciatica), RASH (rash), PRURITUS (itch) and INTERCHANGE OF VACCINE PRODUCTS (Interchange of vaccine products). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Rash and Itch, at an unspecified dose and frequency; LIDOCAINE (LIDODERM) at an unspecified dose and frequency; DICLOFENAC (topical) at an unspecified dose and frequency and PARACETAMOL (TYLENOL) for Pain, at a dose of UNK, prn. The patient died on an unknown date. The cause of death was not reported. An autopsy was performed, but no results were provided. At the time of death, BODY TINEA (tinea corpus), OSTEOARTHRITIS (osteoarthritis/Knee pain,hip/hip pain bilaterally/back pain), SCIATICA (sciatica), RASH (rash), PRURITUS (itch), MALAISE (reported she had not been feeling well/had not been feeling well since she had received the Moderna vaccine), PAIN IN EXTREMITY (severe leg pain) and INTERCHANGE OF VACCINE PRODUCTS (Interchange of vaccine products) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered PAIN IN EXTREMITY (severe leg pain) to be related. No further causality assessments were provided for DEATH (Somewhere between 20JUN2022 and 04JUL2022, the patient passed away), BODY TINEA (tinea corpus), OSTEOARTHRITIS (osteoarthritis/Knee pain,hip/hip pain bilaterally/back pain), SCIATICA (sciatica), RASH (rash), PRURITUS (itch), MALAISE (reported she had not been feeling well/had not been feeling well since she had received the Moderna vaccine) and INTERCHANGE OF VACCINE PRODUCTS (Interchange of vaccine products). Patient height was reported as 5/4.5 Patient concomitant medications included Multivitamins with Iron and Neocin and Allergy tablet as needed. Patient had severe leg pain on the evening after receiving the vaccine. The pain had continued, and she had not been feeling well up until 13-Jun-2022. Patient then visited urgent care on 20-Jun-2022 to get a diagnosis and treatment for the leg pain she was experiencing. The urgent care report stated the patient's diagnoses as hip pain bilaterally, tinea corpus, hip, knee, back pain, osteoarthritis, and sciatica. Urgent care also prescribed medicine for rash and itch for the patient. However, caller was not aware of this complaint. Somewhere between 20-Jun-2022 and 04-Jul-2022, the patient passed away. Her deceased body was found on 04-Jul-2022 at her residence after a wellness check was performed. The exact date of death of patient is unknown. The medical examiner stated that the patient had passed away at least several days before being discovered. Toxicology was performed and however, the result will not be available for 90 days. The medical examiner has also stated that the patient's body had decayed enough, that if a clot was the suspect in the death, it would not be identified due to the decomposition of the body. Patient had not been feeling well since she had received the Moderna vaccine. The reporter thought that patient's leg pain could have been since she was running errands on 25-May-2022. She states that this could be a potential severe, rare side effect of the vaccine and finds it necessary to report it. Company Comment This spontaneous case concerns an 82-year-old female patient, with concurrent medical conditions of Type 2 diabetes mellitus, Blood pressure high, Obesity and past medical history of Thyroid cancer (Started on 2019 or 2020 and Cancer in remission in February 2022), who experienced the serious Fatal unexpected event of Death (Somewhere between 20JUN2022 and 04JUL2022, the patient passed away) and other non-serious events which occurred approximately after 25 days of fourth dose of mRNA-1273 vaccine in the covid-19 vaccination series. An autopsy was performed and the result and further details were not provided. Patient had severe leg pain on the evening after receiving the vaccine. The pain continued for 20 days later consulted and diagnosed as hip pain bilaterally, tinea corpus, hip, knee, back pain, osteoarthritis, and sciatica with medicine for rash and itch. Somewhere between 20-Jun-2022 and 04-Jul-2022, the patient passed away and identified by wellness check. The medical examiner has stated that the patient's body had decayed enough, that if a clot was the suspect in the death, it would not be identified due to the decomposition of the body. It was also noted that patient received 3 doses with PFIZER BIONTECH COVID-19 VACCINE prior to current vaccination (interchange of vaccine products). Patient's Concurrent medical conditions of Type 2 diabetes mellitus, Blood pressure high, Obesity and elderly age could be the risk factors and Thyroid cancer (Started on 2019 or 2020 and Cancer in remission in February 2022) could be contributing factors for the event death. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.; Sender's Comments: This spontaneous case concerns an 82-year-old female patient, with concurrent medical conditions of Type 2 diabetes mellitus, Blood pressure high, Obesity and past medical history of Thyroid cancer (Started on 2019 or 2020 and Cancer in remission in February 2022), who experienced the serious Fatal unexpected event of Death (Somewhere between 20JUN2022 and 04JUL2022, the patient passed away) and other non-serious events which occurred approximately after 25 days of fourth dose of mRNA-1273 vaccine in the covid-19 vaccination series. An autopsy was performed and the result and further details were not provided. Patient had severe leg pain on the evening after receiving the vaccine. The pain continued for 20 days later consulted and diagnosed as hip pain bilaterally, tinea corpus, hip, knee, back pain, osteoarthritis, and sciatica with medicine for rash and itch. Somewhere between 20-Jun-2022 and 04-Jul-2022, the patient passed away and identified by wellness check.The medical examiner has stated that the patient's body had decayed enough, that if a clot was the suspect in the death, it would not be identified due to the decomposition of the body. It was also noted that patient received 3 doses with PFIZER BIONTECH COVID-19 VACCINE prior to current vaccination (interchange of vaccine products). Patient's Concurrent medical conditions of Type 2 diabetes mellitus, Blood pressure high, Obesity and elderly age could be the risk factors and Thyroid cancer (Started on 2019 or 2020 and Cancer in remission in February 2022) could be contributing factors for the event death. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.; Reported Cause(s) of Death: Somewhere between 20JUN2022 and 04JUL2022, the patient passed away

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Blood pressure high (Started 20 years ago or so (Unsure of exact date) and currently in Stable condition); Drug allergy (Allergy to Cholestyramine, Simvastatin and Timolol); Glaucoma (Eye drops possibly for glaucoma); Obesity (Started 40 years ago (Unsure of exact date) and improved, with weight loss of about 17-18 lbs in 3 months from FEB2022 to MAY2022); Penicillin allergy (Penicillin (vaginal infection)); Type 2 diabetes mellitus (Started 15 years ago)
Vorgeschichte: Medical History/Concurrent Conditions: Thyroid cancer (Started on 2019 or 2020 (Unsure of exact date) and Cancer in remission); Comments: Patient had never diagnosed with COVID positive test or diagnosis. and No other vaccines were given to the patient within 1 month prior to Moderna COVID-19 vaccine.
Andere Medikamente: AMLODIPINE; ASPIRINE; CLOTRIMAZOLE; COD LIVER OIL [COD-LIVER OIL]; DORZOLAMIDE; FLUOCINONIDE; GOLD BOND; HYDROCHLOROTHIAZIDE; INSULIN LISPRO; INSULIN; KETOCONAZOLE; LANTUS; LATANOPROST; LEVOTHYROXINE; SYNTHROID; LISINOPRIL; METFORMIN; CALCI
Allergien: -
Vorherige Impfungen: -

VAERS 2341849

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

kritisch

Staat: LA
Alter: 95,0
Geschlecht: M
Eingang: 29.06.2022
Impfdatum: 15.06.2022
Beginn: 16.06.2022
Tage bis Beginn: 1,0
Dosis: 4
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death Increased upper airway secretion Respiratory rate increased

Symptomtext

THE FOLLOWING ARE NURSES NOTES. 6/9/22 - RESIDENT ADMITTED TO HOSPICE CARE. 6/15/21 APPROX 8AM - PRN OXYCODONE GIVEN FOR MOANING/GRIMACING. 6/15/22 11:15AM - SECOND MODERNA BOOSTER GIVEN. 6/15/22 APPROX 1PM - PRN MEDS (OXYCODONE, ATIVAN & LEVSIN) GIVEN FOR INCREASED SECRETIONS AND RAPID RESPIRATIONS. 6/16/22 APPROX 6AM - VITALS: BP 81/63, P 111, SPO2 82% ON RA, T 97.7. 6/16/22 1:47 - TIME OF DEATH.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: NONE
Aktuelle Erkrankungen: ALZHEIMERS DEMENTIA MAJOR DEPRESSIVE D/O DYSPHAGIA GLAUCOMA INSOMNIA HTN MACULAR DEGENERATION BPH OPEN WOUND DELIRIUM CONSTIPATION
Vorgeschichte: SEE ABOVE
Andere Medikamente: NORVASC PROSCAR LATANOPROST DIFLUCAN FLOMAX NYSTATIN SYSTANE TYLENOL LEVSIN BENADRYL BACTROBAN ATIVAN HALDOL NORCO OXYCODONE LASIX CLARITIN TESSALON PERLES DULCOLAX
Allergien: RED DYE
Vorherige Impfungen: -

VAERS 2338863

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

kritisch

Staat: IA
Alter: 90,0
Geschlecht: M
Eingang: 28.06.2022
Impfdatum: 21.06.2022
Beginn: 22.06.2022
Tage bis Beginn: 1,0
Dosis: 4
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death

Symptomtext

Patient was found deceased in his home the next morning after receiving the covid vaccine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: Acute Bronchitis on 6/21/22, Anemia,
Vorgeschichte: AFIB, Amyloidosis, Aortic regurgitation, BPH, Cardiomyopathy, CHF, Colon polyps, Diverticulosis, GERD, HTN, Hyperlipidemia, Hypothyroidism, Decreased cardiac ejection fraction, impaired tissue integrity, Anemia
Andere Medikamente: Lantanoprost ophthalmic solution 1 drop eyes daily Brimonidine ophthalmic 0.2% solution 1 drop both eyes TID Famotidine 20mg daily Centrum Silver 1 tab daily Coreg 25mg daily Lasix 20mg daily Lovastatin 40mg daily Levothyroxine 88mcg daily
Allergien: No Known Allergies No Known Medication Allergies
Vorherige Impfungen: -

VAERS 2310169

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

kritisch

Staat: OH
Alter: 83,0
Geschlecht: M
Eingang: 06.06.2022
Impfdatum: 26.05.2022
Beginn: 27.05.2022
Tage bis Beginn: 1,0
Dosis: 3
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death Haematemesis

Symptomtext

Resident was vomiting blood and ended up with death in facility.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: malignant neoplasm of rectum s/p colostomy placement
Vorgeschichte: glaucoma, pulmonary hypertension, benign intracranial hypertension, GERD
Andere Medikamente: Lisinopril 20mg , Flomax 0.4mg, Tadalafil 20mg, Therapeutic multivitamin with mineral, naproxen 500mg, Zofran 8mg, Brimonidine Tartrate ophthalmic solution, dorzolamide HCL Timolol Mal Ophthalmic Solution, Vitamin B 12, hydrochlorothiazide
Allergien: ciprofloxacin
Vorherige Impfungen: -

VAERS 2664143

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

schwer

Staat: -
Alter: 68,0
Geschlecht: F
Eingang: 01.08.2023
Impfdatum: 04.06.2022
Beginn: 20.03.2023
Tage bis Beginn: 289,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Deep vein thrombosis

Symptomtext

ACUTE DVT OF BILAT LEGS, UNSPECIFIED VEINS

Weitere VAERSDATA-Felder

Praegender Schweregrund: Deep vein thrombosis
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2629933

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

schwer

Staat: GA
Alter: 22,0
Geschlecht: F
Eingang: 10.05.2023
Impfdatum: 11.06.2021
Beginn: 01.06.2021
Tage bis Beginn: -
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: ja ER: unbekannt Erholt: nein

Electrocardiogram Palpitations Syncope

Symptomtext

HEART PALPITATIONA after vaccine 2 FAINTING after vaccine 3

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: EKG
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: none
Allergien: none
Vorherige Impfungen: -

VAERS 2587935

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

schwer

Staat: -
Alter: 72,0
Geschlecht: F
Eingang: 27.02.2023
Impfdatum: 14.06.2022
Beginn: 12.01.2023
Tage bis Beginn: 212,0
Dosis: 2
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acidosis Acute kidney injury Angiogram abnormal Angiogram pulmonary abnormal Blood culture positive Blood folate normal Blood pressure increased COVID-19 Clostridium test negative Colitis Condition aggravated Diarrhoea Haemoglobin decreased High density lipoprotein normal Hyperlipidaemia Hypovolaemic shock Leukocytosis Lipids

Symptomtext

Patient is a 72 y.o. female with PMHx significant for CAD, HTN, HLD, COPD, tobacco use disorder, vitamin D deficiency, and insomnia who presented to DH on 1/12/2023 with syncopal episode. Initial work-up concerning for septic shock secondary to underlying colitis. There was initially concern for C. difficile colitis and patient was on oral vancomycin and IV Flagyl due to possibility of fulminant C. difficile. Patient was also briefly on a bicarb drip due to worsening AKI and acidosis. Patient was found to be COVID-positive, but without COVID-pneumonia. Infectious disease was consulted and started the patient on remdesivir. C. difficile testing and stool PCR testing came back negative and patient was transitioned to Vanco and Zosyn. However, due to no obvious infectious etiology, antibiotics were initially discontinued. Subsequently 1/2 Bcx turned out to be positive for GNB without any further confirmation. Patient was there fore treated with IV antibiotic and transition to oral for total 7 days as recommended by infectious disease. Patient has finished remdesivir, improved respiratory status, on RA, diarrhea resolved, ambulating on her own with plans to discharge home with family. Septic versus hypovolemic shock-resolved Diarrhea Off pressors, BP stable. AF, on RA LA 4.6>1.7. Leukocytosis at 16>13K CTA C/A/P suggestive of possible diffuse colitis. C. difficile testing and stool PCR negative, blood cultures negative today Imodium prn given ongoing diarrhea. Diarrhea improving BP stable, good urine output Discontinued IV fluid stable COVID-19 infection Suspect incidental COVID infection, on RA COVID test + on 1/12/23 Not requiring oxygen and no pulmonary infiltrates on CT Procal markedly elevated at 86.5 finished remdesivir per ID recommendations Improved overall Positive blood culture 1/2 GNB 1/12 Unclear significance, ID PCR inconclusive Clinically looks better, afebrile, no leukocytosis Abx transitioned to Augmentin for 5 more days per ID. Anemia normocytic normochromic Hb on arrival at 12.1>10.7>7.3 Check iron panel and stool occult. Transfuse for Hb <7.0 No active bleeding at this time Iron studies consistent with iron deficiency anemia Patient not allergic to iron, discussed with her IV iron x 3 doses Outpatient work up for anemia Hgb stable at 7.7 B12 and folate adequate Hyperlipidemia Lipids 6/20/2022: TC 179, TG 79, HDL 89, LDL 74 Continue home atorvastatin 80 mg daily Hypertension Home medications: Amlodipine 2.5 mg daily and losartan 25 mg daily BP meds held in the setting of shock BP now elevated Resumed amlodipine at 5 mg daily 1/16 BP elevated, resumed losartan 1/17 Increased Losartan to 50 mg daily for better BP control Vitamin D deficiency Vitamin D 6/20/2022: 22 Ergocalciferol 50,000 units weekly Insomnia Continue home zolpidem as needed Tobacco abuse On Chantix at home Encourage continued cessation

Weitere VAERSDATA-Felder

Praegender Schweregrund: Hypovolaemic shock
Hospital-Tage: 7,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2578124

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 037a22b

schwer

Staat: OH
Alter: 75,0
Geschlecht: M
Eingang: 08.02.2023
Impfdatum: 30.06.2022
Beginn: 27.10.2022
Tage bis Beginn: 119,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Balance disorder Dizziness Fall Ischaemic stroke Laboratory test Magnetic resonance imaging Nausea Visual field defect

Symptomtext

Ischemic occipital stroke affected me by blocking right eye peripheral vision and balance . I was dizzy and nauseous for about 20 hours. Treatment and 6 day rehab mitigated most of it though loss of peripheral is ongoing after 3 months. My Doctor and Opthamologist are treating . The first indication/sign was immediately prior with heavy dizziness causing a fall.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Ischaemic stroke
Hospital-Tage: -
Labordaten: CRT, MRI OCTOBER 27 2022
Aktuelle Erkrankungen: None
Vorgeschichte: None - good blood pressure (range 124-130 over 75 to 80); resting pulse low 60s; bad cholesterol up to 138
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: -

VAERS 2530367

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

schwer

Staat: DC
Alter: 46,0
Geschlecht: F
Eingang: 13.12.2022
Impfdatum: 03.06.2022
Beginn: 01.06.2022
Tage bis Beginn: -
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Autonomic nervous system imbalance Biopsy skin Blood test Dry eye Dysuria Electric shock sensation Electromyogram Exercise tolerance decreased Fatigue Feeling abnormal Full blood count Gait inability Hypoaesthesia Immunology test Impaired work ability Lumbar puncture Magnetic resonance imaging head Magnetic resonance imaging spinal

Symptomtext

I received my 4th Moderna covid shot (and 2nd booster) on June 3, 2022. After two days of fatigue and aches, I continued to have fatigue over the next week. Starting on Friday, June 10th and continuing for 48 hours, I experienced severe leg pains in both legs. On June 12th, I noticed a bubble rash on my fingers. The fatigue continued the week of June 13th and by the end of that week I experienced another 48 hours of severe bone-deep leg aches. On Monday June 20th, I went to go for my daily 5-7 mile walk and my legs felt strange, weak and achy. On Tuesday June 21st, I went to a shopping mall and found myself unable to walk across the hall between stores. I felt like I couldn't signal to my legs that I wanted to walk. My legs felt numbness, tingling, aches, weakness and a lack of motor coordination. I managed to drive myself to the Emergency Room. By Tuesday June 22nd the sensations had spread to my arms and hands. I also noticed short sharp electric sensations in my pelvis. Over the next couple of weeks, this evolved into neurogenic bladder and an inability to void. I also developed tingling and muscle soreness and severe dryness in my eyes. After too many tests, hospital and doctor visits to count, I have been diagnosed with a "mild" case of transverse myelitis. However, this "mild" case in reality has meant being unable to do my work, barely able to walk let alone exercise (and I had been an avid athlete/exercise enthusiast all of my life), continuous sensory, motor and autonomic problems, ongoing neurogenic bladder, neuropathy, eye problems, etc. I had some improvement in October, but found that the slightest bit of exertion set me back and here I am in December 2022, six months after the shot, still uncertain what my health outcome will be.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Electric shock sensation
Hospital-Tage: 7,0
Labordaten: 6 MRIs (brain/spine) -- 2 in June 2022, 3 in July 2022, 1 in November 2022 2 spinal taps -- July 2022 1 skin biopsy for small fiber neuropathy -- Augst 2022 2 EMGs -- July and August 2022 Various blood work (CBC, autoimmune, paraneoplastic tests) -- June, July, August, November 2022
Aktuelle Erkrankungen: N/A
Vorgeschichte: POTS; suspected hypermobile Ehlers Danlos
Andere Medikamente: Propranolol 20mg; vitamin D; iron
Allergien: Penicillin
Vorherige Impfungen: -

VAERS 2357065

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037a22b

schwer

Staat: KY
Alter: 25,0
Geschlecht: M
Eingang: 04.07.2022
Impfdatum: 29.06.2022
Beginn: 29.06.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Face injury Fall Loss of consciousness

Symptomtext

Systemic: Dizziness / Lightheadness-Severe, Systemic: Fainting / Unresponsive-Severe, Additional Details: patient was instructed to wait 15 minutes after receiving injection for monitoring. patient left after approx 7 minutes, walked out to the parking lot and "passed out" hitting his chin on the concrete. patient became responsive shortly after fall (exact time un-known) non-pharmacy staff attended to him at first but patient left before ambulance could be called

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2323295

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037a22b

schwer

Staat: MI
Alter: 61,0
Geschlecht: F
Eingang: 17.06.2022
Impfdatum: 15.06.2022
Beginn: 15.06.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Arthralgia Loss of consciousness

Symptomtext

Patient called to let us know that she had passed out after receiving her vaccines. Per phone conversation she stated, she remembers letting the dog out when she got home on Wednesday, the next thing she remembers is waking up on the floor face down and her knees are sore and stated she was down for 2 days. States she feels better today. She was instructed by staff to go to ER she stated she would have her brother take her.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Cancer; Diverticulosis; GERD; Motion sickness; Stomach ulcer.
Vorgeschichte: Brain tumor; Bilateral lung cancer; Adrenal gland.
Andere Medikamente: Vitamin D3 50000; vitamin D3; Colace; Advil PM; Multivitamin; Nicotine patch; Nicorette gum; Prilosec.
Allergien: Codeine and Vicodin.
Vorherige Impfungen: -

VAERS 2313083

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

schwer

Staat: NY
Alter: 69,0
Geschlecht: F
Eingang: 08.06.2022
Impfdatum: 05.06.2022
Beginn: 05.06.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Chest pain Chills Cough Dyspnoea Fatigue Headache Loss of personal independence in daily activities Musculoskeletal chest pain Nausea Pulmonary oedema Pyrexia

Symptomtext

Approximately 6 hours after receiving vaccine, headache started. Took one dose Advil every four hours thereafter until the next day. Experienced fever, chills, tiredness, nausea. Approximately 20 hours after vaccine, chest pain started - it felt like my lungs were swollen. Rib cage ached. Shortness of breath. Coughing. Inability to function normally for three full days. PS - I am not a crybaby. I have a high tolerance for pain. Never had any reaction to flu shot, pneumonia shot, etc. My family members received the same vaccine with no reaction. Why is this happening to me? I will not take another dose. My doctor pushed me to take this one. Thank you.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary oedema
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: Calcium, Vitamin D, Lutein
Allergien: Codeine
Vorherige Impfungen: Moderna second dose and booster

VAERS 2309867

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22b

schwer

Staat: CA
Alter: 27,0
Geschlecht: M
Eingang: 06.06.2022
Impfdatum: 02.06.2022
Beginn: 02.06.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Nervousness Syncope

Symptomtext

, Additional Details: patient fainted for 1 minute or so and then came back. He said he was ok but nervous. I ask if he wanted me to call ems he said no but we went ahead and called ems anyway. They checked him out he was ok and came inside store to thank and said he was ok now.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2301577

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

schwer

Staat: CA
Alter: 74,0
Geschlecht: F
Eingang: 29.05.2022
Impfdatum: 29.05.2022
Beginn: 29.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Back pain Fall Pain in extremity Syncope Walking aid user

Symptomtext

Approximately 35 minutes after vaccination patient fainted and fell into a cardboard makeup display in the store. Patient reports that she normally has to use her walker due to back and leg pain. Requested that 911 be called, patient was taken to ER. No further information given.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2298548

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037a22b

schwer

Staat: CT
Alter: 19,0
Geschlecht: F
Eingang: 27.05.2022
Impfdatum: 23.05.2022
Beginn: 23.05.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Asthenia Dizziness Fatigue Flushing Hyperhidrosis Lethargy Syncope Unresponsive to stimuli

Symptomtext

Systemic: Dizziness / Lightheadness-Severe, Systemic: Exhaustion / Lethargy-Severe, Systemic: Fainting / Unresponsive-Severe, Systemic: Flushed / Sweating-Severe, Systemic: Weakness-Medium

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2289905

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

schwer

Staat: GA
Alter: 75,0
Geschlecht: F
Eingang: 22.05.2022
Impfdatum: 17.05.2022
Beginn: 18.05.2022
Tage bis Beginn: 1,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Injection site induration Injection site warmth Loss of consciousness Muscular weakness

Symptomtext

The next morning (5/18/22), she stated she had weakness in the legs. EMS came, said vitals were fine and no need to transport. That afternoon, she was coming to dining room for dinner when I was at facility. On 5/21/22, she passed out while being changed. She had not been wearing her oxygen. (She is supposed to wear it all the time but is not compliant per the staff.) EMS was called. It was noted that her injection site was warm to touch and solid at the site. EMS transported her to the hospital.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: COPD, lung cancer, others unknown
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2728836

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

moderat

Staat: VA
Alter: 69,0
Geschlecht: M
Eingang: 29.12.2023
Impfdatum: 25.10.2023
Beginn: 25.10.2023
Tage bis Beginn: 0,0
Dosis: 7+
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Injected limb mobility decreased Injection site pain

Symptomtext

Pain has persisted to my left deltoid and upper arm unrelieved by heating pad, tylenol or ibuprofen. The pain is mild to moderate and has at times limited raising my arm above my head.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Injected limb mobility decreased
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: Hypertension
Vorgeschichte: Chronic back pain with radiculopathy to right leg
Andere Medikamente: Losartan, Amlodipine, Cialis, Advil, Tylenol, Benadryl
Allergien: Sildenifil, Oxycodone, Codeine, Flexeril
Vorherige Impfungen: -

VAERS 2679383

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

moderat

Staat: -
Alter: 82,0
Geschlecht: F
Eingang: 05.09.2023
Impfdatum: 01.06.2022
Beginn: 11.08.2023
Tage bis Beginn: 436,0
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Asthenia Blood culture Blood pressure increased COVID-19 Cough Decreased appetite Decubitus ulcer Diarrhoea Dyspnoea Echocardiogram abnormal Fatigue Hip arthroplasty Left atrial dilatation Leukopenia Mobility decreased Procalcitonin SARS-CoV-2 test positive Wound closure

Symptomtext

HPI Patient is 83 years old with past medical history of asthma, congestive heart failure, aortic valve replacement, hyperlipidemia, interstitial lung disease, rheumatoid arthritis presented to the hospital with a chief complaint of shortness of breath, and diarrhea associated with generalized weakness and fatigue. Patient was found to have COVID yesterday morning. She was initiated on Paxlovid by her PCP. Patient recently had a total hip replacement. She has not been moving much and stayed in bed and subsequently developed decub ulcer in the back. She currently has a wound VAC. Patient has not been eating or drinking much. She was initiated on prednisone daily which she has been taking. When seen, patient was resting in bed comfortably. Otherwise patient has no fever, chills, chest pain, abdominal pain, nausea, vomiting, difficulty with urination, dysuria. Admits to dry cough. In the ED, patient was given a bolus normal saline 500 cc.?HPI per admitting nocturnist Clinical Summary Clinical course Include/ Problem list COVID infection Dyspnea Hx Interstitial lung disease and Bronchiectasis HX Asthma and COPD COPD with chronic respiratory failure - Home Covid test positive on 8/11. - Continue Dexamethasone - Patient received 2 doses of Paxlovid OP prior to arrival - She is at baseline oxygen 2-3 liters - Blood cultures pending - Pulmonology consult, recommendations appreciated - Continue albuterol, incentive spirometer and supportive care - Procal 0.13 will hold off on antibiotics as this is likely viral - Special isolation Leukopenia likely 2/2 Covid/resolved - CBC in AM, will monitor Weakness General weakness with reduced mobility, POA - PT and social consult, PT recommended continued therapy at DC - Family and patient are interested in SNF for therapy at discharge Diarrhea rule out C. Difficile vs Side Effect Paxlovid - Cdiff and Stool PCR pending - No BM since arrival to hospital. Diarrhea started after taking Paxlovid at home. Elevated blood pressure?no prior history of hypertension - BP improved from admission currently 119/77 - Continue Amlodipine, will add hold parameters Continue Hydralazine PRN SBP greater than 160 - May need antihypertensive at DC, however will monitor as hypertension could be 2/2 acute infection/illness ?Hydralazine was given scheduled every 8 hours during patient's admission. Patient be discharged with hydralazine and a blood pressure kit with instructions to hold if systolic blood pressures less than 110. Decubitus ulcer stage 4, POA - Wound Vac in place - Consult wound care Anxiety/depression - Continue Home Lexapro - Will add Hydroxyzine PRN anxiety CHF?currently compensated Aortic Stenosis S/p TAVR in 2018 - Echocardiogram ordered and pending - Previous Echo from April 2023 shows EF 55-60%, Severely dilated left atrium. TAVR well seated and function normal. - Cardiology consulted - Continue home ASA and betablocker

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: 4,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2662728

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

moderat

Staat: -
Alter: 79,0
Geschlecht: F
Eingang: 28.07.2023
Impfdatum: 18.07.2022
Beginn: 11.01.2023
Tage bis Beginn: 177,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Hypotension Hypoxia

Symptomtext

HYPOTENSION HYPOXIA

Weitere VAERSDATA-Felder

Praegender Schweregrund: Hypotension
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2647906

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

moderat

Staat: IL
Alter: 61,0
Geschlecht: F
Eingang: 21.06.2023
Impfdatum: 16.06.2022
Beginn: 01.10.2022
Tage bis Beginn: 107,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Electromyogram abnormal Neuropathy peripheral Paraesthesia

Symptomtext

I had Tingling on my left hand, in my pinky, had of my finger #4. This started October 1st, 2022. On Feb 9th, 2023, I saw tour doctor and he referred me to have an EMG, I had it and the diagnose was that I had Ulnar Neuropathy at the elbow. It is a mild to moderate case.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Paraesthesia
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: N/A
Vorgeschichte: Rosacea
Andere Medikamente: Multi Vitamins; Vitamin D; Oracea;
Allergien: N/A
Vorherige Impfungen: -

VAERS 2613750

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

moderat

Staat: VA
Alter: 64,0
Geschlecht: F
Eingang: 12.04.2023
Impfdatum: 01.06.2022
Beginn: 01.09.2022
Tage bis Beginn: 92,0
Dosis: 5
Route/Site: - / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Blood test abnormal Computerised tomogram abdomen abnormal Dyspepsia Muscle spasms Nausea Pain Palpitations Pancreatic failure Stool analysis Vitamin D decreased

Symptomtext

I am having severe burning in my stomach and feel my heartbeat in my stomach. I have nausea, pain, and cramping. CT scan showed problems with the pancreas showing EPI. I am very limited now on what I can eat. I still need more exams by the gastrologist which I am seeing next month.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Palpitations
Hospital-Tage: -
Labordaten: CT scans; fecal samples; blood work. Blood showed my vitamin D was low but that was it.
Aktuelle Erkrankungen: None
Vorgeschichte: IBS; dairy sensitivities
Andere Medikamente: None
Allergien: Sulfa drugs
Vorherige Impfungen: -

VAERS 2586865

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

moderat

Staat: MI
Alter: 84,0
Geschlecht: F
Eingang: 24.02.2023
Impfdatum: 28.06.2022
Beginn: 17.02.2023
Tage bis Beginn: 234,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Abdominal X-ray Asymptomatic COVID-19 Blood culture negative Computerised tomogram head normal Condition aggravated Constipation Culture urine Encephalopathy Metabolic encephalopathy SARS-CoV-2 test positive Urinary tract infection

Symptomtext

Discharge Provider: MD Primary Care Provider: PA Admission Date: 2/17/2023 Discharge Date: 2/19/2023 Clinical Narrative: Acute encephalopathy likely metabolic on admission resolved, patient is awake alert oriented x3, able to engage in a conversation and answer questions. CT scan of the head done on admission was unremarkable She was started on IV ceftriaxone for urinary tract infection, she is afebrile no leukocytosis, blood cultures are negative to date, urine culture also pending to be completed. Patient is asymptomatic presently in and she has completed 3 days of IV ceftriaxone, will give a dose of fosfomycin and discharged without antibiotics. Family physician to follow up on finalization of cultures and the need for continued antibiotics COVID-19 positive of which she is asymptomatic no shortness of breath no chest pain no significant cough, she is advised to continue to follow social distancing Constipation as evident on abdominal x-ray patient received MiraLax and later Doculax suppository I was able to have bowel movement. She can continue with p.r.n. MiraLax at home

Weitere VAERSDATA-Felder

Praegender Schweregrund: Condition aggravated
Hospital-Tage: 2,0
Labordaten: -
Aktuelle Erkrankungen: 5/22/2022 - 5/28/2022 (6 days) Hospital PRESENTING PROBLEM: Spontaneous intraparenchymal intracranial hemorrhage, acute [I62.9]
Vorgeschichte: Lumbar radiculopathy Stricture intestinal Diabetes mellitus type 2, insulin dependent Coronary artery disease involving native coronary artery of native heart without angina pectoris Essential hypertension Acquired hypothyroidism History of CVA (cerebrovascular accident) UTI (urinary tract infection) Spinal stenosis of lumbar region with neurogenic claudication Colitis, acute Acute diverticulitis Solitary lung nodule Lumbar stenosis with neurogenic claudication Acute urinary retention Spontaneous intraparenchymal intracranial hemorrhage, acute Left thyroid nodule Unspecified severe protein-calorie malnutrition Iron deficiency anemia Acute encephalopathy COVID-19 virus infection Electrolyte imbalance
Andere Medikamente: acetaminophen (TYLENOL) 325 MG tablet acetaminophen-codeine (TYLENOL #3) 300-30 MG per tablet albuterol HFA (PROVENTIL HFA, VENTOLIN HFA, PROAIR HFA) 108 (90 Base) MCG/ACT inhaler ciprofloxacin (CIPRO) 250 MG tablet (Expired) gabapentin (NE
Allergien: LatexRash
Vorherige Impfungen: -

VAERS 2572268

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

moderat

Staat: KY
Alter: 33,0
Geschlecht: F
Eingang: 31.01.2023
Impfdatum: 27.08.2021
Beginn: 17.09.2021
Tage bis Beginn: 21,0
Dosis: UNK
Route/Site: SYR / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: ja ER: unbekannt Erholt: nein

Fatigue Immunology test normal Impaired work ability Malaise Mobility decreased Pain

Symptomtext

The week that I received my booster shot, I started feeling ill. My body was hurting and I was so tired that I could not get out of bed. I have since been going to several different doctors and have been tested for several auto immune disorders. Every test comes back negative, but the pain and fatigue are still persistent. I have been unable to work because of this.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Mobility decreased
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: NONE
Vorgeschichte: I have chronic pain all over, mostly in my joints and muscles. I am fatigued. I hurt and feel so poorly that I am unable to work.
Andere Medikamente: BUSPAR KLONOPIN SYNTHROID
Allergien: SHELLFISH
Vorherige Impfungen: -

VAERS 2604602

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037a22b

moderat

Staat: -
Alter: 76,0
Geschlecht: M
Eingang: 10.01.2023
Impfdatum: 26.06.2022
Beginn: 29.06.2022
Tage bis Beginn: 3,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Dyspnoea Erythema Pruritus Urticaria

Symptomtext

Narrative: 1) hives all over/big welts-all over arms,shoulders,chest,stomach,back redness,itchy Transfer to RN - ongoing x Moderna shot yesterday Unable to screen for COVID 19 due to BAT symptoms. Nurse Notes; COVID vaccine - Hives all over body. Has had immunization in the past, without any difficulty. Pt states that he has hives that are all over his body, and spreading as well as hived on his neck, no difficulty swollowing at this time, but reports that he feels slightly short of breath.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2604530

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037a22b

moderat

Staat: -
Alter: 76,0
Geschlecht: M
Eingang: 10.01.2023
Impfdatum: 29.06.2022
Beginn: 29.06.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Dyspnoea Erythema Pruritus Urticaria

Symptomtext

Narrative: 1) hives all over/big welts-all over arms,shoulders,chest,stomach,back redness,itchy Transfer to RN - ongoing x Moderna shot yesterday Unable to screen for COVID 19 due to BAT symptoms. Nurse Notes: COVID vaccine - Hives all over body. Has had immunization in the past, without any difficulty. Pt states that he has hives that are all over his body, and spreading as well as hived on his neck, no difficulty swollowing at this time, but reports that he feels slightly short of breath.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2555823

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

moderat

Staat: MI
Alter: 88,0
Geschlecht: F
Eingang: 10.01.2023
Impfdatum: 05.02.2021
Beginn: 26.11.2022
Tage bis Beginn: 659,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Chest pain Cough

Symptomtext

11/26/22 presents to ED for "cough, chest pain". PMHx of "MCI, urinary incontinence, HTN and CKD 3b"

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2521952

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

moderat

Staat: IA
Alter: 54,0
Geschlecht: F
Eingang: 02.12.2022
Impfdatum: 02.06.2022
Beginn: 27.11.2022
Tage bis Beginn: 178,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Chest discomfort Chest pain Discomfort Dyspnoea Exposure to SARS-CoV-2 Fatigue Feeling abnormal Headache Influenza virus test negative Oropharyngeal pain Pain SARS-CoV-2 test SARS-CoV-2 test positive

Symptomtext

I received my second Moderna booster for COVID-19 on 6/2/2022. On the morning of 11/27/2022, I woke up with body aches, a headache, and a sore throat. At this point, I was in the process of weaning myself off of the prednisone I had been taking to treat a pre-existing condition, and I assumed that my discomfort was a result of this. However, my husband and son had not been feeling well recently, so I also wondered if we should all test ourselves for COVID-19. My husband and son both tested positive for COVID-19 on an antigen test on 11/27/2022. However, when I took the test that day, I got a negative response. When I woke up on 11/28/2022, I felt a little worse. When I tested myself again that day, I got another negative result. I was having some difficulty breathing, so I used an albuterol inhaler, which helped some. I also had some chest pains, but these aren't unusual for me, since they are a frequent symptom of my autoimmune disorder. I took some OTC cold and flu tablets, and they helped a little with the headache. I had difficulty sleeping on the night of 11/28/2022, because I had some difficulty breathing, plus I had chills and more body aches. When I woke up the morning of 11/29/2022, I felt even worse than I did the day before. I had difficulty breathing, so I used my albuterol inhaler. I called my doctor's office and left a message for them to call me back, but I did not hear back from my doctor that day. I was so fatigued that I just fell asleep and didn't stay awake long enough to call back the doctor's office after I didn't hear from them. I had a rough night when I went to bed, because I had body aches, chills, and difficulty breathing. I ended up waking up several times in the night, so I did not have a sound sleep. On 11/30/2022, I got up early and used my albuterol inhaler. This time, though, the inhaler didn't help with my difficulty breathing. I then took some ibuprofen, because I'm prone to inflammation, which can negatively affect my ability to breathe, and I hoped that the ibuprofen would calm any inflammation that could possibly be contributing to my breathing difficulty. Unfortunately, though, it did not work. I took the albuterol again about 4 hours later, because I hoped that a combination of the albuterol and the ibuprofen would help my breathing. It did not help, so I called my doctor's office, because I was really struggling. They instructed me to come to their clinic to be tested for COVID-19, which I did. I was administered both a rapid test and a PCR, plus a test for the flu. They informed me within a few minutes that my results on the rapid test were positive. And because I was having difficulty breathing, they also checked my blood oxygen level, which was within in the normal range, as were also my vitals. My doctor thought that my difficulties were caused by asthma symptoms that were exacerbated by COVID-19 and by my ongoing ANCA-associated granulomatous vasculitis with polyangiitis, so she switched me over from the albuterol inhaler to an albuterol nebulizer. I was also prescribed PAXLOVID. My PCP wanted to start me back on prednisone, but she advised to consult with my rheumatologist first, and he agreed with this, so I was also given some prednisone. I began taking the PAXLOVID, the albuterol nebulizer, and the prednisone that day. When 12/1/2022 rolled around, I felt much better. I've been taking the albuterol nebulizer every 4 hours ever since, even in the middle of the night. I had less difficulty breathing on 12/1/2022, though I am having a little more difficulty at the time of this writing, as I currently have a little more pain and tightness in the chest. However, things aren't nearly as difficult now as they were at the time of the onset of symptoms. I feel a little more tired now, but that could possibly be due to the prednisone, since it often has that effect on me, plus I had difficulty sleeping last night.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: -
Labordaten: Home antigen tests 11/27/2022 and 11/28/2022 negative results; 11/30/2022 clinical antigen test positive result; 11/30/2022 flu test negative result.
Aktuelle Erkrankungen: None.
Vorgeschichte: ANCA-Associated Granulomatous Vasculitis with Polyangiitis; Selective IgA Deficiency; Asthma; Chronic Allergies; Osteoarthritis; Bulging Intervertebral Disk Between L4 and L5.
Andere Medikamente: ALLEGRA; FLONASE nasal spray; azelastine nasal spray; calcium with vitamin D; black cohosh; multivitamins; biotin; fish oil; ADDERALL XR.
Allergien: Sulfa drugs; hydroxychloroquine; latex; adhesives.
Vorherige Impfungen: When I got my pneumonia and Shingrix vaccines on 5/27/2022, I had a severe headache and body aches. The area below the injection

VAERS 2520495

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

moderat

Staat: PA
Alter: 38,0
Geschlecht: F
Eingang: 30.11.2022
Impfdatum: 01.06.2022
Beginn: 02.06.2022
Tage bis Beginn: 1,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: ja ER: ja Erholt: nein

Acoustic stimulation tests Arthralgia Computerised tomogram head Conjunctival oedema Deafness neurosensory Hypertension Labyrinthitis Magnetic resonance imaging head Oedema peripheral Ophthalmological examination Scleral haemorrhage Tinnitus Vertigo

Symptomtext

In order of onset: scleral hemorrhage, scleral chemosis, lower extremity edema, acute onset labrynthitis (vertigo, tinnitus, R ear sensorineural hearing loss), joint pain, worsening hypertension. At this time, hearing loss is permanent

Weitere VAERSDATA-Felder

Praegender Schweregrund: Hypertension
Hospital-Tage: -
Labordaten: Eye exam, ER visit, CT and MRI of head, ENT exam, hearing test
Aktuelle Erkrankungen: None
Vorgeschichte: Kidney transplant recipient
Andere Medikamente: Tacrolimus Cellcept Prednisone Coreg Chlorthalidone Telmisartan Clonidine patch (for hypertension) Claritin Norethindrone Vitamin D Aranesp injections monthly Nasal steroid rinse
Allergien: Vancomycin (red man syndrome); peanuts (anaphylaxis)
Vorherige Impfungen: -

VAERS 2496652

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

moderat

Staat: -
Alter: 75,0
Geschlecht: M
Eingang: 02.11.2022
Impfdatum: 07.06.2022
Beginn: 29.09.2022
Tage bis Beginn: 114,0
Dosis: 4
Route/Site: UN / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Dyspnoea

Symptomtext

SOB

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: 2,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2320157

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037a22b

moderat

Staat: FL
Alter: -
Geschlecht: F
Eingang: 24.10.2022
Impfdatum: 01.06.2022
Beginn: 01.06.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Arthralgia Arthritis Mobility decreased Peripheral swelling Skin reaction Diarrhoea Erythema

Symptomtext

index finger turned red; diarrhea; finger swelled up/twice the size for several days; This spontaneous case was reported by a patient and describes the occurrence of PERIPHERAL SWELLING (finger swelled up/twice the size for several days), ERYTHEMA (index finger turned red) and DIARRHOEA (diarrhea) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis. Previously administered products included for Product used for unknown indication: Pfizer vaccine (Dose 1), Pfizer vaccine (Booster dose) and Pfizer vaccine (Dose 2). Past adverse reactions to the above products included No adverse event with Pfizer vaccine, Pfizer vaccine and Pfizer vaccine. In June 2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In June 2022, the patient experienced PERIPHERAL SWELLING (finger swelled up/twice the size for several days). On an unknown date, the patient experienced ERYTHEMA (index finger turned red) and DIARRHOEA (diarrhea). At the time of the report, PERIPHERAL SWELLING (finger swelled up/twice the size for several days) had resolved and ERYTHEMA (index finger turned red) and DIARRHOEA (diarrhea) outcome was unknown. No concomitant medications was reported. The patient mentioned that right after the booster dose, her finger swelled up. It was twice the size for several days. It just blew up. It was back to normal at the time of reporting. Her finger turned red. It was her index finger. This happened after her fourth shot in June 2022. No treatment medications was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Mobility decreased
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2433409

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

moderat

Staat: MI
Alter: 62,0
Geschlecht: F
Eingang: 08.09.2022
Impfdatum: 13.04.2021
Beginn: 11.08.2022
Tage bis Beginn: 485,0
Dosis: 3
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Cough Dyspnoea Fatigue Pyrexia SARS-CoV-2 test positive

Symptomtext

63y.o. female with HX of T2DM, PE, HLD, and Hypertension presented to the ED with c/o shortness of breath, cough, and fever. Patient was on a one week cruise and returned 7 days ago. 5 days ago, she developed cough, fatigue, fever, and difficulty in breathing. She took a at home covid test which was positive today. Patient is Vaccinated X3 with booster a couple weeks ago. Denies chest pain and reports improvement in her breathing. Denies fevers, chills, nausea, emesis, sore throat, edema, and chest pain. Discussed with ID, plan of care discussed with RN, letter typed for patient's employer. Medically stable for discharge, she is agreeable

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: 1,0
Labordaten: 8/11 SARS-CoV-2 (COVID-19) by Nucleic Acid Amplification, POC-- detected
Aktuelle Erkrankungen: unknown
Vorgeschichte: unknown
Andere Medikamente: unknown
Allergien: unknown
Vorherige Impfungen: -

VAERS 2429723

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

moderat

Staat: -
Alter: 71,0
Geschlecht: F
Eingang: 06.09.2022
Impfdatum: 20.05.2022
Beginn: 31.08.2022
Tage bis Beginn: 103,0
Dosis: 3
Route/Site: UN / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Dyspnoea Oropharyngeal pain Rhinorrhoea

Symptomtext

rhinorrhea, sore throat, SOB

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: 3,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2416938

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

moderat

Staat: GA
Alter: 42,0
Geschlecht: F
Eingang: 21.08.2022
Impfdatum: 18.08.2022
Beginn: 20.08.2022
Tage bis Beginn: 2,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Axillary mass Back pain Breast pain Musculoskeletal chest pain Pain in extremity Pyrexia

Symptomtext

Golf-ball sized lump under arm; pain in right breast all the way down midway to ribs and all the way down to right arm and right-side of back. Pain extends down right-side more and more every day. Intermittent fever.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Musculoskeletal chest pain
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: POTS (post-COVID-19), asthma, HTN
Vorgeschichte: POTS (post-COVID-19), asthma, HTN
Andere Medikamente: Metoprolol, Aspirin, Losartan, Albuterol
Allergien: Benadryl, Singulair
Vorherige Impfungen: -

VAERS 2400515

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

moderat

Staat: TX
Alter: 47,0
Geschlecht: M
Eingang: 03.08.2022
Impfdatum: 01.07.2022
Beginn: 01.07.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: SYR / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Arthralgia Chest pain Fatigue Hepatic function abnormal Immunisation reaction Joint swelling Laboratory test abnormal Loss of personal independence in daily activities Pain in extremity Renal impairment Temperature intolerance Thyroid disorder

Symptomtext

Arm and Hip pain, body fatigue and sudden chronic inability to tolerate heat, chest pain, debilitating exhaustion. Thyroid, kidney and liver functioning and levels now affected for the first time in life and daily functioning is now impaired significantly. Daily living skills and overall functioning is now hindered severely as a result of post injection from vaccine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: 1,0
Labordaten: Was admitted to ER and testing shows levels and functioning are abnormal post vaccine. Prior testing and lifetime labs never showed abnormal levels in areas of thyroid, liver, inflammation and sudden joint swelling in knuckles, and kidney. Functioning is impaired now and suffering is occurring daily.
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Sertraline that has been taken daily for the last 15 years.
Allergien: None
Vorherige Impfungen: -

VAERS 2387813

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

moderat

Staat: TX
Alter: 65,0
Geschlecht: M
Eingang: 24.07.2022
Impfdatum: 07.06.2022
Beginn: 17.06.2022
Tage bis Beginn: 10,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Injection site pain Paraesthesia

Symptomtext

Site: Pain at Injection Site-Mild, Systemic: Tingling (specify: facial area, extemities)-Mild, Additional Details: EXTEMITIES

Weitere VAERSDATA-Felder

Praegender Schweregrund: Paraesthesia
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2376602

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037a22b

moderat

Staat: -
Alter: 72,0
Geschlecht: M
Eingang: 21.07.2022
Impfdatum: 30.06.2022
Beginn: 01.07.2022
Tage bis Beginn: 1,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Asthenia Fall Gait disturbance Tremor

Symptomtext

Patient more shakey, weakness, and unsteady on feet. On Neuro checks due to a fall from the symtpoms. By 7/02/22 patient symptoms improved.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Tremor
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2367401

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037a22b

moderat

Staat: MI
Alter: 66,0
Geschlecht: F
Eingang: 13.07.2022
Impfdatum: 24.06.2022
Beginn: 24.06.2022
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Dizziness Mobility decreased

Symptomtext

patient got dizzy, we called 911 because she claimed she could not get up, her sister told us after the vaccination that she gets dizzy after every shot or injection. ems came and determine she was ok and she was able to go home, her sister drove her home

Weitere VAERSDATA-Felder

Praegender Schweregrund: Mobility decreased
Hospital-Tage: -
Labordaten: moderna vaccination given
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2632284

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

moderat

Staat: MI
Alter: 65,0
Geschlecht: M
Eingang: 01.07.2022
Impfdatum: 26.02.2021
Beginn: 26.02.2021
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: SC / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Mobility decreased Muscle discomfort Musculoskeletal discomfort Tremor X-ray normal

Symptomtext

At first, discomfort to the muscle area of the right shoulder area. As time went on, the pain in this area became more severe and was reported to my PC at the Facility 1.5 years ago. Sonce that time, the pain has become so severe that at times ona scale of 1-10, it was an absolute 10, unable to move the left arm without assistance or holding an item without shaking or dropping. Each time I had reported the discomfort with my PC each additional appointment, now totaling 3 times. There's no topical sensitivity except from the injection site from 2/26/21, and if pushed inward, discomfort can be felt. Radiology was ordered whereas no abnormality was found to the bone structure. Physical Therapy was also ordered.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Mobility decreased
Hospital-Tage: -
Labordaten: Radiology-6/2022
Aktuelle Erkrankungen: No illnesses
Vorgeschichte: Cardiovascular work injury: 12/15/2016
Andere Medikamente: SEE PAGE 2 CONTINUATION
Allergien: Penicillin, Sulfa Drugs, Mycins
Vorherige Impfungen: -

VAERS 2345153

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

moderat

Staat: LA
Alter: 70,0
Geschlecht: M
Eingang: 30.06.2022
Impfdatum: 10.06.2022
Beginn: 16.06.2022
Tage bis Beginn: 6,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Bradycardia Cardiac stress test Decreased appetite Dyspnoea Echocardiogram Electrocardiogram ambulatory Fatigue Nausea

Symptomtext

I experienced fatigue, queasiness, loss of appetite, and I was diagnosed with Bradycardia as well. I went to the doctor on the 06/21/2022 where I had a stress test, wore a Holter monitor for 24 hours, and had an echo done. I have an appointment on 07/06/2022 to go over my results and discuss treatment which could possibly include a pacemaker. I am still experiencing intermittent shortness of breathe and Bradycardia.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: Stress Test; Holter monitor for 24 hours ; Echo on 06/21/2021
Aktuelle Erkrankungen: N/A
Vorgeschichte: AL5 on Back; PTSD; Hypertension
Andere Medikamente: Amlodipine; Metoprolol; Terazosin; Amitriptyline; Vitamin D
Allergien: Primaquine Phosphate
Vorherige Impfungen: -

VAERS 2336029

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

moderat

Staat: NY
Alter: 81,0
Geschlecht: F
Eingang: 27.06.2022
Impfdatum: 04.06.2022
Beginn: 17.06.2022
Tage bis Beginn: 13,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Autoimmune disorder Condition aggravated Skin disorder

Symptomtext

After the vaccine my autoimmune skin condition morphia became active again.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Condition aggravated
Hospital-Tage: -
Labordaten: No.
Aktuelle Erkrankungen: No.
Vorgeschichte: No.
Andere Medikamente: SYNTHROID; atenolol; rosuvastatin; calcium daily vitamin; coQ10; magnesium; vitamin D; PEPCID; biotin; melatonin
Allergien: No.
Vorherige Impfungen: Moderna 10/30/2021 lot# 045C21A.

VAERS 2323996

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037a22b

moderat

Staat: CO
Alter: 83,0
Geschlecht: M
Eingang: 19.06.2022
Impfdatum: 07.06.2022
Beginn: 07.06.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Arthralgia Paraesthesia

Symptomtext

Error: Shoulder Joint Injury (prolonged pain, tingling, etc.)-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Paraesthesia
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2323299

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

moderat

Staat: MA
Alter: 38,0
Geschlecht: F
Eingang: 17.06.2022
Impfdatum: 10.06.2022
Beginn: 10.06.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Chest pain Dyspnoea Headache Muscular weakness

Symptomtext

Patient contacted Health Center 6/11/22 stating 1 hour after administration severe chest pain, sob, muscle weakness, severe headache. Reports going to Emergency Room.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: -
Labordaten: Patient self-reports going to Emergency Room on 6/10/22 and was refered to ER on 6/11/22 upon contacting Health Center reporting persistent symptoms.
Aktuelle Erkrankungen: No reported illness at time of vaccination and one month prior
Vorgeschichte: Patient self-attested to "immunocompromised" state. Patient historically reported 3 times "immunocompromised" at prior vaccine visits.
Andere Medikamente: Unknown, PCP not at site where vaccine administered
Allergien: No reported allergies, no report of adverse reaction to previous vaccines
Vorherige Impfungen: -

VAERS 2317339

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

moderat

Staat: TX
Alter: 56,0
Geschlecht: F
Eingang: 13.06.2022
Impfdatum: 07.06.2022
Beginn: 08.06.2022
Tage bis Beginn: 1,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Chills Dyspnoea Epistaxis Fatigue Headache Injection site erythema Injection site nodule Injection site pain Oxygen saturation decreased Pain Pyrexia

Symptomtext

6/7/22-Shortness of breath, low oxygen saturations, cold chills, fever of 101, body aches, headache, 6/8/22-Thursday morning nose bleeding x2, stood up walked to bathroom started bleeding. Got it to stop and 5 minutes later began bleeding again. Continued symptoms as previous day with fatigue. Arm local reaction: soreness, raised redness of the upper part of the left arm at injection site. "Felt like it had a ball in there", in reference to her arm.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: -
Andere Medikamente: -
Allergien: Amoxicillin Leviquin
Vorherige Impfungen: 1/25/21 Moderna 013L20A Left Deltoid 55 years of age. Moderate Flu like symptoms

VAERS 2314559

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

moderat

Staat: OH
Alter: 65,0
Geschlecht: F
Eingang: 09.06.2022
Impfdatum: 07.06.2022
Beginn: 08.06.2022
Tage bis Beginn: 1,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Limb discomfort Mobility decreased Musculoskeletal discomfort

Symptomtext

Patient called today stating her arm and shoulder are still "bothering her" and she feels that she is unable to "properly use her arm". She is concerned about the placement of the shot, she feels it might have been done too high in her arm and potentially caused damage. She says the shot itself didn't hurt but that the symptoms developed the next day and have worsened and now she is unable to lift her arm or properly use it and it is not getting any better. I told her that it may take a couple of days to feel better, each shot is different, and that I would report the event. She could also speak to the pharmacist who administered it if she called in on Saturday when he was working.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Mobility decreased
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2314279

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

moderat

Staat: CT
Alter: 63,0
Geschlecht: F
Eingang: 09.06.2022
Impfdatum: 03.06.2022
Beginn: 03.06.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Arthralgia Limb injury Paraesthesia

Symptomtext

Error: Shoulder Joint Injury (prolonged pain, tingling, etc.)-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Paraesthesia
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2313117

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037a22b

moderat

Staat: NY
Alter: 29,0
Geschlecht: F
Eingang: 08.06.2022
Impfdatum: 07.06.2022
Beginn: 07.06.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Burning sensation Chest pain Hypoaesthesia Pain in extremity

Symptomtext

sore burning arm, numb fingers, burning in chst and shoulders

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2311611

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

moderat

Staat: MA
Alter: 65,0
Geschlecht: F
Eingang: 07.06.2022
Impfdatum: 29.05.2022
Beginn: 05.06.2022
Tage bis Beginn: 7,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Benign neoplasm of skin Benign soft tissue neoplasm Chills Condition aggravated Cyst Fatigue Lipoma Mass Night sweats Pain Tenderness

Symptomtext

I got my second booster on Sunday, May 29, 2022 at 11:10 am. I had aches, exhaustion, chills and night sweats that night, and night sweats for the following 3 nights. On the morning of Sunday, June 5, I woke to find a grape-sized lump on my back, left side, just below iliac crest. No pain, but tender. Context: my husband recently died of cancer. I went to Urgent Care and was diagnosed with "1 Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk"(a fatty cyst). I have a history of cysts in my 20's and 30's, including a Pilonidal Cyst that was incised twice. I am seeing my I am seeing my dermatologist tomorrow for follow up. I would not have made the connection were it not for a friend who says she breaks out in pimples like a high schooler after each shot. So?causative or coincidence? Don't know.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Condition aggravated
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: None proclivity to cysts in my 20s and 30s
Andere Medikamente: Atorvastatin, Vit D, CoQ10
Allergien: Neosporin, Avocado
Vorherige Impfungen: I had menopausal symptoms (hot flashes & night sweats) for weeks after my first shots (April 1, 2021 & April 29, 2021), and abou

VAERS 2306999

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

moderat

Staat: TX
Alter: 63,0
Geschlecht: F
Eingang: 02.06.2022
Impfdatum: 28.05.2022
Beginn: 28.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Arthralgia Burning sensation Chills Condition aggravated Diarrhoea Fibromyalgia Headache Herpes zoster Impaired work ability Insomnia Muscle spasms Pain Paraesthesia Pruritus Pyrexia

Symptomtext

After receiving the vaccine I had some chills, fever, and achiness. I also had severe joint pain with muscle spasms to the point to where I just couldn't sleep. It felt like a major fibromyalgia flare up. It was very painful. That started to go away on May 29, 2022. On May 30th it got better. On the back of my left thigh under my buttocks I felt a little itch. On May 31st the muscle spasms went away at that time, but again the back of my left thigh kept itching. On June 1st the spot behind my left thigh began alternating from a burning and tingling sensation. I tried looking at it, and though it looked like shingles. I went to the doctor, and they looked at it. They said that it does appear to be a mild case of shingles. I am not working today or tomorrow. They put me on Valtrex 1 gram once every 8 hours to not allow it to get too severe. It's strictly on my left thigh below the buttocks. My immune system reacts extremely sensitive to covid vaccines. The doctor recommended gabapentin. I also had severe uncontrollable diarrhea after the vaccine. It's still a little bad but I'm almost over that. I didn't have any vomiting just headaches, chills, and a light fever. My blood type is A-. I found out that my family with an A- blood type gets shingles.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Condition aggravated
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: None
Vorgeschichte: Fibromyalgia; Severe Herniations in my neck and spine; High Blood Pressure; Hypothyroidism; High Cholesterol; Chronic Pain
Andere Medikamente: Atenolol 50mg 1xday; Protonix 40mg 1xday; Adderall 30mg 1xday; Prozac 10mg 1xday; Lipitor 40mg 1xday; levothyroxine 112mcg 1xday; liothyronine 5mcg 1xday; Inderal 10mg 1xday; cetirizine hydrochloride 10mg 1xday
Allergien: Penicillin; codeine; synthetic codeine; MSG; sodium; nitrates; sulfites; preservatives
Vorherige Impfungen: 1st dose Covid Vaccine (3/20/2021), less than 5 minutes after getting this vaccine I had the weirdest feeling. It felt like the

VAERS 2305064

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

moderat

Staat: MI
Alter: 60,0
Geschlecht: F
Eingang: 01.06.2022
Impfdatum: 26.05.2022
Beginn: 26.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Anxiety Arthropod bite Biopsy skin Blister Blood culture Blood lactic acid normal Blood test C-reactive protein normal Condition aggravated Erythema Full blood count normal Glomerular filtration rate normal Infected bite Metabolic function test normal Pemphigoid Pruritus Red blood cell sedimentation rate increased Swelling

Symptomtext

Ten mintues after vaccination (Thursday 5/26) had a couple of hives that itched. That pm through Friday (5/27) I appeared to have hives. I also had a UTI and assumed hives related. Went to Urgent Care 5/28 for UTI. Also had doctor look at what I thought was a bug bite that I had scratched and was infected. Treated me for both. 5/28 PM blisters began for form where all hives and potential bite were located. 6/30 due to significant exacerbation; blisters, redness and swelling doc's office encouraged me to go back to Urgent Care. Urgent Care worried I had necrotizing fasciitis and referred me to ER. ER r/o necrotizing fasciitis but could not rule out chicken pox, MRSA, but also discussed tick bites etc... Treated symptoms and referred to a dermatologist. Dermatologist suspects bullous pemphigoid. Punch biopsy taken

Weitere VAERSDATA-Felder

Praegender Schweregrund: Condition aggravated
Hospital-Tage: -
Labordaten: 528: Urine dipstick. Worried about infection around bite - Keflex 500mg 4 x/day. 5/30 ER visit: Prescribed Doxy 100mg 2x/day (told to continue Keflex). Prednisone 20mg 1 for 5 days. Blood tests completed; Blood Culture (no results to date), C-reactive protein - neg, CBC, Comprehensive panel, EGFR and lactic acid all normal. High sedimentation rate. 5/31 Dermatology vist; Punch Biopsy taken x 2; and a biopsy of blister. Results expected within two weeks. Perscribed Clobetasol Propionate 2x/daily and increased prednisone to 10mg with titration; 4 per day for 4 days, 3 for 4 days, 2 for 4 and 1 for 4.
Aktuelle Erkrankungen: infected bug bite? UTI
Vorgeschichte: high blood pressure, osteoarthritis of spine, low thyroid
Andere Medikamente: Snythroid; lisinopril, meloxicam; OTC: Women's probiotic, Multivitamin, Mg Maleate
Allergien: penicillin
Vorherige Impfungen: -

VAERS 2304965

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037a22b

moderat

Staat: VA
Alter: 74,0
Geschlecht: F
Eingang: 01.06.2022
Impfdatum: 31.05.2022
Beginn: 31.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Chills Headache Tremor

Symptomtext

About 12 hours after the shot I got severe chills and shaking, with a headache. This lasted about 6 and a half hours, in spite of taking a Tylenol ever 4-5 hours after the shot.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Tremor
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Atenolol, Nexium, vitamins d, e, b12, biotin, algaecal
Allergien: Tetracycline, doxycycline, cipro, penicillin, shellfish, latex, medical dyes
Vorherige Impfungen: Similar reaction to the first Moderna booster given on March 22, 2021

VAERS 2300285

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

moderat

Staat: NY
Alter: 68,0
Geschlecht: M
Eingang: 28.05.2022
Impfdatum: 24.05.2022
Beginn: 24.05.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Arthralgia Musculoskeletal pain Paraesthesia

Symptomtext

Dull pain in buttocks/Pain when he was laying straight on bed; Tingling pain in buttocks; Hip pain; This spontaneous case was reported by a patient and describes the occurrence of MUSCULOSKELETAL PAIN (Dull pain in buttocks/Pain when he was laying straight on bed), PARAESTHESIA (Tingling pain in buttocks) and ARTHRALGIA (Hip pain) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037A22B and 041A2B) for COVID-19 vaccination. Previously administered products included for Product used for unknown indication: Pfizer (Lot : EM9810) on 05-Feb-2021 and Pfizer (Lot : EM6205) on 24-Feb-2021. Past adverse reactions to the above products included No adverse event with Pfizer and Pfizer. Concurrent medical conditions included Drug allergy (Yes to medication allergies, but did not specify which and no food allergies.). Concomitant products included LISINOPRIL and SITAGLIPTIN PHOSPHATE (JANUVIA) for an unknown indication. On 24-May-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-May-2022, the patient experienced MUSCULOSKELETAL PAIN (Dull pain in buttocks/Pain when he was laying straight on bed), PARAESTHESIA (Tingling pain in buttocks) and ARTHRALGIA (Hip pain). The patient was treated with PARACETAMOL (TYLENOL) for Buttock pain, at an unspecified dose and frequency. At the time of the report, MUSCULOSKELETAL PAIN (Dull pain in buttocks/Pain when he was laying straight on bed), PARAESTHESIA (Tingling pain in buttocks) and ARTHRALGIA (Hip pain) outcome was unknown. Other concomitant product used include Statins . Patient states that he started experiencing this pain when he was laying straight on bed. He explains that the pain is so subtle that he can walk, bend and work even when it is a little uncomfortable when he lays down.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Paraesthesia
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Drug allergy (Yes to medication allergies, but did not specify which and no food allergies.)
Vorgeschichte: -
Andere Medikamente: LISINOPRIL; JANUVIA
Allergien: -
Vorherige Impfungen: -

VAERS 2296443

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

moderat

Staat: -
Alter: 73,0
Geschlecht: F
Eingang: 26.05.2022
Impfdatum: 21.05.2022
Beginn: 22.05.2022
Tage bis Beginn: 1,0
Dosis: 4
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: unbekannt

Hypotension

Symptomtext

hypotension; sounds like orthostatic in nature

Weitere VAERSDATA-Felder

Praegender Schweregrund: Hypotension
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2289893

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

moderat

Staat: FL
Alter: 38,0
Geschlecht: F
Eingang: 22.05.2022
Impfdatum: 19.05.2022
Beginn: 19.05.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Arthralgia Chills Gait disturbance Headache Injection site pain Injection site pruritus Injection site warmth Migraine Muscle spasms Nausea Pyrexia

Symptomtext

Soreness, warmth, and itchy skin at the injection site began on the evening of 5/19/22 (date of vaccination). On 5/20/22, around mid-day (12:00-1:30pm) more severe adverse reactions occurred. A headache progressed to migraine progressed and Sumatriptan was taken to alleviate the pain. Joint pain throughout the body (all major extremities) which caused difficulty walking/ambulating. Also severe, frequent, consistent muscle spasms and cramps (an inability to lay still for more than 30 seconds), fever, chills, and mild nausea. The migraine subsided within 90 minutes of taking medicine. The other symptoms lasted for approximately 2-3 hours. Note, the spasm were predominately on the left side of the body. The fever comes and goes, lasting up to 45 minutes. Ice packs on my body and a fan were used to quickly cool me down. As of today 5/22/22, fever continues to come in less frequent waves and seems to be managed with Tylenol, the injection site is still warm to the touch, itchy, and sore. *I refused to go to the hospital despite the concerns of my husband.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Migraine
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: None
Vorgeschichte: Rheumatoid Arthritis and Lupus
Andere Medikamente: Methylphenidate 54mg, Folic Acid 3mg, Vitamin D, Acidophilus
Allergien: Actemra, Ultram
Vorherige Impfungen: -

VAERS 2649881

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

mild

Staat: -
Alter: 75,0
Geschlecht: M
Eingang: 27.06.2023
Impfdatum: 08.09.2022
Beginn: 07.02.2023
Tage bis Beginn: 152,0
Dosis: 5
Route/Site: UN / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Arthralgia Neuropathy peripheral

Symptomtext

G62.9 NEUROPATHY 4/11/2023 RIGHT HIP JOINT PAIN G62.9 NEUROPATHY 4/11/2023 RIGHT HIP JOINT PAIN G62.9 NEUROPATHY 4/11/2023 RIGHT HIP JOINT PAIN

Weitere VAERSDATA-Felder

Praegender Schweregrund: Arthralgia
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2592448

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

mild

Staat: MI
Alter: 92,0
Geschlecht: F
Eingang: 07.03.2023
Impfdatum: 03.06.2022
Beginn: 20.02.2023
Tage bis Beginn: 262,0
Dosis: 3
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 Fatigue Pyrexia SARS-CoV-2 test positive

Symptomtext

02/20/23 presents to ED for "fever, fatigue". PMHx of ". fib on Eliquis, CAD status post CABG ?2, diastolic heart failure with EF of 55%, hypertension, sick sinus syndrome status post pacemaker placement, hemorrhoids, and PUD"

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: 02/20/23 SARS-CoV-2 (COVID-19) by NAA detected
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2572170

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

mild

Staat: CA
Alter: 74,0
Geschlecht: M
Eingang: 31.01.2023
Impfdatum: 31.05.2022
Beginn: 14.06.2022
Tage bis Beginn: 14,0
Dosis: 5
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Mechanical urticaria Pruritus Scratch Urticaria

Symptomtext

We went to an allergist and found out he had Dermographia, known a skin writing. Anything that slightly scratches his skin he gets raised welts or hives and marks usual disappear within 30 minutes and it could be triggered by medications and infections. He also has intense itching, itching starts from various things. He was told to take an antihistamine and if he doesn't take it, it gets worse. We were told it could last for years. He also uses hydrocortisone.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Mechanical urticaria
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: None
Vorgeschichte: Rheumatoid Arthritis; Depression; Heart Issues
Andere Medikamente: PLAQUENIL; WELLBUTRIN; TOPROL XL; LIPITOR; PROZAC; D-3; calcium; folic acid; baby aspirin; fish oil
Allergien: Corn products
Vorherige Impfungen: -

VAERS 2539436

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

mild

Staat: IL
Alter: 49,0
Geschlecht: F
Eingang: 21.12.2022
Impfdatum: 21.06.2022
Beginn: 15.12.2022
Tage bis Beginn: 177,0
Dosis: 3
Route/Site: SYR / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Ageusia Anosmia Asthenia COVID-19 Headache Respiratory tract congestion SARS-CoV-2 test positive

Symptomtext

My COVID-19 infection started on 12/15/2022. I had a headache, congestions, and weakness. On 12/16/202 in the evening about 06:30PM - 07:00PM I was having a drink and I couldn't smell or taste anything. I tested with a home COVID-19 test on 12/16/2022 which was positive. On 12/18/2022 I went to the local clinic and they prescribed me with PAXLOVID for 5 days.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Headache
Hospital-Tage: -
Labordaten: 21DEC2022 COVID-19 test positive
Aktuelle Erkrankungen: None
Vorgeschichte: Lupus; Autoimmune; Hashimoto's Disease; CODP; Hypertension
Andere Medikamente: UNITHROID; hydroxy chlorine; WELLBUTRIN; amlodipine; montelukast; BREO; multivitamins; probiotics; fish oil; tea; XIIDRA
Allergien: Doxycycline
Vorherige Impfungen: -

VAERS 2537893

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

mild

Staat: OK
Alter: 77,0
Geschlecht: F
Eingang: 20.12.2022
Impfdatum: 30.06.2022
Beginn: 30.09.2022
Tage bis Beginn: 92,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja

Blood test normal COVID-19 Chest X-ray normal Fatigue Influenza Influenza B virus test positive Nasopharyngitis Oxygen saturation decreased SARS-CoV-2 test positive Wheelchair user

Symptomtext

I thought I was getting a cold. I was so tired. I tested positive for COVID-19 on October 02, 2022, and it was positive. I had a telehealth visit with the nurse practitioner. The symptoms I had were that of pneumonia. I physically went to see the doctor on November 13, 2022, and they checked my blood oxygen level which was really low around 88. They had the medical staff personnel to take me to the emergency room in a wheelchair. They did a flu test and I tested positive for the B strain of flu. They admitted me and I was taking TAMIFLU, amoxicillin, and steroids via IV. I was on 2 liters of oxygen and given a generic form of ROBITUSSIN. I was hospitalized for 6 days. When I was discharged, I was prescribed oxygen which I took for about a week and a half. I was placed on a machine to determine how much oxygen I was using at night and if it's within normal levels, they will pick up the oxygen. I was placed in isolation due to the flu virus.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: 6,0
Labordaten: COVID-19 home test positive October 02, 2022. Flu test November 13, 2022 positive flu B. Chest X-ray normal October 02, 2022. Blood work normal October 02, 2022.
Aktuelle Erkrankungen: N/A
Vorgeschichte: Emphysema
Andere Medikamente: Atorvastatin; SYMBICORT; calcium with D3; multivitamin CENTRUM SILVER; loratadine; vitamin D3
Allergien: Neomycin; Unknown antibiotic
Vorherige Impfungen: -

VAERS 2529025

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

mild

Staat: VT
Alter: 31,0
Geschlecht: F
Eingang: 12.12.2022
Impfdatum: 07.06.2022
Beginn: 06.11.2022
Tage bis Beginn: 152,0
Dosis: N/A
Route/Site: SYR / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Fatigue Post-acute COVID-19 syndrome SARS-CoV-2 test positive

Symptomtext

Since my second booster I have now had COVID a third time. I have had COVID three times since January 2022. After conversations with my doctor, we have spoken about whether my body is having a hard time really getting rid of the virus. I have had adverse effects to all vaccines. I am in the process of being tested for issues relating to fatigue and there is concern that I could unknowingly be experiencing some sort of "long COVID" side effects.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: COVID for the second time in May 2022 and Flu in April 2022
Vorgeschichte: Migraines, Anxiety, Depression, PTSD
Andere Medikamente: -
Allergien: Shellfish and Seafood
Vorherige Impfungen: Jansen COVID Vaccine, 1st dose.

VAERS 2528856

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

mild

Staat: MI
Alter: 71,0
Geschlecht: F
Eingang: 12.12.2022
Impfdatum: 27.05.2022
Beginn: 21.11.2022
Tage bis Beginn: 178,0
Dosis: 3
Route/Site: UN / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Fatigue Malaise Respiratory viral panel SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

Breakthrough COVID infection. Symptom of malaise and fatigue. Unsure symptom onset. Positive test collected 11/21/2022.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: Respiratory virus panel by PCR positive for COVID on 11/21/2022.
Aktuelle Erkrankungen: -
Vorgeschichte: Chronic obstructive pulmonary disease, type 2 diabetes mellitus, congestive heart failure, coronary artery disease
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2525622

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

mild

Staat: TX
Alter: 70,0
Geschlecht: M
Eingang: 07.12.2022
Impfdatum: 07.06.2022
Beginn: 28.09.2022
Tage bis Beginn: 113,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Headache Malaise Rhinorrhoea SARS-CoV-2 test positive

Symptomtext

On 09/28/2022 in the evening I had slight headaches and runny nose. I did a COVID-19 home test which was positive. My symptoms were very mild . On 09/29/2022 I called my doctor who prescribed me Steroids' for 5 days. I felt better within 4 days. I tested positive for 12 days. On 10/12/2022 I tested negative.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Headache
Hospital-Tage: -
Labordaten: 07DEC2022 COVID-19 Test-Positive
Aktuelle Erkrankungen: None
Vorgeschichte: High Blood Pressure;
Andere Medikamente: Atorvastatin
Allergien: None
Vorherige Impfungen: -

VAERS 2522956

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

mild

Staat: NY
Alter: 63,0
Geschlecht: M
Eingang: 05.12.2022
Impfdatum: 03.06.2022
Beginn: 26.11.2022
Tage bis Beginn: 176,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Cough Gastrointestinal disorder Headache Pain Respiratory tract congestion SARS-CoV-2 test positive

Symptomtext

11/26/2022 started with headache later in the day. The pain was severe for a few days and then was lessor. Congestion and intestinal issues, started on 11/27 with a mild cough. Symptoms continued but did not get worse until 11/ 29. 11/30 I took an at home COVID-19 test that was positive. I spoke to the doctor that day. Doctor prescribed PAXLOVID, MUCINEX and rest. Participant only took MUCINEX, opted out of PAXLOVID. Congestion lasted about a week. Headaches tapered off. Headaches pretty well gone by 12/5.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Headache
Hospital-Tage: -
Labordaten: COVID-19 test that was positive 11/26/2022.
Aktuelle Erkrankungen: No
Vorgeschichte: Diabetes; High Blood Pressure
Andere Medikamente: Metformin; eplerenone; amlodipine; losartan; atorvastatin; omeprazole; levothyroxine; trazadone; vitamin C; peppermint oil; multivitamin; fish oil; B complex; FIBERCON
Allergien: Iodine; shellfish
Vorherige Impfungen: -

VAERS 2516825

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

mild

Staat: MD
Alter: 58,0
Geschlecht: F
Eingang: 25.11.2022
Impfdatum: 25.05.2022
Beginn: 31.10.2022
Tage bis Beginn: 159,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Chills Cough Fatigue Headache Night sweats Oropharyngeal pain Pain Parosmia Pyrexia Respiratory tract congestion Rhinorrhoea SARS-CoV-2 test positive Taste disorder

Symptomtext

I tested positive for COVID-19 on 10/31/2022. On 10/28/2022, I noticed I had a sore throat, terrible headaches, body aches, congestion, runny nose, chills, low grade fever, dry cough, night sweats, fatigue, altered smell, and altered taste. I did not have diarrhea, nausea, or vomiting. I received the monoclonal antibody therapy, bebtelovimab was the name of it. They did not want me to take PAXLOVID. I am feeling much better now.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: 31OCT2022 COVID-19 test positive
Aktuelle Erkrankungen: N/A
Vorgeschichte: Tricuspid Value Regurgitation; Sjogren's Disease; Neuropathy; Osteoporosis; Raynaud Syndrome; Osteoarthritis
Andere Medikamente: Vitamin D3; amlodipine; pregabalin; TYLENOL; hydroxychloroquine; furosemide; baclofen
Allergien: Penicillin
Vorherige Impfungen: -

VAERS 2515296

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

mild

Staat: NY
Alter: 69,0
Geschlecht: M
Eingang: 23.11.2022
Impfdatum: 24.05.2022
Beginn: 28.10.2022
Tage bis Beginn: 157,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

COVID-19 Dysgeusia Facial pain Feeling abnormal Headache Nasopharyngitis Oropharyngeal pain Pain Parosmia Rhinorrhoea SARS-CoV-2 test positive Sinus disorder Sinus pain Toothache

Symptomtext

Four days before I tested positive for COVID-19 my wife had tested positive. I was having a sore throat but because she was positive, I took a test, and it was positive. I then had a runny nose, a temperature of 99, and just had bad cold symptoms. After about three days in my primary care doctor and my cardiologist wanted me to take Paxlovid, the bad taste was horrible, but I was having horrible anxiety and an uneasiness taking it. About the second day I was having tooth aches and throbbing like sinus issues on the right side of my face. At that point I went to a walk-in clinic, and they gave me ten days of a Doxycycline but after four days of that it did nothing. I was now having that fogginess that comes with COVID. I ended up at my PCP and also at my dentist to see if I really had something going on with my tooth and that was causing my major pain, but they found nothing at the dentist and figured it had to sinus related. Soon after that the sinus pain moved from my right side of my face and to my forehead area and it was present in both places. On day seven I was told to stop the Doxycycline and put onto Cefuroxime. This new medication eliminated the right side of my face pain, but it remained in the forehead area. I have this horrible fowl smelling slightly metallic smell and taste in my nose and mouth. I now only have mild cold symptoms but have tested negative for COVID but I am taking Tylenol every day to feel better.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Facial pain
Hospital-Tage: -
Labordaten: COVID-19 Home Test
Aktuelle Erkrankungen: N/A
Vorgeschichte: Cardiovascular Disease
Andere Medikamente: Baby Aspirin; Ezetimibe; Atorvastatin; Omega 3; CoQ10
Allergien: Penicillin
Vorherige Impfungen: -

VAERS 2466717

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

mild

Staat: OH
Alter: 82,0
Geschlecht: F
Eingang: 01.10.2022
Impfdatum: 30.06.2022
Beginn: 10.09.2022
Tage bis Beginn: 72,0
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Acoustic stimulation tests Balance disorder Deafness Dizziness

Symptomtext

When I got out of bed in the morning I started to walk across the room to the bathroom but instead took off at a run to the left, only stopping when I ran into the dresser. I scheduled an appointment with an ENT doctor, who I saw on 09/27/2022. He found no ear infection. He made an appointment for an inner ear exam on 10/05/2022. I also had a hearing exam on 09/27/22 at Dr. office, showing loss of hearing, with a hearing aid presentation scheduled for 10/12/2022. My existing hearing loss is worse after the 09/10/22 incident, as is my existing unsteadiness on feet. I also have some dizziness that comes and goes.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dizziness
Hospital-Tage: -
Labordaten: No results yet.
Aktuelle Erkrankungen: -
Vorgeschichte: Fibromyalgia; Neuropathy; ARMD; Rheumatoid Arthritis; Osteoarthritis; Type 2 Diabetes; Osteopenia; Obstr; Sleep Apnea; Bradycardia.
Andere Medikamente: Eylea; Gabapentin; Metformin; Nexium; PreserVision; Tramadol; Valsartan; Welchol; Aspercreme; Aspirin;Biotin; Vit. B1; Vit. D3; Fish Oil; Folic Acid; HCT; Multi-vitamin; Optive eye drops; Turmeric Welchol
Allergien: Levofloxacin; Lisinopril; Doxycycline; Fenofibrate; Amoxicillin.
Vorherige Impfungen: -

VAERS 2461484

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

mild

Staat: FL
Alter: 65,0
Geschlecht: M
Eingang: 27.09.2022
Impfdatum: 25.05.2022
Beginn: 01.05.2022
Tage bis Beginn: -
Dosis: 4
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Immunisation reaction Rash SARS-CoV-2 test Skin disorder Urticaria

Symptomtext

really bad reaction / severe reaction; made my skin go crazy; half of my body was covered in welts; minor, then a moderate, and a severe rash for each dose; This spontaneous case was reported by a patient and describes the occurrence of IMMUNISATION REACTION (really bad reaction / severe reaction), SKIN DISORDER (made my skin go crazy), URTICARIA (half of my body was covered in welts) and RASH (minor, then a moderate, and a severe rash for each dose) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A22B) for COVID-19 vaccination. Previously administered products included for Drug use for unknown indication: J&J vaccine (Dose Number: 1st booster, Lot number: 212A21A and Dose: unknown) on 23-Oct-2021. Past adverse reactions to the above products included No adverse event with J&J vaccine. Concurrent medical conditions included Drug allergy (allergy to codein) and Prostate cancer (started coming back in 2000) since 1998. Concomitant products included RELUGOLIX (ORGOVYX), BICALUTAMIDE (CASODEX), DUTASTERIDE (AVODART) and BISOPROLOL for an unknown indication. On 25-May-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In May 2022, the patient experienced IMMUNISATION REACTION (really bad reaction / severe reaction), SKIN DISORDER (made my skin go crazy), URTICARIA (half of my body was covered in welts) and RASH (minor, then a moderate, and a severe rash for each dose). The patient was treated with TRIAMCINOLONE at a dose of UNK, 0.1%; PREDNISONE at a dose of UNK, pills and CORTISONE at an unspecified dose and frequency. In 2022, IMMUNISATION REACTION (really bad reaction / severe reaction) and SKIN DISORDER (made my skin go crazy) had resolved. In September 2022, URTICARIA (half of my body was covered in welts) and RASH (minor, then a moderate, and a severe rash for each dose) had resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In February 2022, SARS-CoV-2 test: (Positive) Positive. Caller mentioned he got 2 primary and booster shots, but never had the Pfizer COVID-19 Vaccine. Caller got the Moderna, then the J & J and the Moderna again; reported having a rash for each 10-12 days after the shot. Caller said he got a minor, then a moderate, and a severe rash for each dose and was given a cortisone injection that lasted 5-6 weeks. After the Moderna vaccine, the patient had a really bad reaction. Half of patients body was covered in welts. That lasted 4-5 weeks to go away, and the patient had to get a Cortisone shot. It seemed to the patient that the reaction got worse and worse all three times. The patient was trying to keep boosted as the patient is a cancer patient, but he is fearful of getting Moderna vaccine. The patient was trying to figure out if the patient was allergic to some ingredient in the vaccine or mRNA technology. The patient reported that the steroid creams made his skin go crazy and did not really help him. The patient was strongly encouraged to speak with a healthcare provider. It was reported that patient had minor, moderate and sever rash for each dose. The patient received Flu vaccine in Sep 2022. The patient visited dermatologist visit after booster dose. The patient never experienced similar event in the past before getting Moderna doses. The patient was prescribed with a cream (triamcinolone ointment 0.1 percent) after the second dose. The patient was put on prednisone pills after the booster. When that did not work, he got a cortisone shot from the dermatologist office. This case was linked to MOD-2022-648653, MOD-2021-339509. Most recent FOLLOW-UP information incorporated above includes: On 22-Sep-2022: Live significant follow up : narrative and event updated

Weitere VAERSDATA-Felder

Praegender Schweregrund: Rash
Hospital-Tage: -
Labordaten: Test Date: 202202; Test Name: COVID-19 virus test; Test Result: Positive ; Result Unstructured Data: Positive
Aktuelle Erkrankungen: Drug allergy (allergy to codein); Prostate cancer (started coming back in 2000)
Vorgeschichte: -
Andere Medikamente: ORGOVYX; CASODEX; AVODART; BISOPROLOL
Allergien: -
Vorherige Impfungen: -

VAERS 2461436

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

mild

Staat: FL
Alter: -
Geschlecht: M
Eingang: 27.09.2022
Impfdatum: 23.10.2021
Beginn: 23.10.2021
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 immunisation SARS-CoV-2 test SARS-CoV-2 test positive Urticaria

Symptomtext

COVID-19 VIRUS TEST POSITIVE; HALF OF THE BODY COVERED WITH WELTS; REVACCINATION WITH DIFFERENT COVID-19 VACCINE; This spontaneous report received from a patient through other manufacturer (Moderna) concerned a male of unspecified age, race and ethnicity. The patient's height, and weight were not reported. The patient's concurrent conditions included: prostate cancer (1998, started coming back in 2000), and codeine allergy. The patient previously received non-company suspect vaccine, first dose, Moderna Covid-19 vaccine (elasomeran) (dose number in series 1) (form of administration, route of administration were not reported, batch number: 011A21A, expiry: unknown), dose was not reported, administered on 05-MAR-2021 for covid-19 prophylaxis. On an unspecified date in MAR-2021, the patient had severe reactions and felt under the weather for 24 hours. On an unspecified date in MAR-2021, two weeks after, he had rash around different parts of his body, arm and legs. The rashes went away and patient thought it was minor poison ivy following vaccination with Moderna Covid-19 vaccine (elasomeran) (dose number in series 1). The patient recovered from felt under the weather for 24 hours and rash around different parts of his body, arm and legs (dose number in series 1). The patient received non-company suspect vaccine, second dose, Moderna Covid-19 vaccine (elasomeran) (dose number in series 2) (form of administration, route of administration were not reported, batch number: 048A21A, expiry: unknown), dose was not reported, administered on 02-APR-2021 for covid-19 prophylaxis. On an unspecified date in APR-2021, two weeks later after the vaccination, he got more of the rash and it took 2-3 weeks to recover. The patient thought it was due to gardening and visited dermatologist (dose number in series 2). The patient recovered from got more of the rash (dose number in series 2). The patient received covid-19 vaccine ad26.cov2.s (dose number in series 3) (suspension for injection, route of admin not reported, batch number: 212A21A, expiry: UNKNOWN) dose was not reported, 1 total, third dose administered on 23-OCT-2021 for covid-19 prophylaxis. On 23-OCT-2021, the patient experienced revaccination with different covid-19 vaccine (dose number in series 3). On an unspecified date in FEB-2022, the patient experienced covid-19 virus test positive (dose number in series 3). Laboratory data included: COVID-19 virus test Positive. Concomitant medications included: bicalutamide, bisoprolol fumarate/hydrochlorothiazide, dutasteride, influenza vaccine, prednisone and relugolix. The patient additionally received Non-company suspect vaccine, fourth dose, Moderna Covid-19 vaccine (elasomeran) (dose number in series 4) (form of admin, route of admin, and were not reported, batch number: 037A22B, expiry: UNKNOWN) dose was not reported, administered on 25-MAY-2022 for covid-19 prophylaxis. On an unspecified date in 2022, the patient experienced the bad reaction and half of his body was covered in welts and he visited dermatologist following vaccination. It lasted for 4-5 weeks to go away and patient took corstione shot (dose number in series 4). The patient was prescribed creams (triamcinolone ointment 0.1%) after the second and booster doses. They put him on prednisone pills after the booster. When that didn't work, he got a Cortisone shot from the dermatologist office. The action taken with covid-19 vaccine ad26.cov2.s, and elasomeran was not applicable. The patient recovered from half of the body covered with welts, and the outcome of covid-19 virus test positive and revaccination with different covid-19 vaccine was not reported. This report was non-serious.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Urticaria
Hospital-Tage: -
Labordaten: Test Date: 202202; Test Name: COVID-19 VIRUS TEST; Test Result: Positive
Aktuelle Erkrankungen: Drug allergy; Prostate cancer (started coming back in 2000)
Vorgeschichte: -
Andere Medikamente: INFLUENZA VACCINE; PREDNISONE; TRIAMCINOLONE; CORTISONE; ORGOVYX; CASODEX; AVODART; BISPROLOL COMP
Allergien: -
Vorherige Impfungen: -

VAERS 2434611

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

mild

Staat: VT
Alter: 56,0
Geschlecht: M
Eingang: 08.09.2022
Impfdatum: 04.06.2022
Beginn: 01.07.2022
Tage bis Beginn: 27,0
Dosis: 4
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Arthralgia Bordetella test negative Chills Headache Myalgia Pyrexia

Symptomtext

On 7/20/22 sudden mild fever, muscle and joint pain, chills, headache. Resolved in 36 hours. Then on 8/3/22 the same symptoms occurred and was advised to go to urgent care, Physicians assistant prescribed Deoxycycline antibiotic and blood test for Lyme disease as I had been hiking and found a tick in my home. Tick was not engorged and I had no indication it had attached to my skin. The blood test I was told came back negative.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Arthralgia
Hospital-Tage: -
Labordaten: 8/3 Lyme Blood test.
Aktuelle Erkrankungen: None
Vorgeschichte: High Cholesterol
Andere Medikamente: Fish oil, Vitamin D
Allergien: None
Vorherige Impfungen: -

VAERS 2433603

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

mild

Staat: MI
Alter: 77,0
Geschlecht: M
Eingang: 08.09.2022
Impfdatum: 27.01.2021
Beginn: 24.08.2022
Tage bis Beginn: 574,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 Fall Mental status changes Pyrexia SARS-CoV-2 test positive

Symptomtext

08/24/22 presents to EC ED for "altered mental status, fall, fever". PMHx of "HTN, HLD, AAA, and a pacemaker"

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pyrexia
Hospital-Tage: -
Labordaten: 08/24/22 SARS-CoV-2 (COVID-19) by NAA detected
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2420920

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

mild

Staat: NY
Alter: 66,0
Geschlecht: F
Eingang: 26.08.2022
Impfdatum: 23.05.2022
Beginn: 15.07.2022
Tage bis Beginn: 53,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Cough Fatigue Headache Pain Pyrexia Respiratory tract congestion Rhinorrhoea SARS-CoV-2 test positive

Symptomtext

The first day I had fever and aches with fatigue and a headache. That lasted for 24hrs. I took PAXLOVID for 5 days. Because I didn't have enough COVID-19 tests after I finished with PAXLOVID I self tested and was positive and continued to for a total of 3 weeks. I'm not sure if I tested negative at one point and then rebounded. I had a rollercoaster ride of symptoms that was primarily congestion, runny nose and a cough which came and went. I continue to have a little bit of a cough today which is unusual for me because I don't have allergies.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: COVID-19 self test positive
Aktuelle Erkrankungen: No
Vorgeschichte: Hypothyroid; 2007 breast cancer mastectomy
Andere Medikamente: Levothyroxine
Allergien: LEVAQUIN antibiotic
Vorherige Impfungen: -

VAERS 2409512

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

mild

Staat: HI
Alter: 82,0
Geschlecht: M
Eingang: 24.08.2022
Impfdatum: 19.01.2021
Beginn: 04.06.2022
Tage bis Beginn: 501,0
Dosis: 4
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Arthropod bite Body temperature COVID-19 COVID-19 immunisation Cellulitis Drug ineffective SARS-CoV-2 test Diarrhoea Interchange of vaccine products

Symptomtext

cellulitis; COVID-19/anosmia/taste is altered/constant coughing/fever/headache; bug bite on his forearm; he started getting diarrhea and assumed it was from doxycycline and the diarrhea began 1-2 days after starting Doxycycline; Interchange of vaccine products; Revaccination with different COVID-19 vaccine; This spontaneous case was reported by a patient and describes the occurrence of CELLULITIS (cellulitis) in an 82-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A22B) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below. Co-suspect product included non-company product TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) for an unknown indication. Concurrent medical conditions included Asthma (diagnosed with asthma about 10 years ago. Albuterol inhaler,uses it 2-3 times a year.). Concomitant products included ALBUTEROL [SALBUTAMOL] for Asthma, ATORVASTATIN and APIXABAN (ELIQUIS) for an unknown indication. On 19-Jan-2021, the patient received first dose of TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) (unknown route) 1 dosage form. On 10-Feb-2021, received second dose of TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) (unknown route) dosage was changed to 1 dosage form. On 23-Sep-2021, received third dose of TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) (unknown route) dosage was changed to 1 dosage form. On 04-Jun-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Jun-2022, the patient experienced INTERCHANGE OF VACCINE PRODUCTS (Interchange of vaccine products) and COVID-19 IMMUNISATION (Revaccination with different COVID-19 vaccine). In July 2022, the patient experienced CELLULITIS (cellulitis) (seriousness criterion medically significant), COVID-19 (COVID-19/anosmia/taste is altered/constant coughing/fever/headache), ARTHROPOD BITE (bug bite on his forearm) and DIARRHOEA (he started getting diarrhea and assumed it was from doxycycline and the diarrhea began 1-2 days after starting Doxycycline). The patient was treated with NIRMATRELVIR, RITONAVIR (PAXLOVID) from 24-Jul-2022 to 29-Jul-2022 for COVID-19 treatment, at an unspecified dose and frequency; ACETYLSALICYLIC ACID, CAFFEINE (ANACIN [ACETYLSALICYLIC ACID;CAFFEINE]) at a dose of took 2 tablets once or twice and DOXYCYCLINE on 21-Jul-2022 at a dose of 100 milligram. At the time of the report, CELLULITIS (cellulitis), ARTHROPOD BITE (bug bite on his forearm), DIARRHOEA (he started getting diarrhea and assumed it was from doxycycline and the diarrhea began 1-2 days after starting Doxycycline), INTERCHANGE OF VACCINE PRODUCTS (Interchange of vaccine products) and COVID-19 IMMUNISATION (Revaccination with different COVID-19 vaccine) outcome was unknown and COVID-19 (COVID-19/anosmia/taste is altered/constant coughing/fever/headache) had not resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 21-Jul-2022, SARS-CoV-2 test: (Negative) Negative. On 07-Aug-2022, SARS-CoV-2 test: (Positive) Positive. On an unknown date, Body temperature: 101.3 degree Celsius. On an unknown date, SARS-CoV-2 test: (Negative) Negative, (Negative) Negative and (Positive) PCR came back Positive. NDC number of Paxlovid was reported as 0069-1085-30. Patient had a bug bite on his forearm and thought it was a mosquito bite and a couple days later this got bigger and redder and was not going away and lasted a couple weeks so then he went to the doctor and was diagnosed with cellulitis and does not know if it was a spider bite and he was then put on doxycycline from 21-Jul-2022.The patient was with a group of people that had Covid the week before so he thought he was exposed to them and better get tested and it was a negative PCR test on 21Jul2022 at 11:30am. On 24-Jul-2022, Patient had a positive home test, took a photo of home test, and was sent to the doctor. Doctor prescribed Paxlovid. Patient took Paxlovid for 5 days of the regimen and felt better. After 3 days after stopping Paxlovid, the rebound came worse than it was before and was tested positive on 07-Aug-2022..The most concerning thing to the caller was through out the entire course of Paxlovid, the patient had no adverse events, but had anosmia and symptoms of food tasted a little bit different after completing Paxlovid. Patient noticed that he could not smell anything. He noticed that somethings are not tasted quite right. Paxlovid medication affected his taste. After a day or so Paxlovid was over, patient was not paying attention to the things that did not taste quite right and did not notice anything.Patient started getting diarrhea after 1-2 days of doxycycline. After he got most recent PCR positive, he decided to get more home test kits, and was negative for two days. At the same time, he got the results from the PCR came back positive. Patient reported that, had no side effects and had zero side effects from all covid vaccines. Company Comment This is a spontaneous case reported by a patient concerning an 82-year-old male patient with no relevant medical history, who experienced the unexpected, serious, medically significant event of Cellulitis and the unexpected, non-serious AESI of COVID-19, which occurred on an unknown date on the next month after the fourth dose of mRNA-1273 vaccination schedule, used as the second booster dose, previously vaccinated with three doses of Pfizer COVID-19 vaccine. The patient experienced symptoms and potential positive self home test several days ago and called his doctor who prescribed Paxlovid, which he took for five days and felt better. About three days after he stopped the medication, he rebounded and it came back worse than before. The patient tested positive about a week after he stopped Paxlovid. He was concerned about anosmia and and taste disorder but had also headache (began two days after he stopped Paxlovid) and pyrexia. When the patient started Paxlovid, he had a bug bite on his forearm that turned into a cellulitis, that was treated with Doxycycline by a doctor. The non-serious event of bug bite could be due to Arthropod bite, however, since the outcome and the exact date onset of the events are unknown, Authority was conservatively retained as related. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.; Sender's Comments: This is a spontaneous case reported by a patient concerning an 82-year-old male patient with no relevant medical history, who experienced the unexpected, serious, medically significant event of Cellulitis and the unexpected, non-serious AESI of COVID-19, which occurred on an unknown date on the next month after the fourth dose of mRNA-1273 vaccination schedule, used as the second booster dose, previously vaccinated with three doses of Pfizer COVID-19 vaccine. The patient experienced symptoms and potential positive self home test several days ago and called his doctor who prescribed Paxlovid, which he took for five days and felt better. About three days after he stopped the medication, he rebounded and it came back worse than before. The patient tested positive about a week after he stopped Paxlovid. He was concerned about anosmia and and taste disorder but had also headache (began two days after he stopped Paxlovid) and pyrexia. When the patient started Paxlovid, he had a bug bite on his forearm that turned into a cellulitis, that was treated with Doxycycline by a doctor. The non-serious event of bug bite could be due to Arthropod bite, however, since the outcome and the exact date onset of the events are unknown, Authority was conservatively retained as related. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Diarrhoea
Hospital-Tage: -
Labordaten: Test Name: Body temperature; Result Unstructured Data: 101.3 degree Celsius; Test Name: Flofex Covid antigen home test; Test Result: Negative ; Result Unstructured Data: Negative; Test Name: Flofex Covid antigen home test; Test Result: Negative ; Result Unstructured Data: Negative; Test Name: PCR test; Test Result: Positive ; Result Unstructured Data: PCR came back Positive; Test Date: 20220721; Test Name: PCR test; Test Result: Negative ; Result Unstructured Data: Negative; Test Date: 20220807; Test Name: PCR test; Test Result: Positive ; Result Unstructured Data: Positive
Aktuelle Erkrankungen: Asthma (diagnosed with asthma about 10 years ago. Albuterol inhaler,uses it 2-3 times a year.)
Vorgeschichte: -
Andere Medikamente: ATORVASTATIN; ALBUTEROL [SALBUTAMOL]; ELIQUIS
Allergien: -
Vorherige Impfungen: -

VAERS 2411662

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

mild

Staat: TX
Alter: 56,0
Geschlecht: F
Eingang: 15.08.2022
Impfdatum: 11.06.2022
Beginn: 12.08.2022
Tage bis Beginn: 62,0
Dosis: 3
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Injection site rash

Symptomtext

Moderna booster. Weeks later, I developed a rash on the arm I received the shot.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Injection site rash
Hospital-Tage: -
Labordaten: N/A.
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: None
Allergien: Chocolate
Vorherige Impfungen: -

VAERS 2405867

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

mild

Staat: IA
Alter: 58,0
Geschlecht: F
Eingang: 09.08.2022
Impfdatum: 28.07.2022
Beginn: 01.08.2022
Tage bis Beginn: 4,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Injection site bruising Injection site erythema Injection site warmth

Symptomtext

Bruising/redness at site of injection. At its peak the redness went halfway down upper arm and was warm to touch. She took 25mg diphenhydramine and within an hour or two the reaction seemed much better. On Monday, August 1st when she showed her arm to me, The redness was localized at injection site and was the size of a lemon with no significant swelling. By August 3rd, the redness had resolved. Patient was instructed to take diphenhydramine as needed or loratidine 10mg daily.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Injection site bruising
Hospital-Tage: -
Labordaten: n/a
Aktuelle Erkrankungen: n/a
Vorgeschichte: n/a
Andere Medikamente: Received Shingrix Vaccine in opposite arm on the same day.
Allergien: Penicillin and Sulfa medications
Vorherige Impfungen: -

VAERS 2401655

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

mild

Staat: MS
Alter: 74,0
Geschlecht: F
Eingang: 04.08.2022
Impfdatum: 15.06.2022
Beginn: 15.06.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Erythema Immunisation reaction Neuralgia Pain Pain in extremity Skin warm

Symptomtext

The Moderna booster she says was given June 15, 2022 upper left arm. She reportsaAbout 6 hours later her pain 10 radiated down to her fingers, caused severe nerve issues and is seeing physical therapy due to the shot causing "covid arm". She said she had reported the SE the next day to a nurse. She had iced it. normal SE hot, red to touch and went away but the nerve pain down to her fingers is not normal and not sure if VARS was completed. She requested we complete the CDC incident report if not done yet. She requested us know it is real, report to cdc and to teach injection site placement.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pain
Hospital-Tage: -
Labordaten: unknown
Aktuelle Erkrankungen: HTN
Vorgeschichte: Unknown
Andere Medikamente: Bystolic, Clarinex, diazepam, eq Famotidine, prednisol, synthr
Allergien: NKA
Vorherige Impfungen: -

VAERS 2395064

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

mild

Staat: MI
Alter: 60,0
Geschlecht: F
Eingang: 28.07.2022
Impfdatum: 27.07.2022
Beginn: 28.07.2022
Tage bis Beginn: 1,0
Dosis: 3
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Full blood count Injection site erythema Injection site mass Injection site swelling Laboratory test Skin induration

Symptomtext

Redness, swelling, minor at injection site - grain size lump (Right Deltoid). Additionally, swelling and redness noted - approximately the size of a silver dollar and slightly hard (Left Deltoid) where no vaccine was administered. This was the patient's first booster dose. No patient reporting on palpation and no discharge evident.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Injection site erythema
Hospital-Tage: -
Labordaten: CBC labs drawn, still awaiting results
Aktuelle Erkrankungen: Schizophrenia, Diabetes Type II, Hypothyroidism, Stage 3 CKD, Diabetic Neuropathy, Depression, Hypotension, Anemia
Vorgeschichte: Schizophrenia, Diabetes Type II, Hypothyroidism, Stage 3 CKD, Diabetic Neuropathy, Depression, Hypotension, Anemia
Andere Medikamente: Coreg, Cozaar, Haldol, Invega Sustenna, Klor-Con M20, Lasix, Levemir, Novolog, Synthroid, Trulicity
Allergien: Ace Inhibitors, Benztropine, Fish Oil
Vorherige Impfungen: -

VAERS 2393178

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

mild

Staat: VA
Alter: 70,0
Geschlecht: F
Eingang: 27.07.2022
Impfdatum: 22.07.2022
Beginn: 22.07.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: SC / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Immediate post-injection reaction Injection site erythema Injection site pain Injection site pruritus Injection site warmth Product administered at inappropriate site Vaccination site discomfort Wrong technique in product usage process

Symptomtext

None stated.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Injection site erythema
Hospital-Tage: -
Labordaten: Patient testimonial via telephone. State that vaccinator used improper technique (SC injection) and wrong location (2-3" below the deltoid). Site was immediately sore. Around 4:00 pm (7/22), noticed increased discomfort and red patch to vaccination site (2"X2"). At 8:00 pm, the patch increased in size (3"X5"), increased redness, and hot to touch. By Sat morning, patch enlarged (4"X5"), itchy, and began migrating to "the right inner arm". Site was not raised. The site continued to increase and migrate through Sunday (7/24). By Tues, 7/26, symptoms began to resolve. Client denies seeking medical attention and denies using any therapies (PO meds or topical agents). She does not wish to seek medical attention in the future but is concerned with the validity of her vaccination status. Informed her that CDC standards do not recommend re-vaccination. Patient was pleasant and cooperative, but concerned.
Aktuelle Erkrankungen: None
Vorgeschichte: -
Andere Medikamente: -
Allergien: PCN (Generalized redness) & Sulfa (Pain to the eye)
Vorherige Impfungen: -

VAERS 2388536

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

mild

Staat: MI
Alter: 55,0
Geschlecht: F
Eingang: 25.07.2022
Impfdatum: 27.05.2022
Beginn: 13.06.2022
Tage bis Beginn: 17,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Chills Fatigue Headache Rhinorrhoea SARS-CoV-2 test positive Sneezing

Symptomtext

On 06/13/2022 I had a headache, runny nose, sneezing, chills and severe fatigue. I had a home test, which was positive on 06/15/2022. My primary care physician prescribed Paxlovid. I had a recurrence after completing Paxlovid on 06/24/2022 that lasted 24 hours.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: 2022 JUN 15 - COVID-19 test - positive
Aktuelle Erkrankungen: None
Vorgeschichte: Hypertension; Pre-diabetes
Andere Medikamente: Losartan; Metformin; Vitamin D; Multivitamin; Probiotic
Allergien: Seasonal allergies
Vorherige Impfungen: -

VAERS 2388159

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

mild

Staat: KY
Alter: 52,0
Geschlecht: F
Eingang: 25.07.2022
Impfdatum: 11.07.2022
Beginn: 14.07.2022
Tage bis Beginn: 3,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Headache Injection site rash Joint swelling Peripheral swelling Pruritus Urticaria

Symptomtext

PATIENT STATES THAT ~3DAYS AFTER VACCINATION SHE EXPERIENCED SWELLING IN THE MORNING (IN THE HANDS, KNEES AND FEET), RASH AT INJECTION SITE, HEADACHE, HIVE AND ITCHING. 2 WEEKS LATER (7/24/22) PATIENTS STATES SHE IS STILL HAVING THE ISSUE.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Headache
Hospital-Tage: -
Labordaten: NONE
Aktuelle Erkrankungen: KIDNEY STONE, UTI
Vorgeschichte: -
Andere Medikamente: VYVANSE 50MG, HYDROCODONE/APAP 5/325MG, ALPRAZOLAM 1MG SULFMETHOXAZOLE/TMP DS LAST DOSE TAKEN 7/11/22 (DAY OF VACCINATION)
Allergien: PENICILLIN
Vorherige Impfungen: -

VAERS 2374900

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037 A22B

mild

Staat: RI
Alter: 59,0
Geschlecht: F
Eingang: 20.07.2022
Impfdatum: 19.07.2022
Beginn: 19.07.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Bone pain Nausea Pain Pain in extremity Vomiting

Symptomtext

patient complained of severe left arm pain the evening of the vaccine administration date. The next day, which is today, she has pain in her left arm, total body pain which she describes as "bone" pain, nausea and vomiting with inability to keep any fluids down. It is a hot day today and there is concern for dehydration.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Bone pain
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: none
Vorgeschichte: hypertension
Andere Medikamente: atorvastatin, amlodipine, chlorthalidone, duloxetine, moexipril, zolpidem
Allergien: ampicillin, seasonal allergies
Vorherige Impfungen: Pfizer #2 February 16, 2021

VAERS 2373928

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

mild

Staat: CT
Alter: 60,0
Geschlecht: M
Eingang: 19.07.2022
Impfdatum: 02.06.2022
Beginn: 13.07.2022
Tage bis Beginn: 41,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Cough Dry throat Headache Lethargy Malaise Oropharyngeal pain Pain Rhinorrhoea SARS-CoV-2 test positive Sneezing

Symptomtext

Contracted COVID-19. Symptoms started Monday July 11. Tested positive using home antigen test July 13. Symptoms included a severe sore throat, headache, body and muscle aches, running nose, sneezing, dry cough and lethargy. Treated with Motrin and cepacol lozenges. Symptoms mostly abated by Sunday July 17. Lingering dry throat and headaches on July 19. Talked to my doctor on July 14, agreed to treat at home.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Headache
Hospital-Tage: -
Labordaten: None.
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Aspirin 81mg, Omeprazole 40mg, Rosuvastatin 20mg, Multivitamin, Clobetasol topical
Allergien: None
Vorherige Impfungen: -

VAERS 2370769

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037a22b

mild

Staat: MA
Alter: 41,0
Geschlecht: F
Eingang: 15.07.2022
Impfdatum: 08.06.2022
Beginn: 07.07.2022
Tage bis Beginn: 29,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Fatigue Feeling abnormal Malaise Nasal congestion Pain Pyrexia SARS-CoV-2 test positive

Symptomtext

I am still somewhat sick with COVID-19 . I started with aches and fevers. Then had stuffy nose and extreme fatigue. I am still on and off with fevers. Stuffy nose has resolved and aches more or less. I had 48 hours of being really miserable. Since Sunday it's been on and off with fatigue.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: COVID-19 at home test July 8th - positive
Aktuelle Erkrankungen: No
Vorgeschichte: Asthma; Seasonal Allergies
Andere Medikamente: Zyrtec; Pristiq; Prenatal vitamin; Intermuscular injections of testosterone
Allergien: Penicillin; Azithromycin; Vancomycin; Sulfur drug
Vorherige Impfungen: -

VAERS 2367805

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

mild

Staat: MA
Alter: 71,0
Geschlecht: F
Eingang: 13.07.2022
Impfdatum: 01.07.2022
Beginn: 04.07.2022
Tage bis Beginn: 3,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Cellulitis Inappropriate schedule of product administration Injection site erythema Injection site induration Pruritus

Symptomtext

The nurse injected the booster into my bicep on the side and not tricep. The area became red, indurated and after 24 hrs a cellulitis developed with intense pruitis all along the arm. I used an antihistamine for 4 days, no anitibiotics were required

Weitere VAERSDATA-Felder

Praegender Schweregrund: Injection site erythema
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: tick bite viral infection that included fever and arthralgia
Vorgeschichte: HTN well controlled on medication x 1 yr Popliteal aneurysm
Andere Medikamente: HCTZ, simvastatin
Allergien: PCN
Vorherige Impfungen: -

VAERS 2362984

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

mild

Staat: AZ
Alter: 64,0
Geschlecht: F
Eingang: 08.07.2022
Impfdatum: 20.06.2022
Beginn: 01.07.2022
Tage bis Beginn: 11,0
Dosis: 4
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Pruritus Urticaria

Symptomtext

Severe hives developed and would not respond to over the counter treatment of antihistamine (Zertex) and topical Cortizone-10, so I went to the hospital and was prescribed Prednisone 20MG (3 tablets for 5 days). It has cleared up my hives, but I am still using Zertex daily to control some itching symptoms.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pruritus
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Glucosamine chondroitin
Allergien: Penicillin
Vorherige Impfungen: -

VAERS 2362614

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

mild

Staat: MA
Alter: 81,0
Geschlecht: M
Eingang: 08.07.2022
Impfdatum: 20.05.2022
Beginn: 22.05.2022
Tage bis Beginn: 2,0
Dosis: 4
Route/Site: SYR / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Chills Culture urine negative Epididymitis Hydrocele Hyperaemia Pyrexia Testicular pain Testicular swelling Ultrasound scan abnormal

Symptomtext

Following injection pt developed fever/chills over the next 48 hours developed Left testicular pain and swelling prompting visit to urgent care. He was diagnosed with epididymitis and started on levofloxacin. Pt saw me in clinic 06/02/2022 with improvement on symptoms on antibiotics.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: Urine Culture 06/02/2022 (on antibiotics) no growth Pelvic US 06/02/2022: Left hyperemia epididymis, complex left hydrocele, right hydrocele Scrotal US 06/10/2022: Prior hyperemia resolved, right hydrocele resolved, left hydrocele resolving Scrotal US 07/08/2022: Left hydrocele resolved.
Aktuelle Erkrankungen: None
Vorgeschichte: BPH Kidney Stone
Andere Medikamente: Terazosin 5mg Theralith
Allergien: NKDA
Vorherige Impfungen: -

VAERS 2357915

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

mild

Staat: TX
Alter: 59,0
Geschlecht: M
Eingang: 05.07.2022
Impfdatum: 27.05.2022
Beginn: 26.06.2022
Tage bis Beginn: 30,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Cough Oropharyngeal pain Pain Respiratory tract congestion SARS-CoV-2 test positive

Symptomtext

I had sore throat, fatigue, congestion, achiness, and cough. I tested the next day on the 27th with a rapid home test and that came back positive. Those symptoms continued and I called the Dr. and they suggested I come in for a prescription for a antiviral. So the Dr. prescribed the antiviral that day and I would say that by the 30th and 1st all of the symptoms have diminished and that has been for the last couple days.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Oropharyngeal pain
Hospital-Tage: -
Labordaten: COVID-19 home rapid test positive. COVID-19 rapid test Dr. office, positive.
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Azelastine; fluticasone
Allergien: None
Vorherige Impfungen: -

VAERS 2357518

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

mild

Staat: AL
Alter: 55,0
Geschlecht: F
Eingang: 05.07.2022
Impfdatum: 27.06.2022
Beginn: 27.06.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Immunisation reaction Injection site bruising Injection site erythema Injection site pain Injection site pruritus Injection site swelling

Symptomtext

Site: Bruising at Injection Site-Mild, Site: Itching at Injection Site-Medium, Site: Pain at Injection Site-Mild, Site: Redness at Injection Site-Severe, Site: Swelling at Injection Site-Severe, Additional Details: Patient came in to pick up prescription. Stated she had "covid arm". Observed swelling and redness of muscle area. Patient states she had not reported it as she read is very common on people who received the covid vaccine. I explained that it needed to be reported as a severe reaction.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Injection site bruising
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2352013

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

mild

Staat: IN
Alter: 36,0
Geschlecht: F
Eingang: 02.07.2022
Impfdatum: 30.06.2022
Beginn: 30.06.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Lymph node pain Lymphadenopathy

Symptomtext

Swollen painful lymph node above right collar bone. Painful lymph nodes in right armpit, right breast, right side of neck, and right side of face-front and back area of ear.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Lymph node pain
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: Genital herpes
Andere Medikamente: Adderall Acyclovir
Allergien: None
Vorherige Impfungen: -

VAERS 2341766

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

mild

Staat: NC
Alter: 53,0
Geschlecht: F
Eingang: 29.06.2022
Impfdatum: 31.05.2022
Beginn: 23.06.2022
Tage bis Beginn: 23,0
Dosis: 4
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Cough Exposure to SARS-CoV-2 Fatigue Headache Myalgia Nasal congestion Pain Rhinorrhoea SARS-CoV-2 test positive

Symptomtext

I had an inconsistent cough that got worse over the day. That developed into a headache, runny nose, nasal congestion, fatigue, and muscle aches. I thought it was just from being tired from traveling, but when I got home on Sunday, I took an at-home COVID-19 test. The test came back negative, but I knew based on my symptoms and my husband being positive that I had it. I retested on 06/28/2022 with another at-home test, and this time it came back positive. I tried to call my doctor to get prescribed anything to help relieve my symptoms. I had to do an on-demand in-office health visit in the doctor's office where I was prescribed an inhaler and cough syrup (promethazine-BM) to aid a speedier recovery. I'm still having fatigue and body aches currently, but the congestion and runny nose has began to fade away.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: COVID-19 tests: 06/28/2022.
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: Sertraline; bupropion; VALTREX; multivitamin supplement
Allergien: Erythromycin
Vorherige Impfungen: -

VAERS 2334388

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037a22b

mild

Staat: CA
Alter: 28,0
Geschlecht: F
Eingang: 25.06.2022
Impfdatum: 17.06.2022
Beginn: 17.06.2022
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Incorrect route of product administration Injection site induration Injection site swelling

Symptomtext

Site: Swelling at Injection Site-Medium, Error: Wrong Route (SC, IM, etc.)-, Additional Details: Patient is a RN states she thinks it might be SQ insted of IM due to no systemic reactions and due to swelling and hardness of deltoid area post vaccination. Informed her to have MD check it out. Will reassess with her in a couple days after speaking to MD.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Injection site induration
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2331942

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

mild

Staat: CA
Alter: 67,0
Geschlecht: F
Eingang: 24.06.2022
Impfdatum: 20.05.2022
Beginn: 01.05.2022
Tage bis Beginn: -
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Abdominal discomfort Abdominal pain lower Colonoscopy normal Faeces soft

Symptomtext

One week it was extremely mild upset tight feeling and pain in lower abdomen. The GI upset feeling was there and sometimes not. I ignored it at first. It lingered for weeks, like over a month. It was quick that the symptoms change around the 8th or 10th day. My stools became too soft and barely formed. It was not diarrhea, it was not there to that point. I called my GI doctor, and got a appointment a month later and the symptoms continued. It last easily a month. I had done nothing or different than ever before. The pain was not consistent, just like upset stomach. I ate more fiber to make it go away. Now I am fine, I made my appointment and had a telehealth appoint and the symptoms were gone by the time I had the appointment. I was recommended to take Metamucil, but did not. I had a colonoscopy and my symptoms were fine and there was nothing unusual found, but a poly that was a 3 millimeters. I was good to go.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Abdominal pain lower
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: None
Vorgeschichte: High Blood Pressure
Andere Medikamente: Lisinopril, Hydrochlorothiazide Vitamin D
Allergien: Latex, Penicillin, and Adhesives
Vorherige Impfungen: -

VAERS 2331876

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037a22b

mild

Staat: NJ
Alter: 69,0
Geschlecht: F
Eingang: 24.06.2022
Impfdatum: 21.06.2022
Beginn: 21.06.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Injection site bruising Injection site erythema Lymphadenopathy

Symptomtext

Site: Bruising at Injection Site-Mild, Site: Redness at Injection Site-Mild, Systemic: Lymph Node Swelling-Mild, Additional Details: Swelling of lymphnodes under armpit, same arm as injection site.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Injection site bruising
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2331411

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037a22b

mild

Staat: CA
Alter: 65,0
Geschlecht: F
Eingang: 24.06.2022
Impfdatum: 07.06.2022
Beginn: 08.06.2022
Tage bis Beginn: 1,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Dizziness

Symptomtext

Systemic: Dizziness / Lightheadness-Medium

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dizziness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2327272

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

mild

Staat: WA
Alter: 49,0
Geschlecht: F
Eingang: 22.06.2022
Impfdatum: 20.06.2022
Beginn: 21.06.2022
Tage bis Beginn: 1,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Erythema Pain in extremity Peripheral swelling Tenderness

Symptomtext

Woke in the very early morning With a terrible pain on the top of my right foot. I didn?t look at it at the time. Took Advil and put some ice on it and it took a few hours to get better. I had no injury prior to that. In the morning it appeared red and swollen at my midfoot, more immediately. It was very tender around the proximal first metatarsal.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pain in extremity
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: None
Vorgeschichte: Menopause Hypothyroidism
Andere Medikamente: Estradiol Progesterone NP thyroid Magnesium
Allergien: None
Vorherige Impfungen: -

VAERS 2323920

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037a22b

mild

Staat: PA
Alter: 70,0
Geschlecht: F
Eingang: 18.06.2022
Impfdatum: 31.05.2022
Beginn: 01.06.2022
Tage bis Beginn: 1,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Asthenia Dizziness Musculoskeletal pain Pain in extremity

Symptomtext

Systemic: pain backside of thigh, butt area-Severe, Systemic: Weakness-Severe, Additional Details: Patient called on 6/13 and said she got Moderna shot on 5/31. Next morning felt extreme pain in backside of thigh/butt area. Dizziness. for several days. she is getting better but wanted us to send the info in case other patient were reacting to the shot like her

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dizziness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2323054

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

mild

Staat: VA
Alter: 50,0
Geschlecht: F
Eingang: 17.06.2022
Impfdatum: 16.06.2022
Beginn: 17.06.2022
Tage bis Beginn: 1,0
Dosis: 4
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Chills Headache Injection site pain Injection site swelling Pain Pyrexia

Symptomtext

Pain and swelling around injection site; Fever; Chills; Headache; Body aches - Lasted about 8 hours

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: Levothyroxine Zyrtec Vitamin D Probiotic
Allergien: -
Vorherige Impfungen: Same reaction to previous Moderna vaccines @ age 49 (Mar, Apr, Nov 2021)

VAERS 2319540

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037a22b

mild

Staat: TX
Alter: 26,0
Geschlecht: F
Eingang: 14.06.2022
Impfdatum: 01.06.2022
Beginn: 01.06.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Dizziness Vertigo

Symptomtext

pt reported vertigo started approximately 2 weeks ago, on day shot was given, pt visited her physician regarding the dizziness

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dizziness
Hospital-Tage: -
Labordaten: pt saw her primary care dr
Aktuelle Erkrankungen: none reported
Vorgeschichte: pt reported hx of longterm health condition, did not report specific condition
Andere Medikamente: unknown
Allergien: none reported
Vorherige Impfungen: -

VAERS 2315263

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

mild

Staat: TX
Alter: 33,0
Geschlecht: F
Eingang: 10.06.2022
Impfdatum: 31.05.2022
Beginn: 01.06.2022
Tage bis Beginn: 1,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Lymphadenopathy Rash

Symptomtext

Systemic: Allergic: Rash (specify: facial area, extremeties)-Medium, Systemic: Lymph Node Swelling-Medium, Additional Details: Patient was having rash the following day on the lower extremities, and swollen lympnodes

Weitere VAERSDATA-Felder

Praegender Schweregrund: Rash
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2314039

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

mild

Staat: MI
Alter: 98,0
Geschlecht: F
Eingang: 09.06.2022
Impfdatum: 08.06.2022
Beginn: 08.06.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Arthralgia Ear pain Musculoskeletal stiffness Pain

Symptomtext

Shooting pain behind right ear and stiff neck (right side). Joint aches. (knees)

Weitere VAERSDATA-Felder

Praegender Schweregrund: Arthralgia
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: None
Vorgeschichte: Afib, stage 4 kidney disease
Andere Medikamente: Eloquis 2.5 Tylenol Vitamin d
Allergien: Shellfish
Vorherige Impfungen: -

VAERS 2313217

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

mild

Staat: PA
Alter: 50,0
Geschlecht: M
Eingang: 08.06.2022
Impfdatum: 01.06.2022
Beginn: 01.06.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Chills Hyperacusis Myalgia Pyrexia Tinnitus

Symptomtext

Approx. 8-10 hours following the injections I experienced muscle pain, fever, chills and ringing in my ears (tinnitus). 24-36 hours after all symptoms subsided with the exception of the tinnitus. Tinnitus has been a constant high frequency ringing non stop since onset. I have become hyper sensitive to loud noises and loud background noise. I assumed it would go away and determined I would wait a week before calling Dr. I contacted my Dr. yesterday and have an appointment tomorrow (June 9, 2022).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: None at this point.
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: Baby Aspirin, Valsartan, Fe
Allergien: -
Vorherige Impfungen: -

VAERS 2308309

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

mild

Staat: -
Alter: 65,0
Geschlecht: F
Eingang: 03.06.2022
Impfdatum: 26.05.2022
Beginn: 27.05.2022
Tage bis Beginn: 1,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Lip swelling Urticaria

Symptomtext

Within 24 hrs of booster dose (moderna) pt reported developing hibves and swollen lips. Pt reports taking Benadryl. Symptoms resolving. Previously vaccinated with Pfizer vaccine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Urticaria
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2306889

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

mild

Staat: WV
Alter: 59,0
Geschlecht: F
Eingang: 02.06.2022
Impfdatum: 18.05.2022
Beginn: 31.05.2022
Tage bis Beginn: 13,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Adverse food reaction Asthenia COVID-19 Chills Diarrhoea Ear pain Headache Hyperhidrosis Impaired work ability Nasal congestion Nausea Oropharyngeal pain Pain Parosmia Rhinalgia Rhinorrhoea SARS-CoV-2 test positive Throat irritation

Symptomtext

On Tuesday at lunch, I didn?t realize that something I was eating (hummus) was burning my tongue. Didn?t think anything about it. Tuesday evening, I spent the evening outside and we were painting. When I got home, my throat started getting sore and I had a paint smell in my nose. When I woke up on Wednesday, my throat was really sore. I figured it was maybe because I was out in the pollen. I took an antigen test just to be safe. I took it and left it on the counter to go to work. My husband took a picture and sent it to me and it was positive. I called my employer and said I wouldn?t be coming to work and turned around to go home. By the time I got home, I was experiencing diarrhea and then my nose continued to hurt and run. My throat was scratchy. Ears were hurting. Headaches and body aches. No fever. Today and last night, sweats, chills, and waking up this morning very weak and nauseous. My temperature this morning was normal. that?s it ? headaches, body aches, chills, sweats, sore throat, and ears. I do have certain foods that also make it feel like my tongue is burning. I don?t have the paint smell in my nose anymore, but it is still stuffy and congested.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: 06/01/2022 - At-Home COVID Test - Positive
Aktuelle Erkrankungen: None
Vorgeschichte: Hx of hysterectomy Thyroid Disease
Andere Medikamente: Levothyroxine 100mcg daily Melatonin 5mg as needed 0.1 Fem Ring Estrogen 3 months at time Zinc Calcium Emergen-C 1000mg Mucinex as needed Alka-Seltzer as needed
Allergien: Prednisone Bacitracin Augmentin
Vorherige Impfungen: -

VAERS 2305500

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

mild

Staat: VA
Alter: 73,0
Geschlecht: F
Eingang: 01.06.2022
Impfdatum: 24.05.2022
Beginn: 27.05.2022
Tage bis Beginn: 3,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: unbekannt

Cough Diarrhoea Influenza virus test negative Oropharyngeal pain Respiratory tract congestion SARS-CoV-2 test negative

Symptomtext

Four days after the shot, I started having a sore throat. On Saturday, I started having congestion, on Sunday I had chest congestion and a really bad cough. On Monday, I had diarrhea and did a at home COVID 19 test and it was negative. I went to the urgent care on the 31st of May, no prescription was given; was told to rest and drink plenty of fluids. A flu test and COVID 19 test was given at the urgent care and my results were negative.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Diarrhoea
Hospital-Tage: -
Labordaten: 05/31/2022 COVID 19 PCR test negative. 05/31/2022 flu test negative.
Aktuelle Erkrankungen: N/A
Vorgeschichte: Hypertension; Arthritis; Neuropathy; Hypercholesterolemia
Andere Medikamente: Levothyroxine; pravastatin; losartan; Celebrex; gabapentin; cinnamon; turmeric; cranberry; fish oil; coenzyme Q10; women's silver multivitamin; Allegra; probiotic
Allergien: Cephalosporin; crab
Vorherige Impfungen: -

VAERS 2305210

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

mild

Staat: TX
Alter: 51,0
Geschlecht: U
Eingang: 01.06.2022
Impfdatum: 26.05.2022
Beginn: 28.05.2022
Tage bis Beginn: 2,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Headache Malaise Rhinorrhoea SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

COVID breakthrough case. I received my 2nd booster shot on 05/26/2022 and my COVID symptoms started on 05/28/2022 allergy type symptoms like headache, runny nose. 05/29/2022 headache along with other symptoms. 05/28/2022 I tested negative for COVID, and on 05/29/2022 tested positive for COVID. I did a telehealth with a doctor and they prescribed me PAXLOVID for 5 days.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Headache
Hospital-Tage: -
Labordaten: Home COVID test.
Aktuelle Erkrankungen: None
Vorgeschichte: Hypertension; asthma related to allergies; hypothyroidism
Andere Medikamente: Multivitamins; vitamin D; Unithroid; lisinopril
Allergien: Hydrocodone; morphine
Vorherige Impfungen: 2nd dose fatigue, resting heart rate, headache.

VAERS 2302594

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

mild

Staat: IN
Alter: 23,0
Geschlecht: F
Eingang: 30.05.2022
Impfdatum: 28.05.2022
Beginn: 30.05.2022
Tage bis Beginn: 2,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Dry mouth Fatigue Headache Urticaria

Symptomtext

I know that sometimes with the booster side effects can be headache and tiredness I did have those. However, my injection site has a welt the size of a half dollar which is unusual for me. Another symptom to report is dry mouth, I was drinking plenty of water but felt my mouth was severally dry.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: N/A
Vorgeschichte: -
Andere Medikamente: Focalin, Singular, Trintellex and Zyrtec
Allergien: N/A
Vorherige Impfungen: At time of second dose of moderna vaccine my lymph nodes were both the size of baseballs.

VAERS 2301872

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037a22b

mild

Staat: SC
Alter: 66,0
Geschlecht: F
Eingang: 30.05.2022
Impfdatum: 26.05.2022
Beginn: 26.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Injection site erythema Injection site pruritus Rash

Symptomtext

Site: Itching at Injection Site-Mild, Site: Redness at Injection Site-Mild, Systemic: Allergic: Rash (specify: facial area, extremeties)-Mild

Weitere VAERSDATA-Felder

Praegender Schweregrund: Injection site erythema
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2300968

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

mild

Staat: TX
Alter: 36,0
Geschlecht: F
Eingang: 28.05.2022
Impfdatum: 22.05.2022
Beginn: 22.05.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Injection site erythema Injection site pruritus Injection site swelling Pruritus Rash Rash pruritic

Symptomtext

Site: Itching at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Systemic: Allergic: Itch (specify: facial area, extremeties)-Medium, Systemic: Allergic: Rash (specify: facial area, extremeties)-Medium, Additional Details: ONSET OF ADVERSE REACTION REPORTEDLY WAS WITHIN ABOUT AN HOUR AFTER RECEIVING THE VACCINE. PATIENT REPORTED ITCHY RASH NOT RESOLVING TO PHARMACY; PLANS TO TAKE 50MG OF BENADRYL AND TRACK RESPONSE AFTER SHE ARRIVES HOME TODAY.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Injection site erythema
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2296761

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037a22b

mild

Staat: MO
Alter: 58,0
Geschlecht: F
Eingang: 26.05.2022
Impfdatum: 17.05.2022
Beginn: 18.05.2022
Tage bis Beginn: 1,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Rash Rash pruritic

Symptomtext

about 12 hours after injection patient experiance rash on ankles. Sometimes it appearson arms, trunk, legs, ankles. Most of the rash are on extremities. the rash comes and goes and itch so bad that she was seen by her doctor and got prescribed steroid po.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Rash
Hospital-Tage: -
Labordaten: n/a
Aktuelle Erkrankungen: unknown
Vorgeschichte: hypertension, mood disorder
Andere Medikamente: unknown
Allergien: unknown
Vorherige Impfungen: -

VAERS 2296252

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037a22b

mild

Staat: MI
Alter: 56,0
Geschlecht: F
Eingang: 26.05.2022
Impfdatum: 21.05.2022
Beginn: 22.05.2022
Tage bis Beginn: 1,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Pruritus Rash

Symptomtext

Systemic: Allergic: Itch (specify: facial area, extremeties)-Medium, Systemic: Allergic: Itch Generalized-Medium, Systemic: Allergic: Rash (specify: facial area, extremeties)-Medium, Systemic: Allergic: Rash Generalized-Medium

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pruritus
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2294469

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

mild

Staat: MS
Alter: 55,0
Geschlecht: F
Eingang: 25.05.2022
Impfdatum: 25.05.2022
Beginn: 25.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Headache Nausea

Symptomtext

Headache Nausea

Weitere VAERSDATA-Felder

Praegender Schweregrund: Headache
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: propranolol atorvastatin Flecainide acetate
Allergien: all things ending in -myacin make me vomit
Vorherige Impfungen: -

VAERS 2688570

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

gering

Staat: MN
Alter: 82,0
Geschlecht: F
Eingang: 29.09.2023
Impfdatum: 07.02.2023
Beginn: 23.09.2023
Tage bis Beginn: 228,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 SARS-CoV-2 test positive

Symptomtext

Patient vaccinated against and then tested positive for COVID19

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: 5,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2685854

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

gering

Staat: MN
Alter: 95,0
Geschlecht: F
Eingang: 25.09.2023
Impfdatum: 09.06.2022
Beginn: 23.09.2023
Tage bis Beginn: 471,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 SARS-CoV-2 test positive

Symptomtext

Patient vaccinated against and then tested positive for COVID-19

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2684979

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

gering

Staat: CA
Alter: 50,0
Geschlecht: M
Eingang: 22.09.2023
Impfdatum: 20.06.2022
Beginn: 01.08.2022
Tage bis Beginn: 42,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: ja ER: unbekannt Erholt: nein

Erectile dysfunction

Symptomtext

Erectile Dysfunction

Weitere VAERSDATA-Felder

Praegender Schweregrund: Erectile dysfunction
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: -

VAERS 2664164

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

gering

Staat: -
Alter: 75,0
Geschlecht: F
Eingang: 01.08.2023
Impfdatum: 01.06.2022
Beginn: 30.01.2023
Tage bis Beginn: 243,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Angina pectoris Angina unstable Symptom recurrence

Symptomtext

UNSTABLE ANGINA ANGINA, UNSPECIFIED 1/29/2023 -- RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS

Weitere VAERSDATA-Felder

Praegender Schweregrund: Angina pectoris
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2663641

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

gering

Staat: NY
Alter: -
Geschlecht: U
Eingang: 31.07.2023
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Product storage error

Symptomtext

This report is being submitted by the guidance of the DOH. 1 patient was affected by storage and handling excursions.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product storage error
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2652755

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

gering

Staat: MI
Alter: 63,0
Geschlecht: F
Eingang: 05.07.2023
Impfdatum: 16.06.2022
Beginn: 24.04.2023
Tage bis Beginn: 312,0
Dosis: 5
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

Breakthrough case admission after 5 vaccines Moderna 2/20/21 lot# 023M20A; Moderna 3/6/21 lot# 002B21a; Moderna 3/16/21 Lot# 002B21A; Moderna 11/12/21 lot# 034F21A; Moderna 6/16/22 lot# 037A22B

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: COVID +
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2643699

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

gering

Staat: NY
Alter: -
Geschlecht: U
Eingang: 09.06.2023
Impfdatum: 15.11.2022
Beginn: 15.11.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

No adverse event; vaccines administered past the expiration date.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (vaccines administered past the expiration date.) and NO ADVERSE EVENT (No adverse event) in a patient of an unknown age and gender who received mRNA-1273 (Spikevax) (batch no. 037A22B) for COVID-19 prophylaxis. No Medical History information was reported. On 15-Nov-2022, the patient received dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 15-Nov-2022, after starting mRNA-1273 (Spikevax), the patient experienced EXPIRED PRODUCT ADMINISTERED (vaccines administered past the expiration date.). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (vaccines administered past the expiration date.) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (vaccines administered past the expiration date.). No concomitant medication was reported. It was reported that the vaccines were stored in a standard freezer (15?C to -25?C). Their temperatures were Max -24C and Min -23C The following doses/Lot numbers were impacted. Trade Name Moderna Bivalent Lot AS7140C Received 9/2/2022 CDC Expiration 5/7/2023 Report Type EXP Date of Administration 5/8/2023 doses 1 Trade Name: Moderna COVID-19 Vaccine Lot: 037A22B Received: 5/19/2022 CDC expiration 10/31/2022 report type EXP Date of administration 11/15/2022 doses: 1 Moderna COVID-19 Vaccine Lot 060H21A received: 12/27/2020 CDC expiration: 3/28/2022 report type: EXP 4/11/2022 doses: 13 Moderna COVID-19 Vaccine Lot: 083B22A received: 11/15/2022 CDC expiration: 2/28/2023 report type: EXP administration date:4/5/2023 doses: 3. HCP doesn?t have any patient identifiers. No treatment information was reported. Most recent FOLLOW-UP information incorporated above includes: On 07-Jun-2023: Live Follow up received contains No NewInformation

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2640294

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

gering

Staat: MI
Alter: 70,0
Geschlecht: F
Eingang: 02.06.2023
Impfdatum: 02.08.2022
Beginn: 29.05.2023
Tage bis Beginn: 300,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

Breakthrough case admission after 4 vaccines Moderna 7/2/21 lot# 049C21A; Moderna 7/30/21 lot# 049C; Moderna 2/9/22 lot# 042J21A; Moderna 8/2/22 Lot# 037A22B

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: COVID +
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2636183

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

gering

Staat: GA
Alter: 50,0
Geschlecht: M
Eingang: 24.05.2023
Impfdatum: 23.05.2022
Beginn: 15.01.2023
Tage bis Beginn: 237,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Cardiac flutter Cardiac monitoring Extrasystoles Supraventricular extrasystoles Ventricular extrasystoles

Symptomtext

I had a heart flutter or skipping beats. Ventricle ectopy, and a supra ventricle ectopy

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cardiac flutter
Hospital-Tage: -
Labordaten: Heart monitor
Aktuelle Erkrankungen: None
Vorgeschichte: High blood Pressure and Cholesterol
Andere Medikamente: Hydrochlorothiazide: Losartan: Atorvastatin: Diclofenac
Allergien: Penicillin
Vorherige Impfungen: shingles vaccine caused fever and aches.

VAERS 2619087

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

gering

Staat: -
Alter: 68,0
Geschlecht: M
Eingang: 21.04.2023
Impfdatum: 02.11.2022
Beginn: 19.11.2022
Tage bis Beginn: 17,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Chronic respiratory failure Respiratory failure

Symptomtext

CHRONIC HYPOXEMIC RESPIRATORY FAILURE CHRONIC HYPERCAPNIC RESPIRATORY FAILURE

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chronic respiratory failure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2617571

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

gering

Staat: -
Alter: 87,0
Geschlecht: M
Eingang: 19.04.2023
Impfdatum: 01.06.2022
Beginn: 02.10.2022
Tage bis Beginn: 123,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Chronic respiratory failure Hypoxia Respiratory failure

Symptomtext

CHRONIC HYPOXEMIC RESPIRATORY FAILURE HYPOXIA

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chronic respiratory failure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2611913

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037a22b

gering

Staat: SC
Alter: 31,0
Geschlecht: M
Eingang: 08.04.2023
Impfdatum: 18.06.2022
Beginn: 18.06.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Anger Phobia Suspiciousness

Symptomtext

Systemic: pt said he's now having phobias and suspicions and other symptoms but would not clarify further-Severe, Additional Details: Pt was very angry when he called on 4/3/23 and said after he received the vaccine on 6/18/2022 he went home and took a nap and after he woke up is when the symptoms began and they have continued since then. He said his symptoms include phobias and being suspicious. He said there are other symptoms, but when I asked for more details he said no.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Anger
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2606806

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

gering

Staat: TX
Alter: 30,0
Geschlecht: F
Eingang: 30.03.2023
Impfdatum: 26.05.2022
Beginn: 26.05.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Blood pressure decreased Pharyngeal swelling Wheezing

Symptomtext

Wheezing, swelling of throat (not completely), drop in blood pressure.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Blood pressure decreased
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Asthma, PSVT, DDD
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2604934

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

gering

Staat: MI
Alter: 62,0
Geschlecht: M
Eingang: 28.03.2023
Impfdatum: 08.06.2022
Beginn: 03.11.2022
Tage bis Beginn: 148,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

Breakthrough case admission after 4 vaccines Moderna 3/13/21 Lot# 040A21A; Moderna 4/10/21 Lot# 016B21A; Moderna 10/2/21 LOt# 017F21A; MOderna 6/8/22 Lot# 037A22B

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: COVID +
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2604030

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

gering

Staat: NJ
Alter: 11,0
Geschlecht: M
Eingang: 27.03.2023
Impfdatum: 25.06.2022
Beginn: 25.06.2022
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Product administered to patient of inappropriate age

Symptomtext

COVID VACCINE INAPPROPRIATELY GIVEN TO A UNDERAGE PATIENT. NO TREATMENTS NECCESSARY, NO OUTCOMES OR SYMPTOMS OBSERVED

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product administered to patient of inappropriate age
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: N/A
Allergien: N/A
Vorherige Impfungen: -

VAERS 2596197

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

gering

Staat: MI
Alter: 89,0
Geschlecht: F
Eingang: 14.03.2023
Impfdatum: 01.12.2022
Beginn: 22.01.2023
Tage bis Beginn: 52,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

Breakthrough case admission after 4 vaccines Pfizer 2/24/21 Lot# EN6202; Pfizer 3/17/21 Lot# Er8727; Pfizer 11/12/21 Lot# 30135BA; 8/1/22 Moderna Lot# 037A22B

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: COVID +
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2590372

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

gering

Staat: MI
Alter: 72,0
Geschlecht: M
Eingang: 02.03.2023
Impfdatum: 18.07.2022
Beginn: 31.08.2022
Tage bis Beginn: 44,0
Dosis: 3
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

Breakthrough case admission after 3 vaccines Moderna 2/25/21 Lot# 037K20A; Moderna 3/25/21 Lot# 011M20A; Moderna 7/18/22 Lot# 037A22B

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: COVID +
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2603910

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

gering

Staat: -
Alter: 76,0
Geschlecht: M
Eingang: 10.01.2023
Impfdatum: 29.06.2022
Beginn: 30.06.2022
Tage bis Beginn: 1,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Unevaluable event

Symptomtext

Narrative:

Weitere VAERSDATA-Felder

Praegender Schweregrund: Unevaluable event
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2539479

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

gering

Staat: NE
Alter: 57,0
Geschlecht: F
Eingang: 21.12.2022
Impfdatum: 09.06.2022
Beginn: 01.09.2022
Tage bis Beginn: 84,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Biopsy lymph gland normal Computerised tomogram abnormal Lymphadenopathy

Symptomtext

I went in for my check up because I had colon cancer. In the CT scan they found a swollen lymph node in the left side of my armpit which I have not noticed before. They did a biopsy, and it was not cancerous. I am due for a follow-up.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Biopsy lymph gland normal
Hospital-Tage: -
Labordaten: 09/2022, CT scan, Lymph node in armpit; Biopsy, Cancer free.
Aktuelle Erkrankungen: N/A
Vorgeschichte: Past Breast Cancer; Past Colon Cancer
Andere Medikamente: Vitamin D3; vitamin C; B12; aripiprazole; lorazepam; PRISTIQ
Allergien: KEFLEX
Vorherige Impfungen: -

VAERS 2528842

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

gering

Staat: PA
Alter: 63,0
Geschlecht: F
Eingang: 12.12.2022
Impfdatum: 05.06.2022
Beginn: 08.06.2022
Tage bis Beginn: 3,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Blood test Glycosylated haemoglobin increased

Symptomtext

June 8,2022. I had gotten lab work done a few days earlier. My doctor called and said my A1C was through the roof. They prescribed insulin and metformin. I modified my diet significantly. My latest A1C is much lower.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Blood test
Hospital-Tage: -
Labordaten: Blood work, A1C was high.
Aktuelle Erkrankungen: None
Vorgeschichte: Afib
Andere Medikamente: CARDIZEM; LIPITOR; ELIQUIS; alpha lipoic acid; OSTEO BIFLEX; multivitamin for women 50 plus
Allergien: Spring respiratory allergy
Vorherige Impfungen: -

VAERS 2516540

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

gering

Staat: MI
Alter: 75,0
Geschlecht: F
Eingang: 25.11.2022
Impfdatum: 31.05.2022
Beginn: 18.11.2022
Tage bis Beginn: 171,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

COVID vaccine breakthrough case

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: COVID positive test 11/23/22
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2514102

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

gering

Staat: MI
Alter: 86,0
Geschlecht: F
Eingang: 22.11.2022
Impfdatum: 04.06.2022
Beginn: 18.11.2022
Tage bis Beginn: 167,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

Breakthrough case admission after 4 vaccines Moderna 1/29/21 Lot# 027L20A; Moderna 2/25/21 Lot#010M20A; Moderna 11/12/21 Lot# 018F21A; Moderna 6/4/22 Lot# 037A22b

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: COVID +
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2512608

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

gering

Staat: -
Alter: -
Geschlecht: U
Eingang: 21.11.2022
Impfdatum: 21.10.2022
Beginn: 21.10.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Circumstance or information capable of leading to medication error No adverse event Wrong product administered

Symptomtext

No adverse event; possibly given the monovalent form as booster after bivalent authorization; possibly given the monovalent form as booster after bivalent authorization; This spontaneous case was reported by an other health care professional and describes the occurrence of WRONG PRODUCT ADMINISTERED (possibly given the monovalent form as booster after bivalent authorization), CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR (possibly given the monovalent form as booster after bivalent authorization) and NO ADVERSE EVENT (No adverse event) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A22B) for COVID-19 vaccination. No Medical History information was reported. On 21-Oct-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Oct-2022, the patient experienced WRONG PRODUCT ADMINISTERED (possibly given the monovalent form as booster after bivalent authorization) and CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR (possibly given the monovalent form as booster after bivalent authorization). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (possibly given the monovalent form as booster after bivalent authorization), CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR (possibly given the monovalent form as booster after bivalent authorization) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for WRONG PRODUCT ADMINISTERED (possibly given the monovalent form as booster after bivalent authorization) and CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR (possibly given the monovalent form as booster after bivalent authorization). No concomitant medications were reported. The reporter had called to ask if the lot number that was given to a patient was a bivalent or a monovalent vaccine. They state that they already called the vaccine provider and they were confused and they could not give them the information. It was reported that they already used the vial expiration checker and got the expiration date and they were wondering why if this were the bivalent vaccine it had an expiration date that was way too soon after the bivalent vaccine was authorized. No treatment medications were reported. Reporter did not allow further contact

Weitere VAERSDATA-Felder

Praegender Schweregrund: Circumstance or information capable of leading to medication error
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2512579

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

gering

Staat: NY
Alter: 31,0
Geschlecht: M
Eingang: 21.11.2022
Impfdatum: 14.11.2022
Beginn: 14.11.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

No adverse event; vaccine was administered past expiration date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (vaccine was administered past expiration date) and NO ADVERSE EVENT (No adverse event) in a 31-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 037A22B) for COVID-19 prophylaxis. No Medical History information was reported. On 14-Nov-2022, the patient received first dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 14-Nov-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (vaccine was administered past expiration date). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (vaccine was administered past expiration date) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (vaccine was administered past expiration date). Concomitant drugs were not reported. It was reported that the monovalent opened vial of 5.5 ml size was initially stored in the refrigerator on 14-Nov-2022. The vial did not underwent any temperature excursion. No additional doses, medications, or treatments were reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2511863

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

gering

Staat: NY
Alter: 31,0
Geschlecht: M
Eingang: 18.11.2022
Impfdatum: 14.11.2022
Beginn: 14.11.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Expired product administered

Symptomtext

VACCINE WAS ADMINISTERED POST ITS MANUFACTURER EXPIRATION DATE

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2508450

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

gering

Staat: MI
Alter: 90,0
Geschlecht: M
Eingang: 15.11.2022
Impfdatum: 17.06.2022
Beginn: 12.11.2022
Tage bis Beginn: 148,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

Breakthrough case admission after four vaccines Pfizer 2/26/21 Lot# En6201; Pfizer 3/19/21 Lot# EN6198; Pfizer 11/19/21 Lot# FF2593; Moderna 6/17/22 Lot# 037A22B

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: COVID +
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2508304

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

gering

Staat: MI
Alter: 53,0
Geschlecht: F
Eingang: 15.11.2022
Impfdatum: 21.07.2022
Beginn: 11.11.2022
Tage bis Beginn: 113,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

COVID vaccine breakthrough case. Moderna 1/27/21 031L20A, 2/24/21 023M20A, 11/3/21 032F21A and 7/21/22 037A22B

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: Positive COVID test on 11/11/22
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2496607

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

gering

Staat: NY
Alter: 51,0
Geschlecht: F
Eingang: 02.11.2022
Impfdatum: 27.10.2022
Beginn: 27.10.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Incorrect product formulation administered

Symptomtext

The patient received the monovalent Moderna COVID-19 Vaccine rather than the bivalent Moderna COVID-19 Vaccine. It was supplied by the inpatient pharmacy and administered by the nurse. No adverse outcome was observed.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect product formulation administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2496603

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

gering

Staat: NY
Alter: 72,0
Geschlecht: M
Eingang: 02.11.2022
Impfdatum: 27.10.2022
Beginn: 27.10.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Incorrect product formulation administered

Symptomtext

The patient received the monovalent Moderna COVID-19 Vaccine rather than the bivalent Moderna COVID-19 Vaccine. It was supplied by the inpatient pharmacy and administered by the nurse. No adverse outcome was observed.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect product formulation administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2496598

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

gering

Staat: NY
Alter: 65,0
Geschlecht: F
Eingang: 02.11.2022
Impfdatum: 27.10.2022
Beginn: 27.10.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Incorrect product formulation administered No adverse event

Symptomtext

The patient received the monovalent Moderna COVID-19 Vaccine rather than the bivalent Moderna COVID-19 Vaccine. It was supplied by the inpatient pharmacy and administered by the Employee Health nurse. No adverse outcome was observed.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect product formulation administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2496593

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

gering

Staat: NY
Alter: 66,0
Geschlecht: F
Eingang: 02.11.2022
Impfdatum: 27.10.2022
Beginn: 27.10.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Incorrect product formulation administered No adverse event

Symptomtext

The patient received the monovalent Moderna COVID-19 Vaccine rather than the bivalent Moderna COVID-19 Vaccine. It was supplied by the inpatient pharmacy and administered by the Employee Health nurse. No adverse outcome was observed.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect product formulation administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2491345

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037a22b

gering

Staat: MI
Alter: 75,0
Geschlecht: F
Eingang: 27.10.2022
Impfdatum: 23.06.2022
Beginn: 15.10.2022
Tage bis Beginn: 114,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 SARS-CoV-2 test positive

Symptomtext

positive covid test in fully vaccinated and boosteredx2 pt

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2491207

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

gering

Staat: MI
Alter: 57,0
Geschlecht: M
Eingang: 27.10.2022
Impfdatum: 23.05.2022
Beginn: 25.10.2022
Tage bis Beginn: 155,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

COVID breakthrough case

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: COVID positive test 10/24/2022
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2486862

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

gering

Staat: MI
Alter: 92,0
Geschlecht: F
Eingang: 24.10.2022
Impfdatum: 23.05.2022
Beginn: 23.10.2022
Tage bis Beginn: 153,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

COVID vaccine breakthrough case

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: COVID positive test 10/23/22
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2472614

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

gering

Staat: MI
Alter: 79,0
Geschlecht: F
Eingang: 08.10.2022
Impfdatum: 14.06.2022
Beginn: 06.10.2022
Tage bis Beginn: 114,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

Breakthrough case after four vaccines Moderna 1/26/21 Lot# 029L20A; Moderna 2/23/21 Lot# 015M20A; Moderna 12/15/21 Lot# 060H21A; Moderna 6/14/22 Lot# 037A22B

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: COVID +
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2471911

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

gering

Staat: MI
Alter: 68,0
Geschlecht: M
Eingang: 07.10.2022
Impfdatum: 27.05.2022
Beginn: 06.09.2022
Tage bis Beginn: 102,0
Dosis: 3
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 SARS-CoV-2 test positive

Symptomtext

Pt tested positive for COVID on 09/06/2022

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2465349

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

gering

Staat: MI
Alter: 68,0
Geschlecht: F
Eingang: 30.09.2022
Impfdatum: 01.06.2022
Beginn: 30.09.2022
Tage bis Beginn: 121,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

covid vaccine breakthrough case dose 1 1/29/21 026L20A Moderna dose 2 2/26/21 010A21A Moderna dose 3 11/1/21 032F Moderna

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: covid+ 9/27/22
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2440777

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

gering

Staat: MI
Alter: 69,0
Geschlecht: M
Eingang: 12.09.2022
Impfdatum: 16.06.2022
Beginn: 10.09.2022
Tage bis Beginn: 86,0
Dosis: 3
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Inappropriate schedule of product administration SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

covid vaccine breakthrough dose 1 8/14/21 Moderna 006C21A dose 2 9/10/21 Moderna 040B21A

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: covid+ 9/10/22
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2433627

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

gering

Staat: MI
Alter: 89,0
Geschlecht: M
Eingang: 08.09.2022
Impfdatum: 26.02.2021
Beginn: 27.08.2022
Tage bis Beginn: 547,0
Dosis: 3
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 Fall SARS-CoV-2 test positive

Symptomtext

08/27/22 presents to EC ED for "fall". PMHx of "advanced chronic systolic congestive heart failure, dementia, chronic kidney disease (stage unknown ), mechanical mitral valve, on anticoagulation with Coumadin"

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: 08/28/22 SARS-CoV-2 (COVID-19) by NAA detected
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2425324

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

gering

Staat: MI
Alter: 74,0
Geschlecht: M
Eingang: 31.08.2022
Impfdatum: 06.07.2022
Beginn: 30.08.2022
Tage bis Beginn: 55,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

Breakthrough case admission after 4 vaccines Moderna 1/28/21 Lot# 026L20A; Moderna 2/25/21 Lot# 031L20A; Moderna 11/19/21 Lot# 067F21A; Moderna 7/6/22 Lot# 037A22B

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: COVID +
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2388135

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

gering

Staat: MI
Alter: 74,0
Geschlecht: M
Eingang: 29.08.2022
Impfdatum: 18.07.2022
Beginn: 04.08.2022
Tage bis Beginn: 17,0
Dosis: 3
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 Inappropriate schedule of product administration SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

Breakthrough case admission after three vaccines Moderna 3/7/21 Lot# 023M20A; Moderna 4/8/21 Lot# 018B21A; Moderna 7/18/22 Lot# 037A22B

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: COVID +
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2422101

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

gering

Staat: OH
Alter: 31,0
Geschlecht: F
Eingang: 27.08.2022
Impfdatum: 21.07.2022
Beginn: 24.08.2022
Tage bis Beginn: 34,0
Dosis: 1
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Accidental underdose No adverse event

Symptomtext

No adverse event; Received half dose instead of a full dose for 2nd primary shot; This spontaneous case was reported by a physician and describes the occurrence of ACCIDENTAL UNDERDOSE (Received half dose instead of a full dose for 2nd primary shot) and NO ADVERSE EVENT (No adverse event) in a 31-year-old female patient who received mRNA-1273 (Spikevax) (batch nos. 037A22B and 037A22B) for COVID-19 vaccination. No Medical History information was reported. On 21-Jul-2022, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 24-Aug-2022, received second dose of mRNA-1273 (Spikevax) (unknown route) dosage was changed to 1 dosage form. On 24-Aug-2022, the patient experienced ACCIDENTAL UNDERDOSE (Received half dose instead of a full dose for 2nd primary shot). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, ACCIDENTAL UNDERDOSE (Received half dose instead of a full dose for 2nd primary shot) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for ACCIDENTAL UNDERDOSE (Received half dose instead of a full dose for 2nd primary shot). No concomitant medications were reported. 31-year-old patient received 2 doses of Moderna COVID-19 vaccine. The 2nd shot was given as a half dose instead of a full dose from a red cap vial of Moderna COVID-19 vaccine. No treatment medications were reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Accidental underdose
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2415605

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

gering

Staat: OH
Alter: 61,0
Geschlecht: F
Eingang: 19.08.2022
Impfdatum: 09.03.2021
Beginn: 06.08.2022
Tage bis Beginn: 515,0
Dosis: 3
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 SARS-CoV-2 test Vaccination failure

Symptomtext

CONFIRMED CLINICAL VACCINE FAILURE; CONFIRMED COVID-19 INFECTION; This spontaneous report received from other company (Pfizer) and from a patient concerned a 63 year old female. Initial information was processed along with the additional information received on 18-AUG-2022. The patient's height and weight were not reported. The patient's concurrent conditions included: asthma and drug allergy (Cholesterol Meds). The patient received covid-19 vaccine ad26.cov2.s (dose number in series 1) (suspension for injection, route of admin not reported, batch number: 1802068 and expiry: UNKNOWN) dose was not reported, dose 1, 1 total administered to the right arm on 09-MAR-2021 15:00 for covid-19 prophylaxis. Age at time of vaccination 61 years old. The patient received non-company suspect vaccine Moderna covid-19 vaccine (elasomeran) (dose number in series 2) (form of admin, route of admin, and were not reported, batch number: 017F21A and expiry: UNKNOWN) dose was not reported, administered to the right arm on 26-OCT-2021 10:00 for covid-19 prophylaxis. Age at time of vaccination 62 years old. The patient received non-company suspect vaccine included: Moderna covid-19 vaccine (elasomeran) (dose number in series 3) (form of admin, route of admin, and were not reported, batch number: 037A22B and expiry: UNKNOWN) dose was not reported, administered to the left arm on 29-MAY-2022 11:30 for covid-19 prophylaxis. Age at time of vaccination 62 years old. The patient received non-company co-suspect drug Paxlovid (form of administration, route of administration, batch number and expiry were not reported) dose was not reported, administered from 26-JUL-2022 to 30-JUL-2022 for treatment of COVID-19. The patient was not receiving any other medications/products within 2 weeks of starting COVID-19 treatment. No concomitant medications were reported. After starting treatment with Paxlovid on 26-JUL-2022, the patient's symptoms gone in a day and a half and she tested negative for covid on 30-JUL-2022, 31-JUL-2022 and 01-AUG-2022. On 06-AUG-2022, the patient started getting symptoms (coded as confirmed covid-19 infection) (dose number in series 3) which led to confirmed clinical vaccination failure (dose number in series 1). On 07-AUG-2022, the patient tested positive. As of 10-AUG-2022, the patient was still testing positive for covid. The action taken with covid-19 vaccine ad26.cov2.s was not applicable, elasomeran (Moderna Covid-19 Vaccine) was not applicable and with Paxlovid was drug discontinued. The patient was recovering from confirmed covid-19 infection, and the outcome of confirmed clinical vaccine failure was not reported. This report was serious (Other Medically Important Condition). This report was associated with a product quality complaint: 9000024698.; Sender's Comments: V0:20220834440-covid-19 vaccine ad26.cov2.s-Confirmed clinical vaccination failure. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: SPECIAL SITUATIONS. Therefore, this event(s) is considered not related.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: Test Date: 20220730; Test Name: COVID-19 TEST; Test Result: Negative ; Test Date: 20220731; Test Name: COVID-19 TEST; Test Result: Negative ; Test Date: 20220801; Test Name: COVID-19 TEST; Test Result: Negative ; Test Date: 20220807; Test Name: COVID-19 TEST; Test Result: Positive ; Test Date: 20220810; Test Name: COVID-19 TEST; Test Result: Positive
Aktuelle Erkrankungen: Asthma; Drug allergy (Cholesterol Meds)
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2413391

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

gering

Staat: MI
Alter: 73,0
Geschlecht: F
Eingang: 17.08.2022
Impfdatum: 20.07.2022
Beginn: 20.07.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 SARS-CoV-2 test positive

Symptomtext

Patient tested positive for COVID on 07/20/22

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2410727

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

gering

Staat: -
Alter: -
Geschlecht: M
Eingang: 13.08.2022
Impfdatum: 08.06.2022
Beginn: -
Tage bis Beginn: -
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Immunisation reaction

Symptomtext

Unforeseen adverse medical side effects suffered as a result of my vaccination on 06/8/22; This spontaneous case was reported by a patient and describes the occurrence of IMMUNISATION REACTION (Unforeseen adverse medical side effects suffered as a result of my vaccination on 06/8/22) in a male patient of an unknown age who received mRNA-1273 (Spikevax) (batch no. 037A22B) for COVID-19 prophylaxis. The patient's past medical history included COVID-19 in 2021. On 08-Jun-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced IMMUNISATION REACTION (Unforeseen adverse medical side effects suffered as a result of my vaccination on 06/8/22). At the time of the report, IMMUNISATION REACTION (Unforeseen adverse medical side effects suffered as a result of my vaccination on 06/8/22) had not resolved. The action taken with mRNA-1273 (Spikevax) (Unknown) was unknown. Concomitant product use was not provided by the reporter. The patient's PCP advised him to hold any further vaccinations until all medical issues had resolved. Treatment information was not provided. Reporter did not allow further contact

Weitere VAERSDATA-Felder

Praegender Schweregrund: Immunisation reaction
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: COVID-19
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2440435

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

gering

Staat: -
Alter: 60,0
Geschlecht: M
Eingang: 05.08.2022
Impfdatum: 03.06.2022
Beginn: 03.06.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Expired product administered No adverse event

Symptomtext

Narrative: Primary care nurse administered dose of COVID vaccine that had been prepared the previous day at 0700. BUD on syringe was 12 hours making it "expired" at 1900 on 6/2/2022. Dose was not turned into pharmacy properly for wasting and was administered the following morning around 1030 on 6/3/2022. No adverse effects to pt noted. Called manufacturer of vaccine for recommendation on effectiveness of dose given and whether it should be repeated. Awaiting analysis of the lot number to make clinical recommendation on repeating dose (3-5 business days for info per Moderna)

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2396542

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

gering

Staat: -
Alter: 12,0
Geschlecht: U
Eingang: 29.07.2022
Impfdatum: 26.07.2022
Beginn: 26.07.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Extra dose administered Product administered to patient of inappropriate age

Symptomtext

pt rec'd a booster dose of moderna, he should not have, pt is under 18years old.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Extra dose administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2388192

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

gering

Staat: MS
Alter: 62,0
Geschlecht: F
Eingang: 25.07.2022
Impfdatum: 22.07.2022
Beginn: 22.07.2022
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Inappropriate schedule of product administration

Symptomtext

patient received second dose in primary series 21 days after 1st dose, no adverse events noted

Weitere VAERSDATA-Felder

Praegender Schweregrund: Inappropriate schedule of product administration
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2388189

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

gering

Staat: MS
Alter: 68,0
Geschlecht: M
Eingang: 25.07.2022
Impfdatum: 22.07.2022
Beginn: 22.07.2022
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Inappropriate schedule of product administration

Symptomtext

second dose in primary series given 21 days apart, no adverse events noted

Weitere VAERSDATA-Felder

Praegender Schweregrund: Inappropriate schedule of product administration
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2387933

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037a22b

gering

Staat: MI
Alter: 75,0
Geschlecht: M
Eingang: 25.07.2022
Impfdatum: 18.07.2022
Beginn: 18.07.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

Vial was stored in refrigerator on 16-Jun-2022 and administered on 18-Jul-2022; receiving doses after its beyond use date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (receiving doses after its beyond use date) and PRODUCT STORAGE ERROR (Vial was stored in refrigerator on 16-Jun-2022 and administered on 18-Jul-2022) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037a22b) for COVID-19 prophylaxis. No Medical History information was reported. On 18-Jul-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (receiving doses after its beyond use date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vial was stored in refrigerator on 16-Jun-2022 and administered on 18-Jul-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (receiving doses after its beyond use date) and PRODUCT STORAGE ERROR (Vial was stored in refrigerator on 16-Jun-2022 and administered on 18-Jul-2022) outcome was unknown. Not Provided For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. 6 patients received dose from affected vial. No concomitant product reported by reporter. Vial did not undergone any temperature excursion issue. The vial was first put into refrigerator on 16 Jun 2022. No treatment medication reported by reporter.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2387932

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037a22b

gering

Staat: MI
Alter: 66,0
Geschlecht: F
Eingang: 25.07.2022
Impfdatum: 18.07.2022
Beginn: 18.07.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

Vial was stored in refrigerator on 16 Jun 2022 and administered on 18 Jul 2022; Vaccine administered 30 days after beyond use date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine administered 30 days after beyond use date) and PRODUCT STORAGE ERROR (Vial was stored in refrigerator on 16 Jun 2022 and administered on 18 Jul 2022) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037a22b) for COVID-19 prophylaxis. No Medical History information was reported. On 18-Jul-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine administered 30 days after beyond use date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vial was stored in refrigerator on 16 Jun 2022 and administered on 18 Jul 2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine administered 30 days after beyond use date) and PRODUCT STORAGE ERROR (Vial was stored in refrigerator on 16 Jun 2022 and administered on 18 Jul 2022) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medication was reported by reporter. Patient had received second booster on 18 Jul 2022. Number of doses and vials were reported as 6 doses from the same vial 3. The vials were stored in refrigerator on 16 Jun 2022. The vial did not undergo any temperature excursions. No treatment medication was reported by reporter.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2387931

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037a22b

gering

Staat: MI
Alter: 74,0
Geschlecht: M
Eingang: 25.07.2022
Impfdatum: 18.07.2022
Beginn: 18.07.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

Vial was stored in refrigerator on 16-Jun-2022 and administered on 18-Jul-2022; receiving doses after its beyond use date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (receiving doses after its beyond use date) and PRODUCT STORAGE ERROR (Vial was stored in refrigerator on 16-Jun-2022 and administered on 18-Jul-2022) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037a22b) for COVID-19 prophylaxis. No Medical History information was reported. On 18-Jul-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (receiving doses after its beyond use date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vial was stored in refrigerator on 16-Jun-2022 and administered on 18-Jul-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (receiving doses after its beyond use date) and PRODUCT STORAGE ERROR (Vial was stored in refrigerator on 16-Jun-2022 and administered on 18-Jul-2022) outcome was unknown. Not Provided For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medication was reported. The patient was administered with second booster dose. Number of doses/vials were 6 doses from the same vial. On 16-Jun-2022, the vial was initially stored in the refrigerator and the patient received dose from the same vial lot. The vial did not undergo any temperature excursions. No treatment information was provided.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2387930

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037a22b

gering

Staat: MI
Alter: 54,0
Geschlecht: F
Eingang: 25.07.2022
Impfdatum: 18.07.2022
Beginn: 18.07.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

Vial was stored in refrigerator on 16-Jun-2022 and administered on 18-Jul-2022; Vaccine administered 30 days after beyond use date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine administered 30 days after beyond use date) and PRODUCT STORAGE ERROR (Vial was stored in refrigerator on 16-Jun-2022 and administered on 18-Jul-2022) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037a22b) for COVID-19 prophylaxis. No Medical History information was reported. On 18-Jul-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine administered 30 days after beyond use date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vial was stored in refrigerator on 16-Jun-2022 and administered on 18-Jul-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine administered 30 days after beyond use date) and PRODUCT STORAGE ERROR (Vial was stored in refrigerator on 16-Jun-2022 and administered on 18-Jul-2022) outcome was unknown. Not Provided For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medication was reported by reporter. Patient had received second booster on 18-Jul-2022. Number of doses and vials were reported as 6 doses from the same vial 3. The vials were stored in refrigerator on 16-Jun-2022. The vial did not undergo any temperature excursions. No treatment medication was reported by reporter. Vaccine administered 30 days after beyond use date. Vial was stored in refrigerator on 16-Jun-2022 and administered on 18-Jul-2022

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2387925

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037a22b

gering

Staat: MI
Alter: 66,0
Geschlecht: F
Eingang: 25.07.2022
Impfdatum: 18.07.2022
Beginn: 18.07.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

viability of a vaccine given past the 30 days beyond use date, first put in the fridge in Jun 16 2022 & Date of administration Jul 18 2022; receiving doses after its beyond use date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (receiving doses after its beyond use date) and PRODUCT STORAGE ERROR (viability of a vaccine given past the 30 days beyond use date, first put in the fridge in Jun 16 2022 & Date of administration Jul 18 2022) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037a22b) for COVID-19 prophylaxis. No Medical History information was reported. On 18-Jul-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (receiving doses after its beyond use date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (viability of a vaccine given past the 30 days beyond use date, first put in the fridge in Jun 16 2022 & Date of administration Jul 18 2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (receiving doses after its beyond use date) and PRODUCT STORAGE ERROR (viability of a vaccine given past the 30 days beyond use date, first put in the fridge in Jun 16 2022 & Date of administration Jul 18 2022) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. Patient received 2nd booster dosage. Patient received dose from the same vial lot and number of doses/vials were 6 doses from the same vial. Vial was initially stored in the refrigerator on 16-Jun-2022 and vial did not undergo any temperature excursions. No treatment medications were reported. Most recent FOLLOW-UP information incorporated above includes: On 21-Jul-2022: Follow-up has Significant information in which case report type was turned from invalid to valid. Patient detail, suspect product name, new event, Vaccine information (Dose Description) and Supplement were updated.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2387102

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037a22b

gering

Staat: MI
Alter: 73,0
Geschlecht: F
Eingang: 24.07.2022
Impfdatum: 18.07.2022
Beginn: 18.07.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

Vial was stored in refrigerator on 16-Jun-2022 and administered on 18-Jul-2022; Vaccine administered 30 days after beyond use date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine administered 30 days after beyond use date) and PRODUCT STORAGE ERROR (Vial was stored in refrigerator on 16-Jun-2022 and administered on 18-Jul-2022) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037a22b) for COVID-19 prophylaxis. No Medical History information was reported. On 18-Jul-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine administered 30 days after beyond use date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vial was stored in refrigerator on 16-Jun-2022 and administered on 18-Jul-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine administered 30 days after beyond use date) and PRODUCT STORAGE ERROR (Vial was stored in refrigerator on 16-Jun-2022 and administered on 18-Jul-2022) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medication was reported by reporter. Patient had received second booster on 18 Jul 2022. Number of doses and vials were reported as 6 doses from the same vial 3. The vials were stored in refrigerator on 16 Jun 2022. The vial did not undergo any temperature excursions. No treatment medication was reported by reporter.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2387101

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037a22b

gering

Staat: MI
Alter: 28,0
Geschlecht: F
Eingang: 24.07.2022
Impfdatum: 18.07.2022
Beginn: 18.07.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

Vial was stored in refrigerator on 16-Jun-2022 and administered on 18-Jul-2022; Vaccine administered 30 days after beyond use date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine administered 30 days after beyond use date) and PRODUCT STORAGE ERROR (Vial was stored in refrigerator on 16-Jun-2022 and administered on 18-Jul-2022) in a 28-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037a22b) for COVID-19 prophylaxis. No Medical History information was reported. On 18-Jul-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine administered 30 days after beyond use date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vial was stored in refrigerator on 16-Jun-2022 and administered on 18-Jul-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine administered 30 days after beyond use date) and PRODUCT STORAGE ERROR (Vial was stored in refrigerator on 16-Jun-2022 and administered on 18-Jul-2022) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medication was reported by reporter. Patient had received second booster on 18-Jul-2022. Number of doses and vials were reported as 6 doses from the same vial 3. The vials were stored in refrigerator on 16-Jun-2022. The vial did not undergo any temperature excursions. No treatment medication was reported by reporter.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2370123

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

gering

Staat: AZ
Alter: 1,3
Geschlecht: M
Eingang: 15.07.2022
Impfdatum: 11.07.2022
Beginn: 11.07.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Product use issue

Symptomtext

Patient was given injection from the presentation of the vaccine with a red cap and light blue label border; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT USE ISSUE (Patient was given injection from the presentation of the vaccine with a red cap and light blue label border) in a 15-month-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A22B) for COVID-19 prophylaxis. No Medical History information was reported. On 11-Jul-2022, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milliliter. On 11-Jul-2022, the patient experienced PRODUCT USE ISSUE (Patient was given injection from the presentation of the vaccine with a red cap and light blue label border). At the time of the report, PRODUCT USE ISSUE (Patient was given injection from the presentation of the vaccine with a red cap and light blue label border) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. It was reported that the patient did not experience any symptoms. No additional doses, concomitant medications, or treatment medications had been administered.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product use issue
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2370114

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

gering

Staat: AZ
Alter: 2,0
Geschlecht: F
Eingang: 15.07.2022
Impfdatum: 11.07.2022
Beginn: 11.07.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Product use issue

Symptomtext

From the 18 and up vials; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT USE ISSUE (From the 18 and up vials) in a 2-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 037A22B) for COVID-19 prophylaxis. No Medical History information was reported. On 11-Jul-2022, the patient received first dose of mRNA-1273 (Spikevax) (Intramuscular) .25 milligram. On 11-Jul-2022, the patient experienced PRODUCT USE ISSUE (From the 18 and up vials). At the time of the report, PRODUCT USE ISSUE (From the 18 and up vials) outcome was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter did not provide any causality assessments. No concomitant medications were provided by the reporter. The vaccine was given from the vial with a red cap and light blue label border No treatment information was provided by the reporter.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product use issue
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2364128

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037a22b

gering

Staat: NJ
Alter: 60,0
Geschlecht: F
Eingang: 10.07.2022
Impfdatum: 07.07.2022
Beginn: 07.07.2022
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Dysphonia

Symptomtext

Systemic: voice changed-Medium, Additional Details: About 1 hour after vaccine administration, patient reports that her voice has changed, it is higher pitched. She says she has no difficulty breathing. No tightness of throat or chest. No swelling. Patient dose have an epipen on hand.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dysphonia
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2362547

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

gering

Staat: FL
Alter: 56,0
Geschlecht: M
Eingang: 08.07.2022
Impfdatum: 29.06.2022
Beginn: 29.06.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Expired product administered

Symptomtext

Received expired 3rd dose of Moderna vaccine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: none
Allergien: nkda
Vorherige Impfungen: -

VAERS 2362544

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

gering

Staat: FL
Alter: 55,0
Geschlecht: F
Eingang: 08.07.2022
Impfdatum: 29.06.2022
Beginn: 29.06.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Expired product administered

Symptomtext

Patient received an expired 3rd dose of the moderna covid vaccine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: diabetes, pain, depression
Vorgeschichte: diabetes
Andere Medikamente: ztlido, humulin, meloxicam, oxycodone, duloxetine, aripiprazole, trulicity, alprazolam
Allergien: nkda
Vorherige Impfungen: -

VAERS 2361155

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

gering

Staat: IL
Alter: 0,5
Geschlecht: M
Eingang: 07.07.2022
Impfdatum: 07.07.2022
Beginn: 07.07.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LL

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Incorrect dose administered

Symptomtext

Patient was given dosage of 0.25 ml. of the adult Moderna Vaccine. Patient is 6 months old at this time. He presented with no symptoms for the initial 15 minutes after having the vaccine. Primary care provider for patient was notified of medication error. Mother of patient also contacted and informed of medication error in which adult dose of Moderna was given to the infant.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect dose administered
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None known
Allergien: No known allergies
Vorherige Impfungen: -

VAERS 2361141

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037a22b

gering

Staat: FL
Alter: 69,0
Geschlecht: M
Eingang: 07.07.2022
Impfdatum: 30.06.2022
Beginn: 30.06.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Expired product administered Extra dose administered No adverse event

Symptomtext

Received expired 4th dose, no adverse event happened.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: none at this time
Vorgeschichte: none at this time
Andere Medikamente: none at this time.
Allergien: nkda
Vorherige Impfungen: -

VAERS 2361125

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

gering

Staat: FL
Alter: 58,0
Geschlecht: F
Eingang: 07.07.2022
Impfdatum: 30.06.2022
Beginn: 30.06.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Expired product administered Extra dose administered No adverse event

Symptomtext

4 dose was given, but realized afterwards that the vaccine was past its expiration date. Patient did not experience any adverse effects.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: no
Vorgeschichte: Depression, pain, high cholesterol, psychotic episodes, migraines
Andere Medikamente: clonazepam, sertraline, lamotrigine, olanzapine, sumatriptin, phenobarbital, hydromorphone, methadone, promethazine, diclofenac, atorvastatin, fenofibrate, amitriptylline
Allergien: nkda
Vorherige Impfungen: -

VAERS 2361015

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

gering

Staat: OH
Alter: 17,0
Geschlecht: M
Eingang: 07.07.2022
Impfdatum: 31.05.2022
Beginn: 31.05.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

No adverse event Product administered to patient of inappropriate age

Symptomtext

-Patient was schedule for and received Moderna primary dose vaccine; although he was not yet eligible (EUA date 06/27 for 17 years of age). No side effects or adverse events occurred as a result, and he received the second dose in the series to complete primary series on 07/07/2022.

Weitere VAERSDATA-Felder

Praegender Schweregrund: No adverse event
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: NA
Vorgeschichte: NA
Andere Medikamente: NA
Allergien: NA
Vorherige Impfungen: -

VAERS 2360971

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

gering

Staat: SC
Alter: 60,0
Geschlecht: M
Eingang: 07.07.2022
Impfdatum: 09.06.2022
Beginn: 09.06.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Inappropriate schedule of product administration

Symptomtext

Booster dose was given before the recommended interval.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Inappropriate schedule of product administration
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2347432

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

gering

Staat: -
Alter: 57,0
Geschlecht: M
Eingang: 01.07.2022
Impfdatum: 28.06.2022
Beginn: 28.06.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

No adverse event

Symptomtext

Patient was given the 22nd dose pulled from the vial. No adverse reaction was noted

Weitere VAERSDATA-Felder

Praegender Schweregrund: No adverse event
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2347425

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

gering

Staat: -
Alter: 66,0
Geschlecht: F
Eingang: 01.07.2022
Impfdatum: 28.06.2022
Beginn: 28.06.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Product preparation issue

Symptomtext

Dose given was the 21st dose taken from the vial. No adverse effect has been noted.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product preparation issue
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2341486

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

gering

Staat: VA
Alter: 36,0
Geschlecht: F
Eingang: 29.06.2022
Impfdatum: 25.06.2022
Beginn: 25.06.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Inappropriate schedule of product administration

Symptomtext

Error: Dose in Series Given Too Early-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Inappropriate schedule of product administration
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2335778

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

gering

Staat: MI
Alter: 93,0
Geschlecht: F
Eingang: 27.06.2022
Impfdatum: 17.06.2022
Beginn: 27.06.2022
Tage bis Beginn: 10,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

COVID BREAKTHROUGH CASE

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: COVID+ 6/27/22
Aktuelle Erkrankungen: -
Vorgeschichte: Fracture of right femur following insertion of orthopedic implant Type 2 diabetes mellitus with hyperglycemia
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2335385

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

gering

Staat: NC
Alter: 49,0
Geschlecht: F
Eingang: 26.06.2022
Impfdatum: 15.06.2022
Beginn: 15.06.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Inappropriate schedule of product administration

Symptomtext

Error: Dose in Series Given Too Early.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Inappropriate schedule of product administration
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2335028

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

gering

Staat: MD
Alter: 29,0
Geschlecht: M
Eingang: 25.06.2022
Impfdatum: 02.06.2022
Beginn: 21.06.2022
Tage bis Beginn: 19,0
Dosis: 1
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Inappropriate schedule of product administration

Symptomtext

Patient received their second dose too soon; This spontaneous case was reported by a nurse and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient received their second dose too soon) in a 29-year-old male patient who received mRNA-1273 (Spikevax) (batch nos. 037A22B and 037A22B) for COVID-19 prophylaxis. No Medical History information was reported. On 02-Jun-2022, the patient received first dose of mRNA-1273 (Spikevax) (Intramuscular) .5 milliliter. On 21-Jun-2022, received second dose of mRNA-1273 (Spikevax) (unknown route) dosage was changed to .5 milliliter. On 21-Jun-2022, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient received their second dose too soon). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient received their second dose too soon) outcome was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter did not provide any causality assessments. No relevant concomitant medications were reported. Treatment medication was not provided by the reporter.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Inappropriate schedule of product administration
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2331423

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

gering

Staat: NC
Alter: 60,0
Geschlecht: M
Eingang: 24.06.2022
Impfdatum: 22.06.2022
Beginn: 22.06.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Inappropriate schedule of product administration

Symptomtext

pt. vaccinated at soup kitchen outreach. Vaccine provided based on records. pt. presented without vaccine card. most recent vaccine data was not updated in either. booster dose given too close to previous booster dose. recommended interval was not met. pt. was vaccinated 2 days apart.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Inappropriate schedule of product administration
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: None indicated.
Vorgeschichte: None indicated.
Andere Medikamente: None indicated.
Allergien: None indicated.
Vorherige Impfungen: -

VAERS 2327187

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

gering

Staat: MD
Alter: 29,0
Geschlecht: M
Eingang: 22.06.2022
Impfdatum: 21.06.2022
Beginn: 21.06.2022
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Inappropriate schedule of product administration

Symptomtext

Patient received 2nd dose of primary series too soon. First dose of primary series with Moderna COVID-19 vaccine on 6/2/22, and second dose of Moderna COVID-19 vaccine received on 6/21/22.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Inappropriate schedule of product administration
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2324248

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

gering

Staat: AR
Alter: 74,0
Geschlecht: F
Eingang: 20.06.2022
Impfdatum: 15.06.2022
Beginn: 15.06.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Incorrect dose administered

Symptomtext

Administered Moderna 0.5 mg IM Left Deltoid for 2nd Booster in err.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect dose administered
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: Psoriasis, Ulcerative Colitis
Vorgeschichte: Psoriasis, Ulcerative Colitis
Andere Medikamente: Skyrizi, Plavix
Allergien: Lactose Intolerance
Vorherige Impfungen: -

VAERS 2323292

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

gering

Staat: LA
Alter: 21,0
Geschlecht: F
Eingang: 17.06.2022
Impfdatum: 09.06.2022
Beginn: 09.06.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Asthenia Flushing Hyperhidrosis Lethargy Pallor

Symptomtext

5 MINUTES AFTER RECEIVING HER FIRST DOSE IN THE MODERNA SERIES - PATIENT STATES THAT SHE SUDDENLY FELT VERY WEAK /LETHARGIC, BECAME BOTH PALE AND FLUSHED AND VERY DIAPHORETIC. SHE WENT TO THE LOCAL ER. VITALS WERE TAKEN. NO IV FLUIDS OR MEDICATIONS WERE GIVEN. NO DIAGNOSTICS TESTS WERE PERFORMED. AFTER MONITORING, SHE WAS DISCHARGED HOME.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Asthenia
Hospital-Tage: -
Labordaten: NONE
Aktuelle Erkrankungen: NONE
Vorgeschichte: NONE
Andere Medikamente: LEXAPRO
Allergien: NKDA
Vorherige Impfungen: -

VAERS 2322761

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

gering

Staat: MS
Alter: 15,0
Geschlecht: M
Eingang: 17.06.2022
Impfdatum: 23.05.2022
Beginn: 23.05.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Product administered to patient of inappropriate age

Symptomtext

Booster dose administered to a 15 year old patient; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Booster dose administered to a 15 year old patient) in a 15-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A22B) for COVID-19 prophylaxis. Previously administered products included for COVID-19 vaccination: Pfizer shot (1st dose, with intramuscular route and Lot number was EWO151 with expiration date of 23-Jul-2021.) on 21-May-2021; for Product used for unknown indication: Pfizer shot (2nd dose and Lot number was EWO151 with expiration date of 23-Jul-2021.) on 14-Jun-2021. Past adverse reactions to the above products included No adverse event with Pfizer shot and Pfizer shot. On 23-May-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-May-2022, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Booster dose administered to a 15 year old patient). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Booster dose administered to a 15 year old patient) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Patient's date of birth was reported as March 2007. No concomitant medications information was reported. No treatment was given, as no AEs were reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product administered to patient of inappropriate age
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2320539

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

gering

Staat: MA
Alter: 54,0
Geschlecht: F
Eingang: 15.06.2022
Impfdatum: 08.06.2022
Beginn: 08.06.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Feeling abnormal Irritability

Symptomtext

Patient states she was experiencing slight mental fogginess for Wednesday 6/8/22 and Thursday 6/9/22 which has since cleared. She stated she is normally a very calm person but since the vaccine she gets very upset at the slightest provication. She stated that she has had nothing different in activity, food or medication that would contribute to either event.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Feeling abnormal
Hospital-Tage: -
Labordaten: non reported.
Aktuelle Erkrankungen: none
Vorgeschichte: unknown
Andere Medikamente: unknown
Allergien: NKA
Vorherige Impfungen: -

VAERS 2320354

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

gering

Staat: NY
Alter: 58,0
Geschlecht: M
Eingang: 15.06.2022
Impfdatum: 15.06.2022
Beginn: 15.06.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Incorrect dose administered No adverse event

Symptomtext

No adverse events. Instead of 0.25ml, patient received 0.5ml

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect dose administered
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: - Other allergic rhinitis - Dermatitis - Nail dystrophy - Tinnitus bilateral - Hyperlipidemia - Obesity - Hypertriglyceridemia - Vitamin D deficiency - Erectil dysfunction - Impaired fasting glucose - Kidney stones
Vorgeschichte: - Obesity - Kidney stones - Hyperlipidemia
Andere Medikamente: Omega 3 , atorvastatin, ergocalciferol, metformin
Allergien: N.k.d.a
Vorherige Impfungen: -

VAERS 2318571

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

gering

Staat: NJ
Alter: 62,0
Geschlecht: M
Eingang: 14.06.2022
Impfdatum: 09.06.2022
Beginn: 09.06.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Error: Expired Product Administered-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2318570

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

gering

Staat: NJ
Alter: 42,0
Geschlecht: F
Eingang: 14.06.2022
Impfdatum: 09.06.2022
Beginn: 09.06.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Error: Expired Product Administered-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2317227

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

gering

Staat: MI
Alter: 89,0
Geschlecht: F
Eingang: 13.06.2022
Impfdatum: 09.06.2022
Beginn: 11.06.2022
Tage bis Beginn: 2,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19

Symptomtext

covid

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2315262

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037a22b

gering

Staat: PA
Alter: 62,0
Geschlecht: F
Eingang: 10.06.2022
Impfdatum: 30.05.2022
Beginn: 02.06.2022
Tage bis Beginn: 3,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Taste disorder

Symptomtext

Systemic: pt report changes in taste 3 days after the vaccination-Mild

Weitere VAERSDATA-Felder

Praegender Schweregrund: Taste disorder
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2315261

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037a22b

gering

Staat: PA
Alter: 75,0
Geschlecht: M
Eingang: 10.06.2022
Impfdatum: 30.05.2022
Beginn: 02.06.2022
Tage bis Beginn: 3,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Taste disorder

Symptomtext

Systemic: experienced changes in taste-Mild

Weitere VAERSDATA-Felder

Praegender Schweregrund: Taste disorder
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2314269

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037a22b

gering

Staat: VA
Alter: 52,0
Geschlecht: M
Eingang: 09.06.2022
Impfdatum: 25.05.2022
Beginn: 04.06.2022
Tage bis Beginn: 10,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

COVID-19 Cough SARS-CoV-2 test positive

Symptomtext

Covid 19 Cough Paxlovid Tessalon pearls Albuterol Still coughing.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: Rapid antigen test, June 5 2022
Aktuelle Erkrankungen: None
Vorgeschichte: Stage 3 colon cancer
Andere Medikamente: Vitamin D, Imodium, align
Allergien: Penicillins
Vorherige Impfungen: -

VAERS 2314128

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

gering

Staat: IA
Alter: 12,0
Geschlecht: M
Eingang: 09.06.2022
Impfdatum: 08.06.2022
Beginn: 08.06.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RL

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Wrong product administered

Symptomtext

12 year old client was administered the Moderna Vaccine in error. No adverse reactions noted after the vaccine was administered. His mother did not report any adverse reactions as well. Encouraged to monitor for an adverse reactions such as breathing pattern, dyspnea, stomach discomfort,

Weitere VAERSDATA-Felder

Praegender Schweregrund: Wrong product administered
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: Mom said pt has been healthy and has not had any other illnesses other than his chronic condition.
Vorgeschichte: pt was born with a brain stem birth defect. pt requires 24 hour care.
Andere Medikamente: No medications taken at the time of his vaccination.
Allergien: Mom stated that pt has not had any severe reactions to a medication or a vaccine.
Vorherige Impfungen: -

VAERS 2312781

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

gering

Staat: OR
Alter: 67,0
Geschlecht: F
Eingang: 08.06.2022
Impfdatum: 01.06.2022
Beginn: 01.06.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Dose administered to patient after morethan 24 hours of vial puncture; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered to patient after morethan 24 hours of vial puncture) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A22B) for COVID-19 vaccination. No Medical History information was reported. On 01-Jun-2022 at 1:45 AM, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Jun-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered to patient after morethan 24 hours of vial puncture). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered to patient after morethan 24 hours of vial puncture) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Concomitant product use was not provided by the reporter. On 19-MAY-2022, the vial was initially stored in refrigerator and on 31-MAY-2022 at 8.55 AM the vial was initially punctured. On 01-JUN-2022 at 1:45 PM, vaccine was administered to patient and vial was stored in fridge post puncture and vial didn't undergo any temperature excursions. Patient received second booster dose of Moderna COVID-19 Vaccine and patient has not reported any adverse reactions to expired dose. Treatment information was not provided.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2312780

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

gering

Staat: MI
Alter: 60,0
Geschlecht: M
Eingang: 08.06.2022
Impfdatum: 03.06.2022
Beginn: 03.06.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

vial was exposed to room temperature range for 27.5 hours; administration of vaccine from prefilled syringe drawn for more than 12 hours; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (administration of vaccine from prefilled syringe drawn for more than 12 hours) and PRODUCT STORAGE ERROR (vial was exposed to room temperature range for 27.5 hours) in a 60-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 037A22B) for COVID-19 vaccination. No Medical History information was reported. On 03-Jun-2022 at 10:30 AM, the patient received first dose of mRNA-1273 (Spikevax) (Intramuscular) .5 milliliter. On 03-Jun-2022 at 10:30 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (administration of vaccine from prefilled syringe drawn for more than 12 hours). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (vial was exposed to room temperature range for 27.5 hours). At the time of the report, EXPIRED PRODUCT ADMINISTERED (administration of vaccine from prefilled syringe drawn for more than 12 hours) and PRODUCT STORAGE ERROR (vial was exposed to room temperature range for 27.5 hours) outcome was unknown. The action taken with mRNA-1273 (Spikevax) (Intramuscular) was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter did not provide any causality assessments. No concomitant medication information was provided. It was reported that the patient was administered with an expired vaccine in a prefilled syringe drawn at 7:00am on 02-Jun-2022 was given to patient 03-Jun-2022 at 10:30am. This would have been the patient's first dose. The total amount of time the vial was exposed to room temperature range (8 to 25 degree C= 46 to 77 degree F) was 27.5 hours. The vial did not undergo any temperature excursions. No treatment medication was provided.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2308737

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

gering

Staat: OR
Alter: 67,0
Geschlecht: F
Eingang: 03.06.2022
Impfdatum: 01.06.2022
Beginn: 01.06.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Expired product administered Product storage error

Symptomtext

Moderna vaccine expired by 18 hours (vaccine had been open 30 hours)

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: None
Vorgeschichte: Diabetels Mellitus type 2
Andere Medikamente: Metformin, calcium
Allergien: None
Vorherige Impfungen: -

VAERS 2303114

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

gering

Staat: NV
Alter: 74,0
Geschlecht: F
Eingang: 31.05.2022
Impfdatum: 23.05.2022
Beginn: 24.05.2022
Tage bis Beginn: 1,0
Dosis: 4
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Dysgeusia Fall Feeding disorder

Symptomtext

I ate a saltine cracker & the taste blew me away. It tasted so salty. I could taste salt again.; It knocked me flat; I couldn't eat; This spontaneous case was reported by a patient and describes the occurrence of FALL (It knocked me flat), FEEDING DISORDER (I couldn't eat) and DYSGEUSIA (I ate a saltine cracker & the taste blew me away. It tasted so salty. I could taste salt again.) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A22B) for COVID-19 vaccination. Concurrent medical conditions included Environmental allergy. On 23-May-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-May-2022, the patient experienced FALL (It knocked me flat) and FEEDING DISORDER (I couldn't eat). On 25-May-2022, the patient experienced DYSGEUSIA (I ate a saltine cracker & the taste blew me away. It tasted so salty. I could taste salt again.). At the time of the report, FALL (It knocked me flat) and FEEDING DISORDER (I couldn't eat) had resolved and DYSGEUSIA (I ate a saltine cracker & the taste blew me away. It tasted so salty. I could taste salt again.) was resolving. Other relevant medical history information included patient received the shingles shot on 23-MAY-2022. No concomitant medications were reported. No treatment information was provided. This case was linked to MOD-2022-577824 (Patient Link).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dysgeusia
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Environmental allergy
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2298761

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

gering

Staat: NY
Alter: 24,0
Geschlecht: F
Eingang: 27.05.2022
Impfdatum: 27.05.2022
Beginn: 27.05.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Extra dose administered

Symptomtext

Administered full dose 0.5ml to a patient who was immunocompetent.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Extra dose administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2298539

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037a22b

gering

Staat: MO
Alter: 29,0
Geschlecht: M
Eingang: 27.05.2022
Impfdatum: 23.05.2022
Beginn: 23.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Product administered to patient of inappropriate age

Symptomtext

Error: Wrong Age for Vaccine Given-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product administered to patient of inappropriate age
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2294465

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

gering

Staat: KY
Alter: 50,0
Geschlecht: F
Eingang: 25.05.2022
Impfdatum: 25.05.2022
Beginn: 25.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

No adverse event Product storage error

Symptomtext

COVID vaccine was administered 26 hours after multidose vial had been punctured. Vaccine was stored in temperature controlled vaccine unit. Patient showed no signs of adverse effects after vaccine was administered.

Weitere VAERSDATA-Felder

Praegender Schweregrund: No adverse event
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: No
Vorgeschichte: Diabetes, Obesity
Andere Medikamente: Lantus, Humalog, Lipitor, Janumet
Allergien: NKDA
Vorherige Impfungen: -

VAERS 2294414

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 037A22B

gering

Staat: MI
Alter: 65,0
Geschlecht: M
Eingang: 25.05.2022
Impfdatum: 25.05.2022
Beginn: 25.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Inappropriate schedule of product administration No adverse event

Symptomtext

Pt was given 2nd booster dose too early. 1st booster was given 3/4/22. 2nd booster 5/25/22. Pt experienced no adverse effects.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Inappropriate schedule of product administration
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -